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Nizar Hamed E. Saeedi 
A Proteomics Approach to Investigate Uropathogenic Escherichia coli 
Uropathogenic Escherichia coli (UPEC) is the most commonly known cause of 
urinary tract infection (UTI). The possession of many virulence factors and 
global dissemination of multi-drug resistant UPEC strains is posing a critical risk 
to treatment worldwide. The most virulent UPEC strains have descended from 
major lineages such as sequence type (ST) 131, ST38 and ST127. Strains of 
ST127 exhibit the highest virulence potential of most UPEC lineages, but little is 
known about their pathogenicity. Previous studies have reported the important 
role of metabolic adaptations in UPEC virulence. This study investigated the 
metabolic adaptations of UPEC isolates, with a focus on ST127, using a 
quantitative proteomics approach. 
We employed a classical shotgun proteomics approach to analyse proteins 
extracted from multiple strains of UPEC following growth in various 
environments (Lysogeny broth, artificial urine medium and co-culture with 
uroepithelial cells). The digested proteins and peptides from all fractions were 
separated on a Dionex Ultimate 3000 RSLC nano flow system and analysed in 
an Orbitrap Velos Pro FTMS. Data were processed using Perseus software. 
Expression and Gene Ontology Enrichment analysis revealed different 
proteomic profiles of UPEC ST127 strains cultured in LB and AUM. This study 
showed that environmental changes have an effect on the metabolic pathways 
expressed by a specific strain. These conditions can be engineered to simulate 
the variety of environments UPEC isolates may need to survive in. This 
methodology was then employed to enhance our understanding of the 
pathogenesis of UPEC. 
Building on previous work with UPEC paired isolates (urine and blood), 
proteomics analysis revealed that members of some STs have a higher 
metabolic potential that could provide virulence advantages. The study also 
revealed minimal proteomic variations among the paired isolates for some STs. 
The methods were then applied during co-culture experiments with UPEC and 
HT1197 bladder epithelial cells. UPEC strain SA189 caused exfoliation effects 
in HT1197 not seen with other UPEC strains. Analysis of the UPEC SA189 
secretome revealed highly abundant bacterial proteins, including hemolysin A. 
Proteomic analysis is helping to understand the pathogenic potential of UPEC 
and may facilitate identification of novel diagnostic or therapeutic targets to 
reduce UTI and potential subsequent bacteraemia. 
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1.1 Escherichia coli: the microorganism 
Escherichia coli is currently one of the most well characterized bacteria. A 
vast number of studies have been conducted to characterise this microorganism 
following episodes of infection outbreaks that have placed it as one of the major 
causes of increasing human mortality, given its burden on the health care 
system (DuPont et al., 1971; Russo & Johnson, 2003; Staley et al., 1972). 
However, for most of the last half century, E. coli was considered to be just 
a part of the normal flora of the mammalian intestine (including that of humans) 
and exhibiting low levels of pathogenicity (Ferguson & June, 1952). E. coli was 
named in 1885 after it’s discoverer Dr. Theodor Escherich, a German 
paediatrician (Shulman et al., 2007), who made his initial description of the 
microorganism and named it Bacterium coli commune, which was reprinted in 
English in 1989 (Escherich, 1989). Over a decade later in 1897, Kiyoshi, a 
Japanese scientist, discovered another bacterium named Bacillus dysentericus 
(Shigella dysenteriae), which has been shown to be closely related to E. coli 
(Trofa et al., 1999). Later on, the names of Escherichia and Shigella were 
assigned to these two organisms, respectively, following their motility, metabolic 
profiles and distinguishing clinical symptoms (Castellani & Chalmers, 1919).  
Nowadays, E. coli is considered to be a global pathogen that is frequently 
causing bacterial infections in humans. Four main types of infections can be 
linked to E. coli based on the clinical symptoms and the virulence factors that 
mediate them. These infections are: urinary tract infections (UTI); bacteraemia 
(bacterial blood stream infection); neonatal meningitis; and gastroenteritis 
(Katouli, 2010; Nataro & Kaper, 1998; Weintraub, 2007). 
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The emergence of antibiotic resistant E. coli strains presents a significant 
global health concern. The two main issues of reduced susceptibility toward 
antibiotics and the limited understanding of virulence mechanisms have to be 
addressed to contain the threat of this pathogen.  
Moreover, different environments can place different challenges that the 
pathogens have to overcome. These situations result in the bacteria utilising 
different virulence factors, of which many are carried on plasmids, to establish 
infections. For instance, E. coli evolution is mainly centred around the 
recombination process (Petty et al., 2014), as antimicrobial resistance genes 
can be widely acquired on plasmids and other mobile elements via horizontal 
genes transfer (Diard et al., 2007). In addition, some diseases are caused by 
multi antibiotic resistance pathogens, which possess the ability for genetic 
exchange (Petty et al., 2014; Rogers et al., 2011). In the last decade or so, 
reported cases regarding outbreaks of antibiotic resistant E. coli strains have 
increased worldwide (Croxall et al., 2011; Lavollay et al., 2006).  
Therefore, it essential to have a deeper understanding of E. coli virulence 
and transmission mechanisms, and this extends to the metabolic activity 
employed by bacteria to survive and establish various infections (Hussain et al., 







1.1.1 General and cultural features 
E. coli bacterium is a Gram-negative bacillus that grows in facultative-
anaerobe conditions, so has the ability to undergo fermentation. It belongs to 
Enterobacteriaceae family. E. coli is a motile, non sporing and versatile 
organism that can grow naturally in a wide variety of environments. E. coli can 
grow optimally between 7°C and 50°C and exhibits acid tolerance down to pH 
4.4. It can be cultured in the laboratory using simple culture media when 
incubated aerobically or anaerobically at 37°C (Salyers & Whitt, 2002). E. coli 
uses these durability characteristics to survive in numerous conditions including 
water, soil and on surfaces; and to establish its presence in different forms as a 
commensal strain or as a pathogen in humans or animals (van Elsas et al., 
2011).  
The morphological structure of E. coli on solid medium is observed in 
formation of non-pigmented colonies with ‘rough’ or ‘smooth’ forms. The rough 
colony form can be described as flat and irregular in shape, while the smooth 
colonies are raised and circular in shape (Hasman et al., 2000). 
E. coli cell structure (Figure 1.1) consists mainly of the cell wall made of 
protein and carbohydrates, which prevent the cell from lysing; a plasma 
membrane, made of lipids and proteins with a key function of controlling the 
movement of molecules in and out of the cell; ribosomes for protein production; 
fimbriae and flagella for the capability of adherence and motility, respectively; 
and a nucleoid, a membrane-less structure, which contains DNA (Bayer & 




Figure 1.1: Generalised structure of a Gram-negative rod shaped bacterium. 
The figure shows the main components of E. coli which include: the outer 
membrane, cell wall, periplasmic space, plasma membrane, cytosol, flagella, 
pili, ribosomes and DNA. Created with BioRender (www.biorender.com).  
 
1.1.2 Serological types of Escherichia coli 
Some key features of the outer membrane in E. coli are the components 
that are the focus of serotyping methods. Serotyping is an effective 
epidemiological tool has been used to differentiate lineages and population 
composition in numerous bacterial species. E. coli strains can be serologically 
classified based on three criteria: the O antigens (lipopolysaccharide); the K 
antigens (capsule); and the H antigens (flagella). Kauffmann initially introduced 
this classification scheme (Kauffmann, 1964) to be later developed to include 
antibodies for detection of 173 O antigens, 80 K antigens, and 56 H antigens, 
creating over 100,000 possible patterns of identification (Orskov & Orskov, 
1992).  
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Solid connections between different serotypes and various pathotypes 
have been shown in many studies. In addition, UTIs have been linked with 
some serotypes (Johnson et al., 1997), which are also associated with specific 
subgroups of E. coli (e.g. UPEC). For example, O antigen groups O11, O17, 
O73, and O77 are shared in UPEC clonal group A strains (E. coli phylogenetic 
group D and ST69) (Lloyd et al., 2007; Prats et al., 2000; Skjot-Rasmussen et 
al., 2013; Tartof et al., 2005). 
 
1.1.3 Phylogenetic organisation of E. coli 
The multi-locus enzyme electrophoresis (MLEE) analysis of 88 reference 
strains of E. coli (72 human isolates and 16 other mammalians isolates) defined 
six major phylogenetic groups, known as A, B1, B2, C, D, and E (Ochman & 
Selander, 1984). 
These groups have great ecological indications. For instance, groups A 
and B2 are the most common in humans with 40.5% and 25.5%, respectively, 
when compared to groups B1 and D (17%). On the other hand, B1 strains are 
the predominant groups in animals (41%), followed by A (22%), B2 (21%) and D 
(16%) (Chaudhuri & Henderson, 2012). 
Remarkably, many strains of group B2 and some of group D strains are 
ExPEC, while strains of groups A and B1 are usually lacking extraintestinal 
virulence factors. This is signifying a connection between phylogeny and 




1.1.4 Pathotypes of Escherichia coli 
E. coli are known to be present in different forms, either being non-
pathogenic commensal strains normally found in the gastrointestinal tract of 
humans and animals, or as a pathogen in humans or animals, where they can 
cause serious infections. 
E. coli strains can be divided into two main categories based on the nature 
of their pathogenesis. These two types are enteric E. coli (EC) and extra 
intestinal pathogenic E. coli (ExPEC). EC strains are essentially limited causing 
infections of the mucous lining of the intestines, while ExPEC strains are 
capable of spread further to various parts of the body (e.g. urinary tract and the 
blood stream) and can cause several serious infections (Kuhnert et al., 2000; 
Marrs et al., 2005; Xie et al., 2006). 
Furthermore, EC strains can also be divided further based on their 
pathogenic features into six subtypes: enteropathogenic E. coli (EPEC); 
enterohaemorrhagic E. coli (EHEC); enterotoxigenic E. coli (ETEC)’ 
enteroinvasive E. coli (EIEC); enteroaggregative E. coli (EAEC); and diffusely 
adherent E. coli (DAEC) (Kaper et al., 2004; Weintraub, 2007). Members of the 
ExPEC group are more commonly known for causing UTI, neonatal sepsis and 
bloodstream infections (Manges & Johnson, 2012; Miajlovic et al., 2016; Pitout, 
2012). 
 
1.2 Urinary tract infection  
UTI is one of the critical causes of morbidity and mortality around the 
world, affecting all age groups. It has one of the highest costs of treatment in 
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the United States, costing ~US$3.5 billion per year, including health care costs 
and loss of work hours from the workforce (Flores-Mireles et al., 2015). In 2011, 
14% of antibiotic prescriptions for community-acquired infections in England 
were for UTIs (Sadler et al., 2017). Recently, for October 2018, the 
recommended first-line UTI treatment in England (Nitrofurantoin) has been 
prescribed over 350 thousand times, with a total cost of over £3 million 
(OpenPrescribing.net, 2017). 
Anatomically, the urinary tract is partitioned into an upper part defined by 
the kidneys, renal pelvis, and ureters; and a lower part made up of the urinary 
bladder and urethra. UTI is an inflammatory reaction of the urothelium to 
bacterial infection that is typically connected with bacteriuria (the presence of 
bacteria in the urine) and pyuria (the presence of pus in the urine, typically 
during a bacterial infection). UTI may include just the lower urinary tract or both 
the upper and lower tracts (Flores-Mireles et al., 2015). 
In addition, UTI can be symptomatic or asymptomatic infection. In the 
latter case, the bacteria are present in patient’s urine but no UTI signs or 
symptoms are present. Asymptomatic infection occurs most commonly in 
patients of a higher age, with an incidence of 40-50% in those above 80 years 
of age (Givler & Givler, 2018). However, most of these cases will not develop 
into symptomatic UTIs nor require antibiotic treatments, except for certain cases 
such as pregnant women (Ditkoff et al., 2018; Wullt et al., 2019).  
 
1.2.1 Epidemiology of UTI  
UTI can be divided clinically into two types: uncomplicated UTI that 
classically occurs in individuals who are otherwise healthy and have no 
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structural or neurological urinary tract anomalies (Hooton, 2012); and 
complicated UTI, which is a disease associated with abnormal aspects affecting 
the urinary tract or even the host defence system (Lichtenberger & Hooton, 
2008).   
Uncomplicated UTIs falls into two categories: lower UTIs (cystitis) and 
upper UTIs (pyelonephritis) (Hannan et al., 2012). Furthermore, Some of the 
risk factors contributing to occurrence of cystitis are: being a female gender, a 
past UTI, sexual intercourse, diabetes, vaginal infection, being overweight and 
being genetically susceptible (Foxman, 2014; Hannan et al., 2012).  
In contrast, complicated UTI risk factors include urinary obstruction due to 
the presence of foreign objects (indwelling catheters and calculi), neurological 
disease causing retention of urine, kidney failure or transplantation, pregnancy, 
and immunosuppression in hospitalised patients (Levison & Kaye, 2013). The 
majority of complicated UTIs are Catheter-associated, where it accounts for 
~80% of the UTI cases in the United States (Assadi, 2018). In addition, CAUTI 
is one of the contributing factors of increased rates of morbidity, mortality, and 
establishing a secondary infection of bacteraemia (Chenoweth et al., 2014).  
Recurrence of UTI could be due to relapses or re-infection. A recurrence 
of bacteriuria is due to reappearance of the same microorganism that was 
displayed before treatment (Nickel, 2005).In E. coli, The bacterial serine-
threonine protein kinase HipA is responsible for catalysing hibernation, resulting 
in temporarily tolerance to antibiotics as it stops growing and become dormant 
bacteria (Semanjski et al., 2018). Re-infection is a repeat of bacteriuria with a 
different microorganism from the original infection or could also be with the 
original microorganism. Chronic UTI indicates perseverance of the same 
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microorganism for a long time with relapses after treatment (Kodner & Thomas 
Gupton, 2010). In addition, many of these infections are associated with 
antimicrobial resistant microorganisms (Pallett & Hand, 2010). 
Both Gram-positive and Gram-negative bacteria can cause UTIs. In 
addition, some fungi such as Candida albicans can infect the bladder and 
kidneys leading to Funguria (Behzadi et al., 2015). However, uropathogenic E. 
coli (UPEC) is the most common bacterial strain that causes uncomplicated and 
complicated UTIs (Flores-Mireles et al., 2015). E. coli represents around 50% of 
hospital acquired UTIs and up to 90% of community acquired infections (Toval 
et al., 2014). Within the E. coli species, various subgroups (serogroups O1, O2, 
O4, O6, O7, O8, O18, O25, O68 and O75) are often detected in patients with 
UTI (Ananias & Yano, 2008; Delannoy et al., 2017; Li et al., 2010).  
The causative agents for the rest of community acquired UTI vary between 
Gram-negative bacteria, for example, Klebsiella and Proteus; and Gram-
positive Enterococcus faecalis and Staphylococcus saprophyticus (Flores-
Mireles et al., 2015). The rest of clinically presenting UTIs typically happen after 
colonisation with Enterobacter, Citrobacter, Serratia, Pseudomonas aeruginosa, 
Providencia, E. faecalis, or Staphylococcus epidermidis (Tabibian et al., 2008). 
Remarkably, the patient's age may impact the kind of infective microorganism 
present, where Staphylococcus saprophyticus now represents 10-15% of UTIs 
in young females in contrast with under 1% in elderly female patients (Kline et 
al., 2010). In fact, UTI is considerably more frequently associated with females 
than males. This indicates the significance of the ascending pathway of UTI as 
the female urethra is shorter and closer to the perianal area than the male 
urethra, thus, more susceptible to contamination. 
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1.2.2 Pathogenicity of UTI  
UTI happens as a result of the interaction between the virulence 
mechanisms of the bacteria and host defence systems. There are three 
possible courses whereby microbes can attack and spread inside the urinary 
tract; the ascending pathway, the haematogenous (descending) pathway, and 
lymphatic route.  
In many studies, different models were used to study and visualise the 
different modes of developing UTI (Hannan & Hunstad, 2016; Hung et al., 
2009). For example, a well-established murine model was used for a study on 
antibiotic treatments for long term ascending UTI (Hvidberg et al., 2000). These 
models enable us to expand our understanding of UTI pathogenicity, thus 
identifying new therapeutic and preventative measures for acute, chronic, and 
recurrent UTI. 
 
1.2.2.1 The ascending pathway for development of UTI 
In this route, infection originates mostly from bowel microorganisms, which 
ascend through the urethra to the bladder and then possibly the upper urinary 
tract (Figure 1.2). It has been demonstrated that organisms that cause UTI in 
females colonise the vaginal and periurethral areas before the occurrence of 
UTI (Gilbert et al., 2017). Inside the bladder, microorganisms may multiply and 
after that spread to the ureter, particularly if vesicoureteral reflux is present, 
then to the renal pelvis and parenchyma (Niveditha et al., 2012). 
Sexual acts can increase transfer of microbes into the female bladder. 
Using spermicides can facilitate colonisation of the vagina with uropathogens. 
In spite of the fact that the predominant Lactobacillus vaginal flora is more 
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susceptible to nonoxynol-9 (an organic compound widely used in contraceptives 
for its spermicidal properties) than E. coli (Ojha et al., 2003), this compound 
also enhances adherence of E. coli to vaginal epithelial cells (Steiner & Cates, 
1997). Lack of oestrogen is presently perceived as a risk factor for repetitive 
UTI in post-menopausal females, in light of the resulting vaginal flora changes 
with loss of defensive Lactobacillus, which are replaced by different 
uropathogens (Kodner & Thomas Gupton, 2010). Using various virulence 
factors (Table 1.1), especially hemolysin A, UPEC strains are able to invade the 
uroepithelial cells layers (Dhakal & Mulvey, 2012). 
In a previous study, it was shown that UPEC (except avian pathogenic E. 
coli strains or fimH deficient mutant UPEC) could interfere with contractility in a 
rat ureter model (Table 1.1) (Floyd et al., 2012). In addition, the study also 
revealed that UPEC strains specifically inhibit contraction of the ureters 
disrupting the flow of urine, which may facilitate ascending infection. 
The ascending route can also be progressed further with uropathogens 
invading the blood stream via the kidneys to cause septicemia (Bahagon et al., 
2007). In fact, E. coli bacteremic urinary tract infections increased in England by 
15.6% in the year 2014 (Goto & Al-Hasan, 2013; Lishman et al., 2018).  
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Figure 1.2: Development by the ascending pathway of urinary tract infection 
caused by uropathogens. Figure adapted from (Flores-Mireles et al., 2015). 
 
1.2.2.2 Haematogenous pathway of developing UTI   
Kidney infection in healthy individuals via the haematogenous route is 
uncommon but may lead to UTI. Infrequently, the renal parenchyma of a 
hospitalised patient may be infected during Staphylococcus aureus bacteraemia 
(Muder et al., 2006) or Candida fungemia that originates from oral sources in 
immunosuppressed patients (Fisher et al., 2011). However, infections of the 
kidney with Gram-negative bacilli rarely occur by the haematogenous route 
(Agarwal et al., 2012). 
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1.2.2.3 The lymphatic pathway 
This pathway of UTI occurrence is very uncommon. On rare events, 
bacteria can spread and invade the urinary tract from the closest organs via the 
lymphatic system. Retroperitoneal abscesses, necrotizing enterocolitis, and 
acute abdominal infections are the most common clinical cases connected to 
the lymphatic route of UTI (Winter et al., 2016). In females, the urogenital tract 
can be infected by pathogens travelling through preuterine lymphatics, while in 
males, the prostate bladder could possibly become infected via the rectal and 
colonic lymphatic (Meares, 1984). 
 
1.3 Uropathogenic Escherichia coli  
Uropathogenic E. coli (UPEC) are considered one of the most common 
causes of UTI, especially in females (Flores-Mireles et al., 2015). Generally, 
bacteriuria is indicated when a midstream urine CFU count is >105 CFU/ml. Yet, 
some cases of UTI in women appears with <105 CFU/ml (Lloyd et al., 2007). 
UPEC strains frequently deliver hemolysins that can result in lysis of host 
cells. These strains have the unique ability to colonise and cause infection in 
the urinary tract (bladder) transitioning from the intestinal tract (Dhakal & 
Mulvey, 2012; Mann et al., 2017). 
 
1.3.1 Molecular epidemiology of UPEC 
Within UPEC, some strains have been seen to have an increased 
prevalence or virulence. The current strategy used to investigate the genetic 
diversity and relatedness between isolates of pathogenic E. coli, including 
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UPEC, is multilocus sequence typing (MLST) (Wirth et al., 2006). Improvements 
and progress made to date in DNA sequencing has helped MLST to become an 
essential technique for typing of epidemiologically significant pathogens (Lau et 
al., 2008a). This technique has been useful in local or sporadic outbreak 
investigation and widely utilized to successfully characterise UPEC strains 
(Croxall et al., 2011; Lau et al., 2008b; Tartof et al., 2005). 
 MLST detects the differences in sequence of normally seven specific 
genes called housekeeping genes (Figure 1.3). In the most common MLST 
scheme for E. coli, these genes are: adk (Adenylate kinase), fumC (Fumarate 
hydratase class II), gyrB (DNA gyrase subunit B), icd (Isocitrate dehydrogenase 
[NADP]), mdh (Malate dehydrogenase), purA (Adenylosuccinate synthetase), 
and recA (Protein RecA). Any selective pressure such as antibiotic exposure 
does not affect these genes, nor do they accumulate neutral genomic variations 
at a high rate. MLST involves DNA sequence analysis of fragments of 450-500 
bp for each gene target, which enables accurate detection of the genome 
fragment with single pair of primers. Each gene has different sequences that, in 
turn, are assigned to different allele numbers. Then, these allele numbers of the 
housekeeping genes provide an allelic profile representing a specific sequence 
type (ST) (Enright & Spratt, 1999; Spratt, 1999; Urwin & Maiden, 2003).  
Application of MLST to global collections of UPEC have revealed the 
importance of a relatively small number of strains/clones including ST10, ST69, 
ST73, ST95, ST127 and ST131 (Petty et al., 2014; Price et al., 2013). ST131 
isolates are well established in the wider UPEC population and are 
acknowledged to be a key strain of UPEC (Johnson et al., 2010).  
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Figure 1.3: E. coli CFT073 complete genome presenting the seven 
housekeeping gene targets, according to the Achtman MLST protocol (Wirth et 
al., 2006). Adapted from (Gibreel, 2011). 
 
In contrast to the global significance of ST131 isolates, ST127 has been 
described as a recently emerged virulent clone that has not been widely studied 
(Gibreel et al., 2012b). ST127 isolates possessed the common uropathogenic 
O6 serotype (Johnson, 1991). However, isolates of UPEC ST127 are not often 
reported in prevalence studies, although they have been reported to be  
significant members of prospective strain collections (Alghoribi et al., 2015; 
Banerjee et al., 2013). One explanation for the low prevalence of ST127 strains 
in some studies could be linked to the fact that UPEC ST127 isolates often 
exhibit full susceptibility to antibiotics that are widely used with UTIs (Croxall et 
al., 2011; Hertz et al., 2016). In addition, knowing that most epidemiological 
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studies are based on clinical laboratory isolates from patients with antibiotic 
resistant strains or recurrent infection, it is more likely for ST127 isolates to be 
underestimated in these surveys.  
In a recent study on community-acquired UTIs, UPEC ST127 isolates 
were the second most prevalent strains, following ST95 strains (Yamaji et al., 
2018). The study also showed that the rate of ST127 isolate detection within a 
Northern California college community had increased from 11% in 1999-2000 to 
16% in 2016-2017. Furthermore, another study revealed that ST127 isolates 
have higher lethality in the in vivo model of Galleria mellonella larvae (GML) 
infection and a higher virulence profile compared to isolates of other STs, based 
on PCR detection of known UPEC related virulence factors (Alghoribi et al., 
2014). In the same study, one isolate of ST127 (UPEC EC18) was found to be 
avirulent toward the wax moth larvae. Genomic analysis revealed that that 
strain has an insertion sequence (IS1) mediated deletion in the O-antigen 
cluster, which could explain the cause of its behavior in the Galleria model 
(Alghoribi et al., 2014). 
Although using MLST has been proven useful to identify different STs, it is 
a costly and time-consuming tool (O'Farrell et al., 2012). Thus, there is a need 
to find more effective and direct approach to identify specific ST. Development 
of ST-specific PCR showed great potentials in surveillance or in culture 
collections screening for a variety of STs (e.g. STs 69, 73, 95, and 131) but not 
for a ST127 clone (Clermont et al., 2009; Doumith et al., 2015; Li et al., 2010). 
However, a recent study by O’Hara and colleagues (O'Hara et al., 2019) 
focused on finding ST127-specific PCR, was able to identify a three-gene 
multiplex PCR, including an extraction/PCR control (gyrB) and two ST127 
specific genes (upaG and fliC). The assay is highly specific to UPEC ST127 and 
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it can be applied in clinical settings for urgent detection and monitoring of this 
high-virulent clone. 
 
1.3.2 Virulence factors of UPEC 
Many virulence factors that contribute to the ability of UPEC to cause UTI 
are well described and the most important ones are listed in Table 1.1. UPEC 
strains produce type 1 pili, which attach to mannose-containing glycoproteins 
(uroplakins) present on the luminal surfaces of bladder epithelial cells through 
the tip protein adhesin (FimH), mediating cellular invasion. Moreover, P pili bind 
particularly to a globobiose (Gal-1,4-Gal) disaccharide connected to a ceramide 
lipid (the P blood group antigens) through the tip protein adhesin (PapG) 
(Mulholland et al., 1984). Ceramide lipid was found particularly on the surfaces 
of host erythrocytes and uroepithelial cells (Hannan et al., 2012).  Thus, the 
presence of the P pili receptor in the human population dictates an individual’s 
susceptibility to UTIs caused by UPEC (Bien et al., 2012). Furthermore, a study 
has shown that both function and expression of type 1 pili of UPEC strain UTI89 
was affected negatively following growth in filtered human urine (Greene et al., 
2015). 
Despite the fact that the physical flow of urine and many host factors can 
limit the contact of UPEC with epithelial cells of the bladder, once contact is 
made, adhesion and invasion can be the result. This will prompt replication 
inside the cellular vacuoles and lead to lysis and sloughing of the cells (Wu et 
al., 2017). On the other hand, a percentage of the microorganisms can persist 
within the underlying epithelial cells, where they cannot be recognised by the 
immune system (Nagamatsu et al., 2015). 
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It was suggested in previous studies that multiple expression of virulence 
factors of UPEC isolates from the upper urinary tract is higher than pathogens 
of the lower urinary tract (Johnson, 1991; Yamamoto, 2007). This suggests that 
upper UTI is likely to develop further and overcome the host innate immune 
system to cause subsequent infections (Table 1.1). 
By shifting expressions of their virulence proteins, UPEC strains can 
drastically change their virulence and pathological profiles (Terlizzi et al., 2017). 
A group of known phenotypes have resulted from horizontal gene transfer, 
through plasmid conjugation and phage mediated gene exchange. The majority 
of UPEC strains have pathogenicity islands (PAIs) (Schmidt & Hensel, 2004), 
which can facilitate gene exchange between different UPEC strains or other 
Enterobacteriaceae species (Messerer et al., 2017; Putze et al., 2009; Schubert 
et al., 2009). For example, UPEC P. fimbriae island contains virulence factors 
such as haemolysin, pili, cytotoxic necrosing factor, and uropathogenic specific 
protein (USP) (Nakano et al., 2001). 
The existence of these strains illustrates the ease with which bacteria can 
change over time, starting with one virotype (organisms of the same species 
with the same pathogenicity) then evolving into different or related types. 
Obviously, the potential for new virotypes to develop is high, and E. coli 
subgroups that vary in their ability to cause these infections without a doubt will 
emerge in the future (Warnes et al., 2012). 
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Table 1.1: Most common virulence factors of E. coli involved in urinary tract infection*. 









Alpha hemolysin is one of the common main virulence factors in ExPEC 
isolated from pyelonephritis, cystitis, asymptomatic bacteriuria, and 
faecal isolates. 
 
CNF1 frequently associated with UTI isolates and significantly related to 
prostatitis cases. 
 
Sat is more frequently associated with isolates causing pyelonephritis. 
------------------------------------------------------------------------------------------------- 
These factors are mainly associated with invasive UTI. They play 
complex roles to aid iron acquisition to disrupt of phagocytosis and apply 
direct toxicity toward host cells. 
(Dhakal & Mulvey, 















under iron restriction 
conditions. 
Present in isolates from pyelonephritis (73%), cystitis (49%), bacteraemia 
(58%), asymptomatic bacteriuria (41%) and faecal (38%). 
Enforce E. coli to cause serious and complicated UTI, as it helps 
bacterial growth in iron-limited conditions. 
(Emody et al., 
2003; Johnson, 
1991) 










 Adhesion to mucosal epithelium and tissue 
matrix, invasion, and 
biofilm formation. 
Present in all E. coli isolates, specifically more detected in E. coli 
phylogroups A and D. 
UPEC had the ability to form intracellular bacterial communities (IBCs) 
due to the high expression of the fimA gene, coding for type 1 fimbrae 
(T1F), which are responsible for adherence to and invasion of luminal 
facet cells of the bladder. 
(Berry et al., 2009; 
Emody et al., 
2003; Johnson, 





Adhesion to mucosal 
epithelium, and 
cytokine induction. 
papC gene has a higher detection rate in pyelonephritis and prostatitis 
isolates than those causing cystitis. 
papGIII gene was significantly detected more among prostatitis isolates 
than pyelonephritis isolates. 
(Emody et al., 
2003) 
* Adapted from (Alghoribi, 2015) 
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cont. Table 1.1: Most common virulence factors of E. coli involved in urinary tract infection*. 
Virulence factors Location Function Characteristics Reference 












endothelial cells and 
mucosal epithelium. 
14 % of F1C fimbriae E. coli strains are associated with UTI, as the 
fimbriae bind to the epithelial and endothelial cells of human kidney and 
bladder. 
(Khan et al., 2000) 





and tissue matrix. 
S fimbriae E. coli strains are associated with newborn meningitis and/or 
UTI, as it was reported that the fimbriae bind to the epithelial cells of the 
proximal and distal tubules, and renal vascular endothelium. 
(Korhonen et al., 





induction, and serum 
resistance. 
Lipopolysaccharide is a major factor contributing to the pathogenesis of 
E. coli infection and responsible for the initial immune response.  
Induces cytokine expression through toll-like receptor 4 (TLR4). 
(Kaper et al., 
2004; Morrison & 
Ryan, 1987) 
K antigen Antiphagocytic, anticomplement 
effect, serum 
resistance, and 
evasion of innate 
immune system 
recognition. 
Certain types of K antigen such as K1, K5, K12, K13, and K20 are 
detected in UTI isolates. Moreover, the major K antigens (63%) detected 
in isolates from pyelonephritis in females are K1 and K5. 
While O antigens associated with UTI isolates are O1, O2, O4, O6, O16, 
O18, O22, O25 and O75. 
These antigens serve as an important tool to differentiate UPEC from 
other E. coli strains. 
(Emody et al., 
2003; Johnson, 








1.3.3 UPEC survival in the urinary tract 
UPEC are a pathotype of ExPEC and originally reside in the intestine, 
where they do not normally cause any complications (Wiles et al., 2008). 
However, following deployment of the virulence factors described earlier, UPEC 
can disseminate and colonize other host environments such as the urinary tract 
and bloodstream (Flores-Mireles et al., 2015). In addition, the ability of UPEC 
isolates to exploit nutrition in diverse environments starting from the intestines 
and the urinary tract to the bloodstream indicates the significance of metabolic 
adaptations in pathogenesis (Eisenreich et al., 2010; Mann et al., 2017). These 
metabolic pathways are highly regulated and any nutritional changes in the host 
can affect their expression (Brown et al., 2008). Expression of the pili enables 
UPEC to attach to the bladder epithelial cells (Table 1.1), leading to invasion 
and intracellular replication to form intracellular bacterial communities (IBCs) 
(Rosen et al., 2007). In IBCs, microorganisms are hidden from antibiotic reach 
and can rapidly multiply and disseminate to invade other cells. Nevertheless, 
IBCs have not been observed within the bladder wall of humans’ cases and 
only seen in relation to mouse models (De Nisco et al., 2019). Transiting to a 
different environment applies pressure on UPEC to metabolically adapt, either 
in intracellular and extracellular microenvironments (Mann et al., 2017).  
For successful transitions to different surfaces and sub-surfaces, UPEC 
must survive and establish growth, initially this being in urine as they transition 
from the gastrointestinal tract.  Urine is the major nutrient source for UPEC in 
the urinary tract, especially during the extracellular phase. It is essential to 
understand the mechanism behind the utilization of urine components by UPEC 
strains; however, urine has a complex composition and variability between 
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different individuals presents challenges to researchers in this field (Brooks & 
Keevil, 1997). Still, the Urine Metabolome Database has all the metabolites 
identified in human urine to date (Bouatra et al., 2013). 
Nutritional sources present at high concentration in human urine are urea, 
creatinine, organic acids, D-serine amino acids, inorganic ions (ammonia), 
sodium, potassium, purines, pyrimidines, and water-soluble toxins, which can 
be utilized by UPEC (Bouatra et al., 2013; Vejborg et al., 2012). Nevertheless, 
urine is considered nutritionally a limited growth medium due to the limited 
concentration of arginine, methionine, valine, uracil, adenine, isoleucine, and 
iron (Stamey & Mihara, 1980; Vejborg et al., 2012). In order to meet the basic 
requirements for growth, UPEC will depend highly on the ability for synthesis 
(via catabolism) of these low-concentration metabolites, such as glucose, 
oxytocin, angiotensin, and melatonin (Bouatra et al., 2013; Mann et al., 2017).  
Therefore, UPEC strains are well developed metabolically and have the ability 
to survive the harsh conditions of the urinary tract.  
 
1.3.3.1 Metabolic adaptations of UPEC 
The metabolic effect of different environments on UPEC growth is yet to 
be fully understood (Mann et al., 2017). However, UPEC can apply adaptive 
strategies by activating genes and metabolic pathways in order to survive the 
urine conditions and cause UTIs (Figure 1.4). The main adaptations happen in 
central carbon metabolism, amino catabolism and other pathways. 
Central carbon metabolism pathways are essential for intracellular 
colonization of the bladder and kidneys (Alteri et al., 2009). For example, 
deletion of the sdhB gene, coding for succinate dehydrogenase involved in 
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conversion of fumarate to succinate during the TCA cycle, showed attenuation 
in pathogenesis in the bladder and kidneys of mouse models (Alteri et al., 
2009). The same study also showed that UPEC fitness in UTI models is 
reduced when the gluconeogenesis process is disrupted by pckA deletion. The 
pckA gene encodes phosphoenolpyruvate carboxykinase that converts 
oxaloacetate to phosphoenolpyruvate (Alteri et al., 2009). 
The amino acid catabolism pathway is significant for UPEC growth in 
human urine and arginine, serine and histidine transporters have been shown to 
be up-regulated in comparison to growth in LB medium (Conover et al., 2016). 
In addition, dppA and oppA deletion mutants showed significantly attenuated 
growth in urine, indicating the importance of small peptide uptake (Alteri et al., 
2009).  
Purines and pyrimidine pathways are important for metabolic adaptation in 
the bloodstream. A study has showed that growth of purA, purE, pyrC, and pyrE 
mutant strains of E. coli was impaired in LB conditions (Samant et al., 2008). In 
addition, deletion of purF, a purine biosynthesis-associated gene, stopped the 
synthesis process in UPEC UTI89 but did not affect its adhesion to the epithelial 
cells. However, UPEC intracellular survival was constrained and cells were 
unable to disseminate further into the intracellular bacterial communities 







Figure 1.4: Summary of the main metabolic adaptaions of UPEC during urinary 
tract infection (UTI). Genes in blue color denote genes that play a role in UPEC 
fitness in the urinary tract, or whose deletion results in attenuation in a mouse or 
in vitro model of invasion and intracellular bacterial community formation. The 
genes in red denote those specifically identified to play a role in kidney 
infection. Transporters are shown in green boxes over the cell membrane. 
sdhB, succinate dehydrogenase; pckA, phosphoenolpyruvate carboxykinase; 
tpiA, triosephosphate isomerase; srlA, sorbitol transporter; lacZ, β-
galactosidase; galK, galactokinase; dsdX, D-serine specific transporter; dsdA, 
D-serine deaminase; dppA, periplasmic dipeptide transport protein; oppA, 
periplasmic oligopeptide-binding protein; tonB, ferric iron uptake mediator; pur, 
genes involved in purine synthesis. Adapted from (Mann et al., 2017). 
 
Iron uptake and transport systems such as siderophores play an important 
role during the intracellular lifecycle of UPEC infection. A deletion of tonB, the 
ferric iron uptake mediator, resulted in reduced colonization of UPEC in the 
mouse kidney model of UTI after 48 hours post-infection (Torres et al., 2001). 
Moreover, many genes involved in siderophore synthesis, such as salmochelin 
receptor iroN and the high pathogenicity island encoded ybtSETU for synthesis 
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and uptake of yersiniabactin, were shown to be up-regulated during in vivo 
mouse UTI (Conover et al., 2016; Henderson et al., 2009; Reigstad et al., 
2007). These findings indicate the requirement of iron uptake and transport 
systems in UPEC pathogenesis in iron-starved conditions. Other known 
metabolic regulators of UPEC, such as nutritional sensing, are also crucial for 
UPEC metabolic adaptation and survival. Examples of these are: RyhB (iron-
acquisition) (Porcheron et al., 2014); BarA-UvrY (gluconeogenesis and 
glycolysis) (Palaniyandi et al., 2012); and Fnr (oxygen related genes) (Barbieri 
et al., 2014).  
Furthermore, genes identified to play a role in UPEC adaptation strategies 
for specific nutrients, have been considered as potential candidates for 
antimicrobial targets for UTIs (Table 1.2).  
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Table 1.2: Summary of metabolic functions in uropathogenic E. coli (UPEC) that represent potential targets for novel antimicrobial 
approaches. 
Targets Target purpose Advantages Disadvantages Reference 
Metabolic genes 










Targets an essential 
bacterial processes 
Impact on gut normal 
flora 
(Alteri et al., 2009; 
Bourne, 2014; Lv et 
al., 2014; Vejborg et 
al., 2012; Yan et al., 
2015) 
Transporters 
(tonB, oppA, dppA) 
No drug is required to 
enter the cell  
Functional redundancy by 
other iron transporters  
Iron receptors 










t  Impacts the initial stages 
of UPEC colonization  
Less effective, as not all 
UPECs have all receptors 
(Brumbaugh et al., 
2013; Garcia et al., 
2011; Miethke & 
Marahiel, 2007; Mike 
et al., 2016; Wieser et 
al., 2010) 
Siderophore synthesis 
(Aerobactin and salmochelin synthesis) 
Potential for a universal 
vaccine candidate 
Functional redundancy in 
iron acquisition systems 
Trimethylamine, acetic acid, creatinine, 
guanine, hypoxanthine Diagnosis  
Inexpensive and quick 
diagnosis via easy 
incorporation on to strips. 
Changeable outcomes 
due to varying levels of 
metabolites 
(Ariza-Heredia et al., 
2014; Karlsen & Dong, 
2015; Su et al., 2016) 
1.3.4 Antimicrobial resistance in UPEC 
Antimicrobial resistance is a major global concern and this threat requires 
urgent attention to control the growth and expansion of antibiotic resistant 
strains. The Review on Antimicrobial Resistance stated that antibiotic resistant 
bacteria kill around 50,000 people a year in the United States and Europe. 
Currently, it is estimated to kill more than 700,000 people a year around the 
world, with an increase to 10 millions deaths a year in 2050 (AMR, 2014). 
E. coli has been the focus of numerous studies regarding surveillance of 
antimicrobial resistance. Many studies have suggested that there is no 
correlation or that there is a negative correlation between the virulence factors 
and the antibiotic resistance profile of UPEC strains (Alghoribi et al., 2014; 
Gibreel et al., 2012b; Johnson et al., 2002; Velasco et al., 2001; Vila et al., 
2002). One study highlighted that UPEC isolates might develop resistance, 
regardless of their virulence profiles, when associated with immune-
compromised patients, who are undergoing antibiotic treatment (Johnson, 
1991). In addition, in Japan similar outcomes were demonstrated, indicating the 
existence of a complex association of virulence potential, antimicrobial 
resistance profile and phylogenetic background of UPEC (Kawamura-Sato et 
al., 2010). 
Reduced susceptibility to antibiotics could possibly lead to the emergence 
of opportunistic pathogens already present as commensal strains, which cause 
UTI and bloodstream infections that are then more difficult to treat (Russo & 
Johnson, 2003). In fact, pathogenic E. coli does not have exclusivity of antibiotic 
resistance, as commensal strains could help pathogenic strains by being a 
major reservoir of resistant genes (van den Bogaard & Stobberingh, 2000).  
 49 
The most commonly used antimicrobial agents for UTI treatment are β-
lactam antibiotics. Uncomplicated UTIs are generally treated with nitrofurantoin 
and trimethoprim/sulfamethoxazole (Bartoletti et al., 2016; Watson et al., 2018). 
Third generation cephalosporin (e.g. ceftriaxone) and cefazolin are used for 
complicated UTIs treatment (Abe et al., 2016; Jorgensen et al., 2018). 
During the last two decades, there has been a significant increase in 
antibiotic resistance in UPEC strains isolated from clinical cases (Olorunmola et 
al., 2013). Some of the key threats are in strains resistant to the main 
therapeutic options for UTI, including fluoroquinolones, the β-lactam antibiotics 
(including the cephalosporins), aminoglycosides and trimethoprim (Phan et al., 
2015; Pitout, 2012; Tang et al., 2014).  
As mentioned previously in this chapter, ST131 is one of the leading 
clones of UPEC currently causing human infections. Members of ST131 are 
often seen to carry resistance to multiple classes of antibiotic, including all front 
line therapies (Alghoribi et al., 2015; Sarkar et al., 2018). Interestingly, and in 
stark contrast, ST127 isolates are comparatively more susceptible to the action 
of a wide range of antibiotics than members of other important clones, like 
ST131 (Alghoribi et al., 2015; Gibreel et al., 2012b).  
In a recent study focused on specimens taken from patients at the point of 
care, within a Californian university community, ST127 found to be the second 
most prevalent lineage increasing from 11% to 16% over a period of 17 years 
(Yamaji et al., 2018). In addition, ST127 UPEC represented 2.3% of the isolates 
(out of 44 isolates) from community acquired UTI study in Switzerland, 
characterized for clonal diversity, virulence potential, and antimicrobial 
resistance (Nuesch-Inderbinen et al., 2017). It was also found that ST127 
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isolates have the highest virulence factor score among other STs but exhibited 
no resistance to any of the antibiotics used studied. Given their high virulence 
potential and recent evidence of emerging resistance to antibiotics, including 
the cephalosporins (Ferjani et al., 2017; Gomi et al., 2017), clinical cases 
associated with ST127 strains could substantially increase, resulting in a 
significant threat to human health.  
 
1.4 Proteomics: an investigative methodology 
Proteins have a fundamental role in cell biology, regulating various 
functions of different cells, controlling activities that range from movement to 
mitosis. Proteins are complex molecules made of one or more chains of amino 
acids ordered specifically according to the sequence of nucleotides in the 
encoding DNA. Following the translation process, more complexity is added via 
post-translational modifications (PTMs). These modifications include 
phosphorylation, sulphation, hydroxylation, methylation, and glycosylation (Han 
& Martinage, 1992). The complete protein content that is analysed with regard 
to their interactions, kinetics, localization, and PTMs is called the proteome 
(Wilkins et al., 1996). In other words, proteomics is not only limited to the 
identification and quantification of proteins (Fields, 2001). 
The proteome varies from cell to cell and is continually changing as a 
result of biochemical interaction with the genome and the environment. Any one 
microorganism has very diverse protein expression in various parts of a host 
body, in various phases of its life cycle and in responding to external stimuli it 
may experience in various environmental conditions. The ability to view 
biological processes occurring and, with understanding that proteins are 
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representatives of mRNA levels, to investigate host translational control and 
regulation, give proteomics an advantage over genomics in understanding the 
cell lifecycle and functions. It could be said that this makes the proteome the 
most significant data set that can be used to understand a biological system 
(Cox & Mann, 2007). 
Although proteomics plays an important role nowadays in developing and 
validating targets for diagnostics and therapy, eukaryotic proteomic studies are 
quite complex due to PTMs, which occur at many sites via various routes 
(Krishna & Wold, 1993). Moreover, prokaryotic proteomic studies are also 
challenging. The difficulties arise from the vast variation in characteristics such 
as quantity dynamic range, molecular size, and hydrophilicity and 
hydrophobicity features (Pandey & Mann, 2000). 
 
1.4.1 Technologies for investigating the proteome 
Proteomics in one of the “omics” technologies that are now widely used in 
biomedical research to understand cell biology. These technologies include 
genomics, transcriptomics, proteomics, and metabolomics. Proteomic methods 
allow investigation of proteins in relation to the underlying genomic architecture 
in an organism, and are especially useful for understanding the structure and 
function of proteins.  
There are many approaches used in the proteomics field such as 
conventional, advanced, quantitative, high throughput, and bioinformatic 
analysis techniques. Conventional techniques for protein purification are 
chromatography-based techniques, enzyme-linked immunosorbent assay 
(ELISA), and Western blotting (Hage et al., 2012). The advanced techniques 
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include protein microarray, Edman sequencing, mass spectrometry (MS), and 
gel-based approaches. Moreover, stable isotopic labelling with amino acids in 
cell culture (SILAC) (Wang et al., 2018), isobaric tagging for relative and 
absolute quantitation (iTRAQ) (Wiese et al., 2007), and Isotope-coded affinity 
tag (ICAT) labelling (Shiio & Aebersold, 2006) are examples of the quantitative 
techniques. In addition, high throughput techniques include both X-ray 
crystallography and NMR-spectroscopy (Aslam et al., 2017).  
 
1.4.1.1 Mass spectrometry proteomics 
MS-based proteomics has become an essential tool for analysis of protein 
expression on a global scale. For mass spectrometry proteomics experiments 
(Figure 1.5), the protein sample is firstly extracted from a biological source (e.g. 
bacteria or cell culture) followed by protein quantification and purification. The 
purification step is usually done on SDS-PAGE gels in order to allow removal of 
a specific band or to check the integrity of the total extracted protein. The 
proteins can be then in-gel digested or total proteome analysis can be 
conducted by digesting the proteins in-solution to yield a set of peptides using a 
sequence-specific protease, such as Trypsin and Lys-C. Both of these cleave 
peptides on the C-terminal side of lysine and arginine amino acid residues 
(Chen et al., 2009; Raijmakers et al., 2010). In fact, Trypsin/Lys-C protease 
combination has enhanced protein digestion and, thus, MS analysis (Saveliev 
et al., 2013).  
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Figure 1.5: An example of a modern mass spectrometry proteomics workflow. 
 
In MS, peptides’ size is measured and compared to reference databases, 
although MS can measure whole intact proteins. Proteins are difficult to work 
with due to solubility variations. Moreover, MS is more sensitive for peptide 
analysis as whole proteins make determining the masses of the resulting 
isoforms impossible due to the wide range of modification possible. 
Furthermore, MS is efficient at detecting sequences ~20 residues long, thus 
peptides are better for obtaining sequence information for protein identification 
(Mørtz et al., 1996; Steen & Mann, 2004; Sze et al., 2002).  
Filter aided sample preparation (FASP) is a common method to obtain 
peptides for LC-MS analysis. The advantage of this method is that is allows 
analysis of detergent-lysed cells and tissues, even at high concentrations of 
detergent. Thus, it is ideal for total proteome studies and fractions containing 
biological membranes. Since the method utilises a filtration device, we can 
obtain a protein digest at high concentrations with no need for precipitation and 
the analysed samples will be free of cell debris (Wisniewski et al., 2009).  
 
 54 
Following protein digestion and obtaining peptides, the sample can be 
analysed on MS firstly via separation using a high-performance liquid 
chromatography (HPLC) system that is connected directly “in-line” to the MS. 
This is followed by injecting the peptides after ionization with soft ionization 
techniques, such as electrospray ionization (Fenn et al., 1989) and matrix-
assisted laser desorption/ionization (MALDI) (Karas & Hillenkamp, 1988).  
It is essential for the peptides to be electrically charged for detection in the 
MS as it passes through voltage gates eliminating any neutrally charged 
peptides. In a tandem MS (MS/MS) (Figure 1.6), there are two consecutive 
stages of MS; the total mass is firstly measured in MS followed by peptide 
collision with an inert gas (e.g. Helium atoms) resulting in fragmentation of the 
peptides (Steen & Mann, 2004). This process is called collision-induced 
dissociation (CID) fragmentation, which helps confirm the structure of the 
detected peptide and can allow de novo peptide sequence determination 
(Demarque et al., 2016). The actual mass of the molecules is not measured by 
mass spectrometry, rather it determines the mass-to-charge ratio (m/z). 
Electrospray ionization creates differently charged ions. To calculate the 
molecular weight of a peptide, the detected m/z value has to be multiplied by z 




Figure 1.6: Peptide sequencing using the tandem mass spectrometry (MS/MS). 
This technique uses collision-induced dissociation (CID) fragmentation. m/z 
stands for mass-to-charge ratio.   
 
At the end of the analysis pathway, the sequence data for fragmented 
peptides are used in searches against a range of protein databases. There are 
many software tools available for analysis of proteomic data, but MaxQuant, a 
complementary computational framework for processing and statistical 
assessment of MS/MS data, facilitates a sensitive six-frame database search 
and is well suited for detailed proteomic analyses. It is worth noting that these 
approaches can also be used in global genome re-annotation applications 
(Krug et al., 2013).  
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Proteomic data can be searched against many databases such as NIH 
genetic sequence database (GenBank), NCBI reference sequence database 
(RefSeq), the universal protein resource (UniProt), and the protein information 
resource (PIR) (Aslam et al., 2017). Other databases can be used for 
understanding the role of proteins in certain pathways including metabolism, 
signalling and network or cellular interactions. Examples of these databases are 
BioCarta, kyoto encyclopedia of genes and genomes (KEGG) (Kanehisa et al., 
2017), and Reactome (Croft et al., 2011). 
In general, proteins act in complex ways with each other. It is essential to 
use protein-protein interaction (PPI) databases to investigate and understand 
biological systems at the protein level to help understand the complex 
connections. BioGRID, IntAct, MINT and HRPD are examples of the most 
widely used PPI databases. In addition, one of the most common PPI 
databases applications is the ‘search tool for the retrieval of interacting 
genes/proteins’ (STRING), which is connected to other databases for more 
confirmatory resources (Szklarczyk et al., 2015). 
 
1.4.2 Proteomic approaches to investigate UPEC pathogenesis  
During the last decade, significant changes in the field of proteomics have 
taken place, especially in investigating the bacterial proteome (Cox et al., 2014; 
VerBerkmoes et al., 2004). Proteomics complements genomic analysis as it can 
indicate, contrary to mRNA, the sub-cellular location of proteins, PTMs, 
macromolecular interactions, structure and molecular characterization (Cox & 
Mann, 2007). However, proteomic studies have much greater analytical 
challenges. Proteins can be expressed in different concentrations depending on 
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the protein function and location, while the genome usually has a set number of 
copies of every gene. In addition, an amplification technique is not available for 
proteomics studies in contrast to genomics studies, where polymerase chain 
reaction (PCR) can increase sensitivity (VerBerkmoes et al., 2004).  
A number of studies have been conducted on the bacterial proteome (Liu 
et al., 2015; Osbak et al., 2016; Schmidt et al., 2016). For example, a study on 
proteome quantification in E. coli, demonstrated the use of multi-enzyme 
digestion FASP and the total protein approach (Wisniewski & Rakus, 2014). 
The study also supported the proposed use of Trypsin/Lys-C combinations for 
better protein digestion (Saveliev et al., 2013) and demonstrated that the total 
protein approach estimates of protein abundances are relative to the values of 
well characterised protein standards. This demonstrates the simplicity and 
applicability of using such a methodology to investigate large-scale proteomics 
(Wisniewski & Rakus, 2014). Another study included a comprehensive analysis 
on the closely related strains of E. coli B and E. coli K-12, investigating the 
intracellular, outer membrane, and extracellular proteomes (Yoon et al., 2012). 
The analysis revealed that E. coli B is favourable for recombinant proteins 
production due to a higher amino acid biosynthesis, lack of flagella, and fewer 
proteases. In addition, E. coli B has more secreted proteins due to possession 
of additional type II secretion system and a different outer membrane 
composition. 
Currently, there are only a limited number of studies investigating the 
virulence of UPEC using proteomic approaches (Lo et al., 2017). Smith and 
colleagues investigated the cellular proteome of E. coli isolates from UTIs and 
random faecal samples (Smith et al., 2011). The analysis revealed that 
individual patients present a similar E. coli population, but different to other 
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patients with the metabolic variations are the highlighted difference. In addition, 
the surface proteins of UPEC were the focus of a previous shotgun proteomics 
study. The analysis showed that using protease to trim the surface-exposed 
peptides off the bacterial cell is not applicable for Gram-negative bacteria as it 
caused contamination to the sample with cytoplasmic proteins (Walters & 
Mobley, 2009). 
More recently, differences in protein expression profiles were used to 
analyse UPEC biofilms and distinguish the different populations within the 
biofilms using matrix-assisted laser desorption/ionization time-of-flight imaging 
mass spectrometry (MALDI-TOF IMS) (Floyd et al., 2015). The study also 
showed that oxygen tension regulates type 1 pili expression, as it was only 
observed in the top-most layer of the biofilm. Moreover, Wurpel and colleagues 
analysed 54 UPEC isolates for their outer membrane proteome (Wurpel et al., 
2015). This study provided an inventory of surface proteins and a comparative 
proteomic analysis of artificially induced outer membrane vesicles using tandem 
mass spectrometry. In a subsequent study, the same group identified the 
surface proteomic profiles of UPEC during growth in pooled human urine and 
identified new factor, UCA-like (UCL) fimbriae, that may contribute to biofilm 
formation in UTI (Wurpel et al., 2016). However, more studies are required for a 
deeper understanding of UPEC biology and pathogenicity, in particular for 
revealing metabolic adaptations. Such proteomic studies may allow 





1.5 Aims of this study 
Considering the reported significance of UPEC infection and its effect on 
the population health and global economics, more detailed studies are required 
into the pathogenesis of UPEC. There has been a substantial focus on leading 
drug-resistant clones on UPEC in many recent studies. One lineage that has 
received less attention is ST127, members of which are often widely susceptible 
to antibiotics, but have a high virulence potential, based on virulence gene 
content and ability to kill G. mellonella larvae. Acquisition of antibiotic resistance 
by ST127 strains could result in highly pathogenic and resistant UPEC, so the 
clone requires more detailed investigation. 
By understanding the biology of UPEC in more detail, it may be possible to 
design new therapies that do not result in further increases in antibiotic 
resistance. One aspect of the pathogenesis of UPEC strains that has not 
received much attention is investigation of their metabolic adaptations during 
infection. Previous work in the group has indicated that there may be some 
variation in the phenotype of UPEC recovered from urine and blood, even 
though the blood isolates were assumed to be derived from the urine colonising 
strains. This suggests metabolic adaptation occurs during transition from urine 
to blood. Proteomic studies can offer a better means to understand the 
pathogenic potential and metabolic adaptation of UPEC, especially when 
employed alongside genomic analysis. 
With the above in mind, the work conducted during this project had the 
overall purpose of using proteomic analysis to explore the biology of UPEC 
clones, in a number of settings, with a focus on members of ST127. The work 
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required development of relevant methods and their application in a range of in 
vitro conditions. The following Aims and Objectives were set: 
Firstly, to establish and optimize the use of proteomics for investigating 
pathogenesis of UPEC strains, the proteome profiles of genetically different 
background strains of UPEC will be determined and compared following growth 
in different laboratory media. This will establish the methodology that will enable 
further investigation of UPEC STs in different settings. 
Secondly, to increase our understanding of the metabolic adaptations and 
underlying mechanisms of UPEC adaptation to different clinical settings (e.g. 
blood versus urine) and to examine the ability of strains to disseminate into and 
grow in blood, a quantitative proteomics and genomic analysis will be 
conducted to investigate and compare the proteome profiles of paired UPEC 
isolates (from blood and urine of the same patient). To reveal changes that 
might be specific to UPEC of certain genetic backgrounds, investigation will 
need to be conducted for strains of different STs.  
Finally, as there have been no comprehensive investigations into the 
underlying mechanisms of ST127 UPEC pathogenesis, it will be informative to 
conduct co-culture experiments with uroepithelial cells and different strains of 
ST127. By using quantitative proteomic approaches to investigate the 
interaction of UPEC with uroepithelial cells, it may be possible to reveal 
potential targets for novel therapeutic or vaccine-based means to control or 










2 Chapter Two: Materials and Methods  
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2.1 Bacterial strains and culture conditions  
Bacterial strains used in this study are listed in Table 2.1. These strains 
were previously collected as a part of other studies (Alghoribi et al., 2014; 
Alghoribi et al., 2015; Gibreel et al., 2012b). Frozen stocks of the used strains 
were stored at -80°C in the Microbank™ preservation system (Pro-Lab 
Diagnostics, UK). E. coli growth cultures were prepared with Lysogeny broth 
(LB) (Fisher BioReagents, UK) and artificial urine medium (section 2.1.1), then 
incubated aerobically at 37°C overnight with constant shaking (~130 rpm).  
For agar cultures, 1.2% LB agar was used, and plates were incubated 
aerobically at 37°C overnight.  
 
2.1.1 Artificial urine medium   
Artificial urine medium (AUM) was also used for growth of E. coli strains. 
AUM was prepared using a method adopted from Brooks and Keevil (1997), as 
shown in Table 2.2. The pH for AUM was made up to 6.5 and then the medium 
was sterilised via filtration with 0.2 µm nylon membrane filters, as autoclaving 
AUM will lead to precipitation (Brooks & Keevil, 1997). Sterilised AUM was 




Table 2.1: Escherichia coli strains used in this study. 
Strain Sample Hospital / Department Sequence Type Reference 
K12 NCIMB 10214 - K12 wildtype ---------- ATCC 23716 (Dimitrova et al., 2017) 
EC1U Urine Manchester Royal Infirmary ST131 (Alghoribi et al., 2015) 
EC1B Blood Manchester Royal Infirmary ST131 (Alghoribi et al., 2015) 
EC10U Urine Mid Yorkshire NHS Trust ST131 (Alghoribi et al., 2015) 
EC10B Blood Mid Yorkshire NHS Trust ST131 (Alghoribi et al., 2015) 
EC18U Urine Mid Yorkshire NHS Trust ST127 (Alghoribi et al., 2014) 
EC18B Blood Mid Yorkshire NHS Trust ST127 (Alghoribi et al., 2014) 
EC41U Urine Manchester Royal Infirmary ST127 (Alghoribi et al., 2014) 
EC41B Blood Manchester Royal Infirmary ST127 (Alghoribi et al., 2014) 
SA189 Urine Riyadh, Saudi Arabia ST127 (Alghoribi et al., 2015) 
EC22U Urine Manchester Royal Infirmary ST73 (Gibreel et al., 2012b) 
EC22B Blood Manchester Royal Infirmary ST73 (Gibreel et al., 2012b) 
EC73U Urine Manchester Royal Infirmary ST73 (Gibreel et al., 2012b) 
EC73B Blood Manchester Royal Infirmary ST73 (Gibreel et al., 2012b) 
EC47U Urine Mid Yorkshire NHS Trust ST38 (Alghoribi et al., 2015) 
EC47B Blood Mid Yorkshire NHS Trust ST38 (Alghoribi et al., 2015) 
EC86U Urine Manchester Royal Infirmary ST38 (Alghoribi et al., 2015) 
EC86B Blood Manchester Royal Infirmary ST38 (Alghoribi et al., 2015) 
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Table 2.2: Artificial urine medium composition*. 
Component  Quantity (g) 
Concentration 
(mmol 1-1) Source 
Peptone 1 N/A Lab M 
Yeast extract 0.005 N/A Sigma-Aldrich 
Lactic acid 0.1 1.1 Sigma-Aldrich 
Citric acid 0.4 2 VWR 
Sodium Bicarbonate 2.1 25 Fisher Scientific 
Urea 10 170 Fisher Scientific 
Uric acid 0.07 0.4 Sigma-Aldrich 
Creatinine  0.8 7 Acros Organics 
Calcium chloride.2H2O 0.37 2.5 Fisher Scientific 
Sodium chloride  5.2 90 Oxoid 
Iron II sulphate.7H2O 0.0012 0.005 VWR 
Magnesium sulphate.7H2O  0.49 2 VWR 
Sodium sulphate.10H2O 3.2 10 Sigma-Aldrich 
Potassium dihydrogen phosphate  0.95 7 VWR 
Di-potassium Hydrogen phosphate 1.2 7 VWR 
Ammonium chloride  1.3 25 VWR 
Distilled water To 1 L  





2.2 Growth kinetics   
Overnight growth cultures (10ml) in LB were prepared. Then, 1 ml of each 
strain was inoculated into 100 ml flasks of LB and AUM. The flasks were 
incubated aerobically at 37°C with continuous shaking (~130 rpm). The optical 
density was measured at 600nm at the following time points: Zero, 30 minutes, 
1 hour, 2 hours, 4 hours, 6 hours, and 18 hours. One ml of the culture was 
placed in a cuvette and measured at OD600 with a photometer cuvette reader 
(Eppendorf, UK) to obtain a growth curve. The last two readings were diluted by 
50% in phosphate buffered saline (PBS) in order to get accurate readings of the 
growth curves. 
In addition, a serial dilution was performed at these time points to allow 
determination of colony forming unit (CFU) counts using the Miles and Misra 
method (Miles et al., 1938). All dilutions were drop plated with 3 drops of 10 µl 
each on LB agar plates, which were incubated at 37°C overnight, counting the 
colonies formed the following day. Three independent experiments were 
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2.3 Lipopolysaccharide extraction and silver staining  
An overnight culture (OD600 of 0.8-1.2) of 5 ml LB broth, incubated at 
37°C, was used to extract LPS using an LPS Extraction Kit (iNtRON 
Biotechnology). First, bacterial pellets were obtained by centrifugation at 16,000 
xg for 10 minutes and all traces of supernatant were removed. Second, cells 
were lysed by adding 1 ml of lysis buffer, with vigorous vortexing. Then, 200 µl 
of chloroform was added and samples were vortexed vigorously for 10-20 
seconds, and incubated at RT for 5 minutes. Chloroform was added to separate 
the phenol layer from the aqueous layer. Next, after centrifugation at 15,115 xg 
for 10 minutes at 4°C, two layers were formed with a separating white 
precipitate containing proteins and genomic DNA. The upper layer (400 µl) was 
transferred to a new 1.5 ml tube. To purify LPS from other components, 800 µl 
of purification buffer was added and samples were mixed well with incubation 
for 10 minutes at -20 °C, followed by centrifugation at 15,115 xg for 15 minutes 
at 4°C. The LPS pellet was washed with 1ml of 70% EtOH and centrifuged at 
15,115 xg for 15 minutes. Finally, 70 µl of 10 mM Tris-HCl buffer (pH 8.0) was 
added to the LPS pellet, which was dissolved at 100°C in a heat block for 3 
minutes. LPS extract was stored at -80°C.  
LPS extract was analysed, along with positive control of LPS extract from 
E. coli (Sigma-Aldrich, UK), by electrophoresis on a Bolt™ SDS gel kit, with 4-
12% Bis-Tris Plus Gels (Invitrogen™) using the conditions described in section 
2.5.6. Following LPS extraction and SDS PAGE, the gel was stained by using 
the ProteoSilverTM Silver stain kit (Sigma-Aldrich, UK), following the 
manufacturer’s protocol.  
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2.4 Tissue culture  
2.4.1 Maintaining epithelial cell culture 
Epithelial cell line HT1197 (ECACC 87032403) (Public Health England-
Culture collections, UK) was used in this study. The cells were maintained using 
MEM with glutamine, 1% non-essential amino acids (NEAA), and 10% Foetal 
Bovine Serum (FBS) (Thermo Fisher Scientific, UK). MEM needs to be 
supplemented with FBS as it lacks proteins and growth factors. Moreover, due 
to the use of sodium bicarbonate buffer system (2.2 g/L) in MEM, it requires a 
5% CO2 environment to maintain the medium pH. Cell culture flasks were 
incubated at 37°C until the cells reached 70-80% confluence (~3.5 days) when 
the cells were split using Trypsin/EDTA and seeded at 2x104 to 5x104 cells/cm2 
into new flasks.  
 
2.4.2 Co-culture conditions 
In this study we co-cultured the epithelial cells HT1197 with different 
UPEC strains. A single colony of each strain was inoculated in a 10 ml of LB 
broth and incubated overnight at 37°C. Then, 10 ml of AUM was inoculated with 
a 1:100 volume of overnight cultures for each strain and incubated at 37°C for 3 
hours (mid log phase). 
Cell culture flasks (75 cm2) were used to carry out the experiment, where 
cell estimations for each flask were ~2.5x106 cells. All flasks were washed twice 
with Dulbecco's Phosphate Buffered Saline (DPBS) before adding E. coli. For 
multiplicity of infection (MOI) of 10 we need 2.5x107 CFU of each strain. After 
calculating the volume required for each strain, it was inoculated into 13 ml of 
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MEM medium only (excluding FBS and NEAA). Then added to the flask and 
incubated at 37°C in CO2 incubator for 5 hours (Wurpel et al., 2016). 
During co-culture, each experiment was monitored every hour to observe 
any cytopathic effects. Following 5 hours incubation, media were collected into 
falcon tubes to be centrifuged at 5000 xg for 10 minutes. Both pellet (containing 
bacterial cells) and supernatant (containing secreted proteins – the ‘secretome’) 
were stored at -80°C for downstream analysis. Attached epithelial cells were 
washed twice with DPBS, as this is recommended to minimize the recovery of 
bacterial cells. Cells were then detached using Trypsin/EDTA and collected in 5 
ml of MEM medium only then centrifuged at 134 xg for 10 minutes. 
Supernatants were discarded and pellets were stored at - 80°C for downstream 
analysis. 
 In some cases, collecting the media at the beginning could result in 
collecting both the bacteria and epithelial cells. To separate them, the pellet 
was re-suspended in 2 ml MEM media only and transferred into an Ultrafree-CL 
centrifugal filter unit (Merck Millipore, UK) with a pore size of 5 µm. Following 
centrifugation at 3000 xg for 3 minutes, flow-through (containing bacterial cells) 
was collected into another tube and centrifuged at 5000 xg for 10 minutes. 
Pellets were stored at -80°C for downstream analysis.  
Following collection of bacteria in the flow through, epithelial cells were 
lysed on the filter using 500 µl of 2% SDT lysis buffer [2%(w/v) SDS, 100mM 
Tris/HCl pH 7.6] and incubated with shaking for 15 minutes. Next, samples were 
centrifuged at 4000 xg for 40 minutes. To eliminate sample viscosity, 20 µl of 
Benzonase Nuclease (≥250 units/µl) (Sigma-Aldrich, UK) was added. Moreover, 
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3 µl/sample of Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific, UK) 
were added and samples were stored at - 80°C for downstream analysis. 
 
2.4.3 Cells viability and MTT assay 
In order to check for cell viability after being co-cultured with UPEC 
strains, the MTT assay was performed. Thiazolyl Blue Tetrazolium Blue (MTT) 
(Sigma-Aldrich, UK) was diluted in PBS with a final concentration of 5 mg/ml, 
then filtered with a 0.2 µm syringe filter and stored at 4°C in the dark, as it is 
light sensitive.  
MTT creates a yellowish colour solution that is transformed to a dark blue 
colour. For co-culture experiments in 24 well plates, we added 45 µl/well of MTT 
at 3hrs, 4hrs, and 5hrs incubation periods. After incubation, excess volumes 
were discarded and 450 µl/well of DMSO was added. The absorbance for each 
plate was then measured at 560 nm and 670 nm with a PHERAstar FS plate 
reader (BMG LABTECH). 
 
2.5 Protein extraction    
For the media comparison study (LB and AUM) and the paired isolates 
experiment (LB only), growth culture media were used to grow UPEC strains for 
performing protein extraction, which was carried out at mid log phase for all 
strains (~3 hours). An overnight culture of 10 ml LB broth was used to inoculate 
100 ml of LB and AUM broth, which were then incubated at 37°C for 3 hours 
with continuous shaking (~130 rpm). For all the samples, we extracted both 
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fractions of soluble and insoluble proteins. An overview of this process is 
provided in Figure 2.1. 
 
2.5.1 Soluble protein extraction    
Proteins were extracted using the B-PER complete bacterial protein 
extraction reagent (Thermo Fisher Scientific, UK). During the procedure, the 
bacterial suspension was centrifuged at 5000 xg for 10 minutes followed by 
addition of equilibrated reagents to 5 ml/g of biomass. Next, 2µL of 0.5M EDTA 
per mL of B-PER Complete Reagent and 10µL of Halt Protease Inhibitor 
Cocktail (Thermo Fisher Scientific, UK) were added per ml of sample to produce 
a 1X final concentration. After adding all the reagents, the suspension was 
mixed well until homogeneous and incubated for 15 minutes at room 
temperature with vortex every 5 minutes for 30 seconds each. Finally, the lysate 
was centrifuged at 16,000 xg for 20 minutes to separate soluble proteins from 
the insoluble proteins (pellet) and then soluble proteins were transferred into 
separate a tube and stored at -80°C.  
 
2.5.2 Extracting insoluble proteins from the cell pellet 
Following B-PER protein extraction, SDT lysis buffer [4%(w/v) SDS, 
100mM Tris/HCl pH 7.6, 0.1M DTT] was added to the insoluble pellets to extract 
all the proteins that were insoluble in B-PER. DTT was added to the sample 
after performing protein estimation, as it will interfere with the OD readings. SDT 
lysis buffer was added to samples in a ratio of 1:10. Next, samples were 
sonicated in a water bath at 4°C for 3-5 minutes. After pellets were dissolved, 
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they were centrifuged at 16,000 xg for 10 minutes and protein was transferred 
into separate tubes for storage at -80°C. 
 
2.5.3 Epithelial cells protein extraction 
Following the collection of the co-cultured HT1197 epithelial cells, we 
lysed them using 500 µl of 2% SDT lysis buffer [2%(w/v) SDS, 100mM Tris/HCl 
pH 7.6] and incubated, after gentle vortexing, for 15 minutes. Next, samples 
were centrifuged at 16000 xg for 20 minutes. Then, 20 µl of Benzonase 
Nuclease (≥250 units/µl) (Sigma-Aldrich, UK) was added to eliminate sample 
viscosity followed by 3 µl/sample of Halt Protease Inhibitor Cocktail (Thermo 
Fisher Scientific, UK) were added and then stored at -80°C for downstream 
analysis. 
 
2.5.4 Protein precipitation for secretome analysis  
Trichloroacetic acid (TCA) was used to precipitate proteins collected in the 
supernatant of the co-culture experiment. TCA (110.132 g) was dissolved in 50 
ml of dH2O and kept at RT. Then, TCA was added to a volume of 20% of the 
sample and kept on ice for 1.5 hours (incubation was also continued overnight 
where necessary). Next, samples were centrifuged at 3500 xg for 30 minutes at 
4°C. Supernatants were discarded and pellets were transferred into another 
tube and centrifuged again at 16000 xg for 30 minutes. Following that, pellets 
were washed twice with 75% Acetone to remove the TCA. Samples were then 
dried in a speed-vac at 30°C for 30 minutes and re-suspended well in 100 µl of 
8M urea buffer. Samples stored at -80°C for downstream analysis. 
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2.5.5 Protein estimation  
Following protein extraction, protein estimation was carried out using the 
PierceTM BCA (Bicinchoninic Acid Assay) (Thermo Fisher Scientific, UK). The 
microplate procedure was followed, as per manufacturer’s instructions, with a 
standard prepared using the B-PER reagent and SDT lysis buffer as diluent for 
soluble and insoluble protein extractions, respectively. Absorbance was 
measured at 562 nm with a PHERAstar FS plate reader (BMG LABTECH). 
Using MARS data analysis software (BMG LABTECH) analysis of readings was 
conducted and standard curves generated. 
 
2.5.6 SDS gel electrophoresis and Coomassie Brilliant blue stain  
Extracted proteins were separated using a Bolt™ SDS gel kit, with 4-12% 
Bis-Tris Plus Gels (Invitrogen™). Samples were prepared as in Table 2.3 with 
20 to 50 µg of sample. After preparation, samples were heated at 70°C for 10 
minutes. Then, they were loaded onto the gels and 10 µl of SeeBlue® Plus2 
Pre-Stained Protein Standard (Life Technologies) was also used. Run 
conditions for the gel were as follows; 160V for 35 minutes.  
For gel staining, one gram of Brilliant blue stain was added to prepare 1 L 
of the stain solution. Coomassie de-stain solution was prepared as follows: 50% 
(v/v) Methanol, 10% (v/v) Acetic Acid, and 40% (v/v) dH2O. The gel was stained 
with Coomassie stain for one hour followed with 3-4 de-stain steps for 30 
minutes each. Lastly, gels were washed with 50% de-stain solution for 30 
minutes and then kept in 10% Acetic acid for storage at 4°C. In some 
experiments, InstantBlue stain (Expedeon Ltd, UK) was used for rapid detection 
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of protein bands. The gel was stained for one hour then washed and maintained 
in dH2O. 
 
Table 2.3: Sample preparation for SDS PAGE gel electrophoresis*. 
Reagent Reduced Sample  Non-Reduced Sample  
Sample X µl  X µl 
Bolt™ LDS Sample Buffer (4X) 10 µl  10 µl 
Bolt™ Reducing Agent (10X) 4 µl ___ 
Deionized Water Up to 26 µl Up to 30 µl 
Total Volume 40 µl  40 µl  
* Adapted from Bolt™ 4-12% Bis-Tris Plus Gels Kit. 
 
2.6 Proteomics   
2.6.1 Sample preparation  
A filter aided sample preparation (FASP) method was used to prepare the 
samples for MS (Wisniewski et al., 2009). A total of 20-150 µg of estimated 
protein was diluted with UA buffer (8 M urea in 0.1 M Tris/HCl pH 8.5) to a 
minimum volume of 300ul and passed through a filter unit [Amicon Ultra-0.5ml 
(10kDa cut off), Merck Millipore] by centrifugation at 16,160 xg for 15 minutes. 
This step was repeated with longer centrifugation times (~20 minutes) to make 
sure the detergent concentration was minimal. Second, 4 µl of 1 M DTT 
(Dithiothreitol, GE Healthcare) was added and the volume made up to 400 µl 
with UA buffer and samples were incubated at RT for 30 minutes then 
centrifuged at 16,160 xg for another 30 minutes. Next, 40 µl of 50 mM CAA 
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(Chloroacetamide) was added and the volume made up to 400 µl with UA buffer 
and incubated at RT in the dark for 20 minutes, then centrifuged at 16,160 xg 
for another 30 minutes. After that, the filter was washed twice with UA buffer 
and centrifuged at 16,160 xg. Later, 1:50 of Lys-c enzyme (Lysyl 
Endopeptidase, Wako Bioproducts, Neuss, Germany) was added and samples 
were incubated at RT overnight. The next day, 50 mM ABC buffer (Ammonium 
Bicarbonate) was added to dilute the samples to ≤ 2 M of urea. Next, 1:100 of 
Trypsin enzyme (Promega) was added and samples were mixed on thermo 
mixer at 6500 rpm for 1 minute and incubated at RT overnight. The following 
day, collection tubes for the filter units were changed and samples centrifuged 
at 16,160 xg for 30 minutes. Next, 50 µl of 0.5 M NaCl was added and samples 
were centrifuged at 16,160 xg for 20 minutes. After that, 50 µl of 2% 
trifluoroacetic acid (TFA) was added to acidify the filtrate and stop the digestion 
reaction. Sample acidity was checked with pH indicator (pH ≤ 3) before moving 
to the next steps. 
Small amounts of peptide digest for LC-MS analysis can be desalted using 
StageTips (Rappsilber et al., 2007). Two plugs (1mm diameter) punched out of 
C18 discs (EMPORE ™ - 3M) were packed to load 10 µg of digested proteins. 
Firstly, each StageTip was conditioned with 100 µl of 100% methanol. For each 
step in the centrifuge, 1475 xg was used for 5 minutes. If after centrifugation a 
small volume still remains in the tip, centrifugation can be repeated by 
increasing the time and optimising according to experimental condition (this was 
applied for all steps). Next, 100 µl of buffer B (80% acetonitrile in 0.5% acetic 
acid) was added and StageTips were centrifuged. Then 100 µl of buffer A (0.5% 
Acetic Acid) was added and StageTips were centrifuged; this step was repeated 
twice. After washing the membrane, samples were added and the assembly 
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centrifuged as described above. Then, the samples were eluted with 25 µl of 
buffer B (twice) into new collection tubes. Lastly, samples were dried in a 
speed-vac at 30°C for 25 minutes. Concentrated samples were transferred to 
glass micro-vials for storage 4°C. 
 
2.6.2 Mass spectrometry analysis 
This work was carried out by the staff in the University of Plymouth 
Systems Biology Centre. Peptides were separated on a Dionex Ultimate 3000 
RSLC nano flow system (Dionex, Camberly UK). An aliquot (3 µl) of sample 
was loaded in TFA/acetonitrile (2% acetonitrile in 0.1% TFA) onto an Acclaim 
Pep Map 100 µm × 2 cm, 3 µm C18 nano trap column, at a flow rate of 5 µl/min, 
bypassing the analytical column. Elution of bound peptides was performed with 
the trap column inline with an Acclaim PepMap C18 nano column 75 µm × 25 
cm, 3 µm, 100 Å (Analytical Column) with a linear gradient of 96% buffer A and 
4% buffer B to 60% buffer A and 40% buffer B, at a constant flow rate of 
300nl/min over 240 minutes. The sample was ionized in positive ion mode using 
a Proxeon nano spray ESI source (Thermo Fisher Scientific, UK) and analysed 
in an Orbitrap Velos Pro FTMS (Thermo Finnigan, Bremen, Germany). The 
Orbitrap Velos Pro instrument, running Xcalibur2.1 software, was operated in 
the data dependent mode to automatically switch between MS and MS/MS 
acquisition. MS spectra of intact peptides (m/z 350-1600) with an automated 
gain control accumulation target value of 1000000 ions were acquired with a 
resolution of 60000. The ten most intense ions were sequentially isolated and 
fragmented in the linear ion trap by collision induced dissociation (CID) at a 
target value of 10,000 or maximum ion time of 200 ms. A dynamic exclusion of 
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ions previously sequenced within 45” was applied. All the singly charged and 
unassigned charge state ions were excluded from sequencing. Typical mass 
spectrometric conditions were: spray voltage, 2.3 kV; no sheath and auxiliary 
gas flow; heated capillary temperature, 275˚C; normalized CID collision energy 
30% for MS2 in LTQ. The ion selection threshold was 10000 counts for MS2. 
An activation q = 0.25 and activation time of 30 ms were used. 
Peptides and proteins were identified by Andromeda via automated 
database searching of all tandem mass spectra against a curated target/decoy 
database, forward and reversed version of the E. coli K12, UPEC 536, and 
UTI89 protein sequence database (http://www.uniprot.org/ UniProt. Release 
July 2015) containing all E. coli protein entries from Swiss-Prot and TrEMBL. 
Spectra were initially searched with a mass tolerance of 6 ppm in MS mode and 
0.5 Da in MS/MS mode and strict trypsin specificity and allowing up to 2 missed 
cleavage sites. The resulting Andromeda peak list-output files were 
automatically loaded into inbuilt MaxQuant software modules for further 
processing, label free quantification (LFQ) and a maximum false discovery rate 





Figure 2.1: General work flow chart of the methodology followed for proteomics 










2.6.3 Proteomics analytical approach  
Raw files obtained after mass spectrometry analysis were provided by the 
Systems Biology Centre and were processed using MaxQuant. All proteomics 
data of this thesis are attached in Appendix VII. Following MaxQuant, we 
processed the data through multiple softwares and online databases for data 
analysis including; Perseus software (Tyanova et al., 2016), GProX software 
(Rigbolt et al., 2011), Microsoft Excel, STRING database (Szklarczyk et al., 
2017), and DAVID tool (Huang da et al., 2009; Huang et al., 2008a). An 
overview of these tools is given below. 
 
2.6.3.1 Perseus software  
Perseus has a comprehensive collection of statistical tools for high-
dimensional omics data analysis including value normalization, pattern 
recognition, cross-omics comparisons, and multiple-hypothesis testing (Figure 
2.2). In this study, we used Perseus software v1.6.1.3 (http://www.perseus-
framework.org) as the main tool for the data analysis (Tyanova et al., 2016).  
The software has five main sections: Loading the data; Processing; 
Analysis; Multi-processing; and data Export (Figure 2.3). At the start, we 
uploaded the output file of MaxQuant as a tab-delimited .txt file, which has a 
header row with the names of all columns. The type of data is specified during 
file loading into three main columns categories; Main columns [contain 
expression columns, e.g. LFQ intensity (Cox et al., 2014), iBAQ 
(Schwanhausser et al., 2011), or ratios of samples], Numerical columns (all 
additional numerical data), and Text columns (identifiers such as protein IDs) 





Figure 2.2: The Perseus data analysis platform. The core data structure of 
Perseus is the data matrix, containing samples and expression values (e.g., 
protein, mRNA). Perseus incorporates data filtration and normalization, and 
multiple methods for examining analysis such as histogram charts, intensity 
curves and scatter plots. Statistical tools including t-tests, PCA, correlation 
analysis and enrichment analysis support classical expression “omics” data 







Following data loading comes data processing, where firstly all expression 
columns were log2 transformed. Then, all rows were categorically annotated by 
annotating all the samples belonging to one condition with the same annotation 
in one group. Following that, data filtration is performed by filtering rows based 
on valid values, where are minimum number of valid values in each group are 
two. This step will reduce the data matrix to only valid groups. Then, we 
performed data imputation by replacing missing values from normal distribution. 
ANOVA test was done for matrix data using permutation-based FDR (FDR 
0.05) for truncation. Although data normalization is not always required, 
different types of normalization can be performed on the data to make it 
comparable (Tyanova & Cox, 2018). 
Regarding the analysis step, multi scatter plots were generated to validate 
the replicate samples for data correlations. Moreover, after performing further 
data treatment in Excel (section 2.6.3.2), we visualized the data using 
Hierarchical clustering, with regard to using Euclidean distance measure and 
complete linkage measure to calculate the squared Euclidean distance (Yim & 
Ramdeen, 2015). It is recommended to preserve the order of the columns tree 
(samples) but not the rows (proteins) in order to have clear clusters of the data. 
Finally, the matrix data were exported and saved as a tab-delimited .txt 
file, where it can be read using any spreadsheet software (e.g. Microsoft Excel). 
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Figure 2.3: Outline summary of the Perseus software workflow. Perseus 
extends over five interfaces, each of which includes various analysis and 
transformation functionalities and visualization possibilities. 
 
2.6.3.2 Microsoft Excel software  
Microsoft Excel is a common spreadsheet program used to create grids of 
text, numbers and formulas specifying calculations. It is extremely useful for 
reading the output text file of Perseus and MaxQuant.  
In this study, we used Excel 2011 to organise and highlight the up-
regulated and down-regulated proteins in colour codes in addition to perform a 
number of statistical calculations. Originally, all protein identifiers come as Fasta 
headers from the MaxQuant output as in the following format: 




Where db is either ‘sp’ for UniProtKB/Swiss-Prot or ‘tr’ for UniProtKB/TrEMBL 
and UniqueIdentifier is the primary accession number of the UniProtKB entry. 
In this study, we focused on using the Unique Identifier (accession 
number; AC) and the Gene Name for the downstream data analysis. The AC is 
allocated to each sequence upon insertion into UniProtKB. Accession numbers 
are constant throughout different version releases (The UniProt Consortium, 
2017). However, using only AC as a protein Identifier in some databases (e.g. 
STRING) is not suitable, as it lacks an updated list from the Uniprot database. 
Thus, using gene names was more appropriate, where the majority of the 
protein entries in the list were recognised.    
Examples of the uses of Excel in this study include generating a ratios 
column of LFQ values, inverse of the function of log2, and finding the relative 
expression values. Relativity in expression data can be found out by dividing 
the average LFQ value of a replicate by the highest value among the samples.  
 
2.6.3.3 Venn diagrams 
A Venn diagram is a diagram that displays all possible logical relations 
between a limited collection of different data sets. Venny 2.1 was the primary 
tool used for the overlap analysis in this study (Oliveros, 2015). 
 
2.6.3.4 GraphPad Prism 
The main statistical software used for data analysis was GraphPad Prism v6 
(https://www.graphpad.com/scientific-software/prism/). It was also used to 
generate all the graph figures presented in this study. 
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2.6.3.5 GProX software 
The Graphical Proteomics Data Explorer (GProX) is a freely available 
complete software platform for comprehensive and combined analysis and 
visualization of large proteomics datasets. The program provides a range of 
data distributions visualization tools such as heatmaps, scatter plots, and 
histograms (Rigbolt et al., 2011).  
GProX v1.1.16 (http://gprox.sourceforge.net/) was used in this study. 
Mainly it functions similarly to Perseus but generates higher quality output 
figures. Data are uploaded as tab-delimited .txt files, where first row must 
contain column headers (non-redundant). The AC must be present for all 
protein ids (Rigbolt et al., 2011). 
 
2.6.3.6 STRING database 
STRING is a database of identified and predicted protein-protein 
interactions (von Mering et al., 2003). The interactions include physical (direct) 
and functional (indirect) associations; they originate from computational 
prediction, from information transfer between organisms, and from interactions 
accumulated from other (primary) databases (Szklarczyk et al., 2015). 
Data sources of interactions in STRING are obtained from five main 
sources; genomic context predictions, high-throughput lab experiments, 
conserved co-expression, automated textmining, and prior information in 
databases (Szklarczyk et al., 2017).  
We used STRING database v10.5 (https://string-db.org/) to analyse the 
clusters generated by Perseus software. Using gene names, clusters of proteins 
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were loaded into STRING. E. coli CFT073 (NCBI:txid199310) data was used as 
a reference strain due to it being a UPEC strain and because a high number of 
proteins were matched with the samples (distinct protein-coding genes: 5369). 
Following loading of the protein list, an interaction map is generated. The 
interaction network edges are based on the confidence of data (line thickness 
indicates the strength of data support). Network analysis can show functional 
enrichment in process such as biological process, molecular functions, and 
KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways (Kanehisa et 
al., 2010). All data can be exported as tab-delimited .txt file format. 
 
2.6.3.7 DAVID tool 
The Database for Annotation, Visualization and Integrated Discovery 
(DAVID) is an online tool that incorporates functional genomic annotations with 
graphical summaries (Dennis et al., 2003; Huang da et al., 2009; Huang et al., 
2008a). DAVID can interpret genome-scale datasets by simplifying the 
conversion from data assembly to biological meaning. 
In this study, we used DAVID v6.7 (https://david-d.ncifcrf.gov) for our 
functional annotation analysis. AC for proteins of interest were used to upload 
the data. Moreover, options such as Fold Enrichment, Bonferroni, Benjamini, 
and FDR were selected in the analysis. Data can be downloaded as tab-





2.6.3.8 Proteomics data analysis pipeline   
 To summarise, the raw data files were obtained from LC-MS/MS to be 
processed in MaxQuant. The output files underwent further processing in 
Perseus for quality control. Following confirmation of the data integrity, 
expression data were averaged on Microsoft Excel to examine the fold change 
(Chapters 3 and 5) or the relative expression (Chapter 4). The data were then 
uploaded again into Perseus to generate hierarchical clusters, which were later 
displayed using Venn diagrams. Next, protein groups of interest were 
investigated using Functional Annotation Enrichment with DAVID tool (Chapters 
3 and 5) or through Protein-Protein Interaction (PPI) network analysis on 
STRING (Chapter 4) (Figure 2.4). 




2.7 Genomic analysis  
2.7.1 Sample preparation and DNA sequence analysis 
Genome sequencing was provided by MicrobesNG (Birmingham, UK) 
(http://www.microbesng.uk), which is supported by the BBSRC (grant number 
BB/L024209/1). A single colony of the strain to be sequenced was mixed in 100 
µl sterile PBS then cultured on LB agar. All bacterial biomass was collected off 
the plate and mixed into a bead tube (Pro-Lab Diagnostics, UK) provided by 
MicrobesNG. Leaving the cryopreservative solution in, tubes were sealed and 
send at room temperature to MicrobesNG. The turnaround time for generating 
raw genome sequence data was 10-12 weeks.  
At MicrobesNG, DNA was extracted directly from an aliquot taken from the 
tube. Illumina MiSeq and HiSeq 2500 platforms were used to perform all 
sequencing. Samples were sequenced using 2x250bp paired-end reads. The 
output of the analysis was provided in fasta, gbk, gff, and fastq file formats. 
MicrobesNG processed the data through a standard analysis-sequencing 
pipeline. This started with the Kraken programme (https://ccb.jhu.edu/-
software/kraken/) (Wood & Salzberg, 2014) to identify the nearest associated 
genome, followed by mapping the reads to a reference genome in order to 
evaluate the data quality using BWA mem 0.7.15 (http://bio-
bwa.sourceforge.net/) (Li & Durbin, 2010). Next, SPAdes 3.8.1 
(http://bioinf.spbau.ru/spades) was used complete the de novo assembly of the 
reads (Nurk et al., 2013). Lastly, the contigs were ordered and annotated using 
MUMmer 3.0 (http://mummer.sourceforge.net/) (Kurtz et al., 2004) and Prokka 
1.1 (http://www.vicbioinformatics.com/software.prokka.shtml) (Seemann, 2014), 
respectively. 
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2.7.2 Bioinformatics analysis  
Contigs were ordered according to the complete genome of UPEC ST127 
reference strain 536 [Accession ref |NC_008253; (Hochhut et al., 2006)] and 
annotated using Prokka v1.12 (Prokka: Prokaryotic Genome Annotation System 
- http://www.vicbioinformatics.com/software.prokka.shtml). This work was done 
in collaboration with Dr Majed Alghoribi (King Abdullah International Medical 
Research Center, Saudi Arabia). 
Multiple software tools including BLAST (Altschul et al., 1990), Artemis 
comparison tool (ACT) (Carver et al., 2005), BLAST Ring Image Generator 
(BRIG 0.95-dev0004) (Alikhan et al., 2011), Easyfig (Sullivan et al., 2011) and 















3 Chapter Three: Investigating the Effect of 
Growth in Different Environments on 




3.1 Introduction  
Uropathogenic E. coli is the most commonly known cause of UTI, being 
responsible for up to 85% of community-acquired infections and 40% of 
hospital-acquired cases (Toval et al., 2014). UPEC strains possess many 
virulence factors that add to their capacity to cause infection (Bien et al., 2012). 
In addition, the global spread of multi-drug resistant UPEC strains is posing a 
critical risk to treatment (Warnes et al., 2012). 
 The most virulent UPEC strains are descended from major lineages, such 
as ST38, ST127 and ST131, some of which have become globally 
disseminated (Gibreel et al., 2012b). This project is investigating different 
isolates of the ST127 lineage. One strain in particular (strain EC18) has a 
deletion in the O-antigen cluster, which results in attenuation of virulence 
toward the Galleria mellonella insect larvae infection model (Alghoribi et al., 
2014). The O antigen is a major component of LPS (Wang & Quinn, 2010), 
which means there could be a complete or partial absence of LPS in E. coli 
EC18. It is not clear how this may affect the pathogenicity of strain EC18. The 
study is also investigating E. coli EC41 and SA189, a UPEC ST127 isolates of 
clinical UTI with intact O-antigen gene clusters, as comparison strains to EC18.  
Proteomics allows investigation of changes in relative abundance of 
proteins in different conditions. Bacteria may exhibit very diverse protein 
expression profiles in various parts of the human body, in various phases of the 
life cycle and under various environmental conditions (Cox et al., 2014; Krug et 
al., 2013). Deciphering these changes can inform our understanding of bacterial 
pathogenesis and proteomic methods have been applied here to investigate 
gene expression profiles in isolates of the ST127 lineage. This study will 
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demonstrate the effect of environmental changes on the metabolic pathways 
expressed by a specific strain. Proteomic based analysis of UPEC strains will 
significantly enhance our understanding of the host-pathogen interaction of 
UPEC isolates in different environments, from a nutrient-limited environment 
(Urine) to a richer environment (Blood); and may facilitate development of novel 
therapies for UTI.  
 
3.1.1 Aim and objectives  
The overall Aim of this chapter is to establish the use of proteomic 
approach for investigating the pathogenesis of UPEC strains. To achieve this 
aim, the following objectives were set: 
• Establish methods for reproducible growth of several strains of ST127 in 
a range of laboratory media. 
• Extract LPS from strains E. coli EC18, E. coli EC41 and E. coli SA189 for 
comparison of LPS structure. 
• Ensure protein extraction yields were reproducible from different strains 
under a range of conditions. 
• Prepare extracted proteins for analysis on the OrbiTrap MS platform. 







3.2 Experimental design  
In this chapter we have three UPEC strains of ST127 (EC18, EC41, and 
SA189). Each strain will be grown in two different conditions (LB and AUM). 
Each sample will have two protein fractions (soluble and insoluble). Two 
individual biological replicates were done for each sample in this project, which 
will bring the total number of samples to 24 samples (Figure 3.1). 
 
 
Figure 3.1: Experimental design of the differential proteomics study. The figure 






3.3 Results  
3.3.1 Growth kinetics 
To investigate if the O-antigen deficient strain E. coli EC18 is affected in its 
ability to grow in a rich medium or not compared to control strains E. coli EC41 
and E. coli SA189 (with intact O-antigen gene clusters), growth assays were 
performed. All strains were grown in LB and AUM without any antibiotic 
selection. Over 18 hours incubation, the OD measurement was recorded for 
growth in LB and AUM (Figure 3.2).  
Comparing the growth curves within a single medium, using 2-way 
ANOVA analysis, there was a statistically significant difference (p≤0.0001) 
between SA189 and other strains in LB media for the last three time points. 
However, all strains in AUM were at a similar density after 18 hours growth. On 
the other hand, it is clear from the graph that there is a significant difference 
(p≤0.0001) between growth in LB and AUM for all three strains, starting from 
the 2 hours’ time point. In addition, analysing the growth curves, it is apparent 
that the mid-log phase for all strains grown in either LB or AUM is at ~3 hours of 
incubation. 
Colony forming units were also calculated for all three UPEC strains in 
both media. In LB media, EC18 showed a statistically significant difference 
(p≤0.01) to EC41 in the last three time points and to SA189 at the 18 hours’ 
time point (Figure 3.3 LB). Moreover, for the last three time points, EC18 and 
EC41 CFU variations in AUM were highly significant (p≤0.001). In addition, 
EC18 and SA189 were only significantly different (p≤0.01) at the 18 hours’ time 




Figure 3.2: Growth kinetics of E. coli EC18, EC41 and SA189 in Lysogeny Broth (LB) and artificial urine medium (AUM). Cultures of 
all strains were grown in LB broth and AUM without any selection. OD600 measurements were taken at zero minutes, 30 minutes, 
1 hour, 2 hours, 4 hours, 6 hours, and 18 hours. Data are plotted as the mean of three biological replicates and error bars represent 
standard error of the mean (SEM). p-Value represented as (**** = p≤0.0001, *** = p≤0.001, ** = p≤0.01, * = p≤0.05) for E. coli 




Figure 3.3: Colony forming unit (log10) of E. coli EC18 and the control strains E. coli EC41 and E. coli SA189 in Lysogeny Broth 
(LB) and artificial urine medium (AUM). Duplicate cultures of all strains were grown in LB broth and AUM, then iculated on LB agar 
plates without any selection. Colonies counted at zero minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, and 18 hours. Data 
are plotted as the mean and error bars represent standard error of the mean (SEM). 
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3.3.2 LPS detection and analysis 
To investigate the LPS structure, LPS was extracted from all strains and 
compared on SDS PAGE gels (Figure 3.4). The results confirmed there is a 
partial absence of LPS structure (O antigen substituted LPS) in E. coli EC18 
compared to E. coli EC41 and SA189. The missing O-antigen repeats for EC18 
are highlighted in the red box (Figure 3.4). Nevertheless, lipid A core 
oligosaccharide was shown in all strains (Alexander & Rietschel, 2001). 
 
 
Figure 3.4: Silver stained SDS-PAGE analysis of LPS extractions for E. coli 
EC18, E. coli EC41, and E. coli SA189. LPS extract from E. coli (Sigma-Aldrich, 
UK) was used as a positive control. Arrows show LPS core and O-antigen 





3.3.3 Protein extractions 
3.3.3.1 Soluble proteins  
All samples were cultured from a single colony in 10 ml LB broths and 
incubated at 37°C overnight. Extraction was performed at mid log phase (~ 3 
hours) on 100 ml of media per sample, as extracting proteins at further time 
points will result in a lower concentration of proteins extracted (Figure 3.5). 
Soluble proteins were extracted using the B-PER complete bacterial protein 
extraction reagent. BCA protein estimation indicated higher protein extraction 
yield in both media for EC18 than the other strains (Figure 3.6). Moreover, 
EC18 was statistically significant in unpaired t test analysis compared to SA189 
in LB (p = 0.0061) and to EC41 in AUM (p = 0.0224). On the gel, it is clear that 
EC18 protein extractions in both media had more consistent results with well-
resolved protein bands visible (Figure 3.7A).    
 
3.3.3.2 Insoluble proteins 
As results from the soluble protein extractions indicated that a large 
proportion of the protein might have been retained in the pellet, we sought to 
extract these proteins using SDT lysis buffer. Following extraction from pellets, 
BCA estimation showed higher insoluble protein extraction yields compared to 
the soluble ones, with statistically significant differences in the AUM samples 
(Figure 3.6), which was observed on SDS PAGE analysis (Figure 3.7B). There 
were no statistically significant variations between insoluble proteins for the 
same medium.  
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Figure 3.5: BCA estimation for soluble protein extracted from E. coli EC41 in 
artificial urine medium (AUM). Soluble proteins extracted by B-PER complete 
bacterial protein extraction reagent at different time points. Data are plotted as 
the mean of two biological replicates and error bars represent standard error of 
the mean (SEM). 
 
 
Figure 3.6: BCA estimation for protein yield extracted from E. coli EC18, E. coli 
EC41 and E. coli SA189 in Lysogeny Broth (LB) and artificial urine medium 
(AUM). Data are plotted as the mean of two biological replicates and error bars 
represent standard error of the mean (SEM). p-Value represented as (**** = 
p≤0.0001, *** = p≤0.001, ** = p≤0.01, * = p≤0.05, n.s. = not significant) for the 
soluble and insoluble proteins fractions comparison of each sample. 
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Figure 3.7: Protein extractions for E. coli EC18, E. coli EC41 and E. coli SA189 
loaded on SDS PAGE gels. (A) Soluble proteins extracted by B-PER complete 
bacterial protein extraction reagent; 30 µg of protein was loaded for all samples 
except for EC41 LB and SA189 LB (20 µg). (B) Insoluble proteins extracted by 
SDT lysis buffer. 50 µg of protein was loaded for all samples. InstantBlue 
staining was used. 
 
3.3.4 Mass spectrometry and data analysis 
As mentioned above, all the samples were subdivided into two fractions: 
Soluble and Insoluble and further processed for mass spectrometry analysis. 
The output data were processed using MaxQuant (1.5.3.1) and the Perseus 
software package. The data indicated a good correlation between replicates of 
≥ 0.9 (Figure 3.8).  Raw files from soluble and insoluble fractions were merged 
to have the overall proteomic profile of the strain in each specific environment. 
Figure 3.9 showed the overlapped protein of both extraction methods (soluble 





Figure 3.8: Correlation matrix of label free quantification (LFQ) of biological 
replicates of UPEC ST127 isolates (EC18, EC41, and SA189) grown in LB and 





Hierarchical clustering (HCL) in Perseus software, based on the level of 
protein detection, showed different label-free quantification (LFQ) clustering 
between LB and AUM samples (Figure 3.10). In addition, strain EC18 clustered 
separately from the O-antigen positive strains in both media. 
A total of 1702 proteins were identified through interrogation of the E. coli 
K12 and UPEC strains (UTI89 and 536) database. However, only 747 proteins 
were quantified across all the conditions due to existence in one condition and 
absence in the other, which means that a ratio could not be obtained. The 
remaining proteins (747) were quantified and provide this study with many 
insights into the proteome profile of these strains of UPEC.  
Examining the HCL of label-free protein quantification (LFQ) intensities for 
ST127 strains (EC18, EC41, and SA189), we can see that 747 proteins were 
clustered into six clusters with a distance threshold of 3.86 (Figure 3.10). These 












Figure 3.9: Overlaps between soluble and insoluble proteins in UPEC ST127 strains. The indicated proteins are the soluble proteins 
(blue) and insoluble proteins (yellow) of UPEC EC18, EC41, and SA189 in Lysogeny Broth (LB) and artificial urine medium (AUM). 




Figure 3.10: Hierarchical clustering (HCL) of z normalized label-free 
quantification (LFQ) Intensities for EC18, EC41, and SA189. Row clusters ID 
numbers are shown (733, 740, 739, 737, 738, and 730). Scale range from 0.0 
(light green) to 4.5 (light red).  
 
3.3.4.1 Expression fold change analysis 
With a closer look at the row clusters (Figure 3.11), we can see what we 
describe in the heat map in addition to more detailed information. Cluster 740 
showed spike in protein expression for EC41 in LB, while clusters 730 and 733 
has spiked in protein expression for EC18 in AUM and EC18 in LB, 








in cluster 739. However, cluster 737 showed raised expression in proteins of 
isolates in the AUM condition.  
 
Table 3.1: Row clusters (n=6) of HCL of label-free protein quantification (LFQ) 
intensities for ST127 strains (EC18, EC41, and SA189) in LB and AUM. Size 
indicates the number of proteins in the cluster. 
Cluster No. 740 739 738 737 733 730 




Figure 3.11: Row clusters (n=6) of HCL of label-free protein quantification (LFQ) 
intensities for ST127 strains (EC18, EC41, and SA189) in LB and AUM. Colour 













































































EC18 has significantly less up-regulated proteins than the other strains, 
while it has the most down-regulated proteins among the ST127 strains 
examined (Table 3.2). On the other hand, examining the up-regulated and 
down-regulated proteins numbers using Venny 2.1 tool (Oliveros, 2015) give us 
insight into the proteome profiles of the strains. In general, EC41 and SA189 
have more than 50% of their proteome profiles differentially regulated. In fact, 
EC41 and SA189 have more shared regulated proteins compared to EC18. 
EC41 and SA189 share 179 (23.9%) up-regulated proteins and 110 (14.7%) 
down-regulated proteins (Figure 3.12). A list of intersecting proteins of Figure 
3.12 are listed in Appendix I. 
 
Table 3.2: Up-regulated and down-regulated proteins (>2 fold) in all strains of 
ST127. The numbers indicates the differentially regulated proteins in LB 
compared to AUM. 
 EC18 EC41 SA189 
Up-regulated proteins 123 258 253 
Down-regulated proteins 195 158 168 
Total  318 416 421 







Figure 3.12: Overlaps between differentially altered proteins in three strains of ST127. The indicated proteins are the up-regulated (A) 
and down-regulated (B) proteins in Lysogeny Broth (LB) compared to artificial urine medium (AUM). Venny 2.1 tool was used to produce 
the figures (Oliveros, 2015). 
(A) (B) 
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3.3.4.2 Enrichment analysis 
Pathway Enrichment Analysis was performed on up-regulated (Figure 
3.12A) and down-regulated (Figure 3.12B) proteins using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) tool (Huang da et 
al., 2009; Huang et al., 2008b).  
Figure 3.13 shows pathways that were enriched by growth in LB, 
compared to AUM. A cut off of up-regulation by ≥2 fold with p<0.05 was used. 
From the pathways that were up-regulated in LB, an overlap analysis was 
carried out using the Venny tool (Oliveros, 2015), which shows that there are six 
commonly shared pathways in all strains (Table 3.3). However, no pathways 
were exclusively up-regulated in EC18 nor shared exclusively with another 
strain. On the other hand, EC41 and SA189 showed exclusive pathway 
enrichment for three and two pathways, respectively. Moreover, they shared 
exclusively five pathways (Table 3.3).  
Pathways enriched by down-regulation during growth in LB (≥2 fold with 
p<0.05) are illustrated in Figure 3.14. The overlap analysis of the pathways 
using Venny tool shows the three common shared pathways. EC18 shared 
exclusively three down-regulated pathways with SA189, and only one with 
EC41 (Table 3.4). In addition, five pathways were exclusively down-regulated in 
EC18. On the other hand, only two pathways were exclusively down-regulated 
in EC41, in addition to the down-regulation of the two-component system 
pathway in SA189 (Table 3.4).   
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Figure 3.13: Pathways enriched in proteins up-regulated by ≥2 fold during growth in Lysogeny Broth compared to artificial urine medium. 
Also shown is the overlap in up-regulated pathways for each of the three UPEC strains.  
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Table 3.3: Pathways enriched in up-regulated proteins (≥2 fold with p<0.05) in 
LB vs. AUM. 
Pathways EC18 EC41 SA189 
Amino sugar and nucleotide sugar metabolism é é é 
Aminoacyl-tRNA biosynthesis é é é 
Purine metabolism é é é 
Pyrimidine metabolism é é é 
RNA polymerase é é é 
Ribosome é é é 
Glycolysis / Gluconeogenesis  é é 
Pentose phosphate pathway  é é 
Pyruvate metabolism  é é 
Starch and sucrose metabolism  é é 
Trinitrotoluene degradation  é é 
Fatty acid biosynthesis  é  
Oxidative phosphorylation  é  
Propanoate metabolism   é  
Bacterial secretion system   é 










Figure 3.14: Pathways enriched in proteins down-regulated by ≥2 fold during growth in Lysogeny Broth compared to artificial urine 
medium. Also shown is the overlap in down-regulated pathways for each of the three UPEC strains.  
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Table 3.4: Pathways enriched in down-regulated proteins (≥2 fold with p<0.05) 
in LB vs. AUM. 
Pathways EC18 EC41 SA189 
Citrate cycle (TCA cycle) ê ê ê 
Glycine, serine and threonine metabolism ê ê ê 
Oxidative phosphorylation ê ê ê 
Alanine, aspartate and glutamate metabolism ê ê  
ABC transporters ê  ê 
Cysteine and methionine metabolism ê  ê 
Glycolysis / Gluconeogenesis ê  ê 
Glutathione metabolism ê   
Glyoxylate and dicarboxylate metabolism ê   
Methane metabolism ê   
Protein export ê   
Pyruvate metabolism ê   
Pyrimidine metabolism  ê  
RNA degradation  ê  










3.3.5 Genomic analysis of UPEC ST127 strains 
Genomic analysis was carried between UPEC strains EC18, EC41, 
SA189, and UPEC ST127 reference strain 536 (Hochhut et al., 2006).  
The analysis indicated an insertion-sequence (IS1) mediated deletion 
(from galE to wcaA) within the O-antigen and colanic acid gene clusters in 
EC18. Many studies have indicated that the O-antigen gene cluster is encoded 
in the region between the essential genes galF and gnd (DebRoy et al., 2011; 
Reyes et al., 2012). 
As a result of this insertion, the majority of the O-antigen gene cluster was 
deleted. This has resulted in a break in the sequence assembly and showed 
evidence of an insertion sequence (IS1) at that position (Figure 3.15)(Figure 
3.16). 
In comparison, the O-antigen cluster was completely assembled into a 
single contig in the EC41 and SA189 assemblies (Figure 3.16). Furthermore, a 
whole genome comparison between all the UPEC strains and the complete 
genome of UPEC 536 was performed. This was done in order to make sure that 
the deleted EC18 O-antigen genes were not present elsewhere in the genome. 
In addition, the hlyA gene was not identified in the genome sequence of 
UPEC EC18 nor EC41. Nevertheless, UPEC SA189 genome possessed this 








Figure 3.15: BLAST ring image of UPEC isolates of ST127 strains EC18, EC41, 
and SA189. UPEC 536 was used as a reference strain. O antigen is indicated in 








Figure 3.16: BLASTn comparison of O-antigen gene cluster (Green) and colanic acid gene cluster (Red) of UPEC EC18, EC41, SA189 
and UPEC ST127 reference strain 536. The grey shading indicates high nucleotide identity between the sequences (99–100%). In EC18, 
there is an insertion-sequence (IS1) mediated deletion of most of the O-antigen gene cluster and the colanic acid gene cluster compared 




3.4.1 Growth conditions  
 Bacterial growth is significant in the overall pathogenesis of an organism. 
It was shown that the rapid growth of E. coli, compared to other less common 
urinary pathogens, might explain why it is the most commonly known cause of 
UTI (Anderson et al., 1979).  
In this study, the O-antigen deficient strain E. coli EC18 was analyzed to 
see if the absence of virulence towards the Galleria mellonella model was due 
to growth impairment as the rapid growth of E. coli is essential in the 
pathogenesis during UTI (Alteri & Mobley, 2007; Anderson et al., 1979). It was 
clearly shown (Figure 3.2) there were statistically significant differences 
between SA189 and other strains in LB media, while all strains in AUM were at 
a similar density after 18 hours growth. This does not explain the lack of 
virulence in the wax moth model. In addition, all three strains grew differently in 
LB compared to AUM. Complex rich media, such as LB, contain a good carbon 
and energy source (e.g., glucose), which has resulted in rapid growth of the 
UPEC strains. While in a minimal medium, such as AUM, nutrients were limited 
(Tao et al., 1999). This variation of medium nutrients could explain the 
statistically significant difference in growth curves of LB and AUM. 
Using AUM instead of filtered normal human urine provides many 
advantages, where different chemical composition of human urine is an issue of 
standardization of the study methods (Bouatra et al., 2013). In addition, urine 
composition is dynamic, which varies according to diet, age, gender and health 
status (Ipe et al., 2016). The AUM medium used in the current study has been 
shown to have all parameters of normal human urine within or close to their 
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normal physiological ranges (Chutipongtanate & Thongboonkerd, 2010). In the 
same study, which compared seven different media simulating human urine, 
AUM data were consistent with respect to cell compatibility and cytotoxicity 
profiles, where it has the least cytotoxic effects. AUM has been proposed to be 
an alternative for renal physiological study using in vitro cell culture models 
(Chutipongtanate & Thongboonkerd, 2010). 
AUM was used to simulate in vivo conditions for the isolated strains with 
its limited source of nutrients. The enriched LB media has been widely used for 
cultivation of bacterial pathogens and other fastidious bacteria and was used 
here as a control medium. The structure of Proteus mirabilis biofilms has been 
studied while growing in AUM and LB media. Two different biofilm structures 
are formed, where AUM biofilm structure was observed as a flat layer lacking 
nutrient channels and inducing swarmer cells to protrude out into the bulk fluid 
where nutrients are abundant (Jones et al., 2007).  
In this study, proteins were extracted at mid-log phase, which was at ~3 
hours of incubation. The significance of mid-log phase extraction has been 
shown in various studies (Makrides, 1996; Sorensen & Mortensen, 2005; 
Stevens, 2000), as this is representative of the phenotype of rapidly growing E. 
coli cells in the bladder during UTI. At the early log phase, E. coli cells are 
healthy and are in the prime state to produce proteins. Extracting proteins at a 
later stage will result in low protein yield (Figure 3.5) and high protein 





3.4.2 Investigating LPS structure  
O antigen is a major component of LPS, as it can promote resistance to 
activity of the innate immune system, such as serum killing and phagocytosis 
and its presence enhances the pathogenicity of E. coli (Reyes et al., 2012). This 
point is particularly interesting as strain EC18 was recovered from a patient 
suffering urosepsis (Alghoribi et al., 2014) indicating that the lack of an O 
antigen did not limit the ability of the strain to cause a serious invasive infection. 
LPS structure consists of three main parts as follows: lipid A, the 
membrane base and the endotoxic part of LPS; the core saccharide of a 
branched chain of hexose and heptose sugars; and the O-antigen side chain, 
which has a repeating unit of sugars that extends into the extracellular space 
(Figure 3.17). The core region is composed of and inner core and outer core. 
The inner core is linked to lipid A and contains of 2-keto-3-deoxy-octanoate 
(Kdo) and L-glycero-D-mannoheptose. The outer core is bound to the O antigen 
and consist of hexoses and hexosamines (Silhavy et al., 2010).  
 
 
Figure 3.17: General chemical structure of LPS from Gram-negative 
enterobacteria (Alexander & Rietschel, 2001).    
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There are three type of LPS structure, where absence of a specific part of 
the LPS structure determines its type. The three types are smooth, semi-rough, 
and rough. Production of LPS with the full structure results in smooth LPS, while 
absence of the O-specific chain results in the semi-rough type and rough LPS is 
present if the outer core is missing as well (Reyes et al., 2012). Absence of the 
O-specific chain on the SDS gels for strain EC18 indicates that it carries a semi-
rough type structure of LPS. Many studies have indicated that bacteria with 
rough or semi-rough LPS have a higher LPS extraction yields than smooth LPS 
bacteria (Darveau & Hancock, 1983; Helander et al., 1992). Moreover, LPS was 
shown to play important role in motility as a wetting agent; thus its mutation 
could indicate limitation in swarming motility (Toguchi et al., 2000).  
 
3.4.3 Protein extraction  
In this study, most bacterial proteins were extracted using the two 
methods described earlier. Using SDS to solubilize and extract the insoluble 
proteins was appropriate for this study as the aim was not to isolate functional 
proteins. Although both soluble and insoluble fractions of proteins were 
processed separately, data files from both fractions were merged in final 
analysis to have the full proteome profile of growth comparison in AUM and LB, 
as the focus of this chapter was method development and optimisation. 
However, data for each extraction method could be examined later in further 
studies to give insight into the difference in proteome profiles between the 
soluble and insoluble proteins of UPEC. Why strain EC18 provided a greater 
proportion of soluble proteins than strains EC41 and SA189 can be linked to the 
difference in LPS (Darveau & Hancock, 1983; Helander et al., 1992).  
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3.4.4 Analysis and interpretation of proteomics data. 
The LFQ method in mass spectrometry aims to determine the relative 
abundance of proteins in a biological sample without using stable isotope-
containing compounds or other chemical labelling methods.(Wasinger et al., 
2013). Using LFQ proteomics approaches requires less preparation steps, thus 
it is a simpler and cost-effective method than stable isotope-based labelling 
methods. In addition, the applicability of LFQ to any type of samples with no 
limitation on the number of compared samples makes it more preferable to use 
(Cox et al., 2014). The data also indicates that the methodology of this study 
was robust with a correlation between replicates of ≥ 0.9.  
The unique clustering of EC18 in HCL for both conditions (LB and AUM) 
compared to EC41 and SA189 correlates with the previous findings of 
genomics analysis and Galleria mellonella infection model data for strain EC41 
(Alghoribi et al., 2014) and SA189 (Klazar & Upton, Unpublished), and suggests 
that the lack of an O-antigen has significantly affected the proteins being 
expressed by the strain. Fold enrichment (the ratio of two proportions) was used 
to illustrate the up-regulated and down-regulated pathways (Figure 3.13)(Figure 
3.14). Some pathways (n=5) included both up-regulated and down-regulated 
proteins and that is due to the different regulation of related proteins within the 
pathways.  
The pathway for amino sugar and nucleotide sugar carbohydrate 
metabolism was commonly up-regulated in all strains in LB. This rational 
regulation is most likely to be due to the rich medium content of LB. The UPEC 
strains also showed up-regulation in genetic information processing pathways, 
including transcription (RNA polymerase) and translation (Aminoacyl-tRNA 
 119 
biosynthesis and Ribosome), which correlate with the growth of organisms in LB 
medium. The increased rate of transcription/translation is a result to adapt to 
this rich and complex environment, where nutrients (e.g. tryptone and yeast 
exact) are necessary to grow bacteria to high cell densities (Christensen et al., 
2017). In addition, both nucleotide metabolism pathways for Purine and 
Pyrimidine were up-regulated in all strains. 
Purine has a key role in cellular energy systems and cellular signaling. 
Purine and pyrimidine are both contributors in RNA and DNA production. This 
correlate to the increased growth rate in LB condition compared to AUM where 
more synthesis of cellular proteins is required (Klumpp & Hwa, 2008). They may 
be produced de novo or reprocessed by a salvage pathway from regular 
catabolism. Uric acid is the final product of purine catabolism (Xi et al., 2000), 
while citric acid cycle intermediates are the outcome of pyrimidine metabolism 
(Turnbough & Switzer, 2008). 
UPEC EC41 and SA189 showed exclusive up-regulation in the pentose 
phosphate pathway and in glycolysis / gluconeogenesis (Table 3.3). These two 
pathways could be an important route of carbon flux through the central 
metabolic pathways during growth in a rich medium, such as LB (Sprenger, 
1995). The activation of an alternative pathway does not necessarily require 
any expressional changes, but instead it may depend on the accumulation of an 
intermediate metabolite (Nakahigashi et al., 2009). This mechanism can 
mediate the strength of these metabolic networks. In addition, gluconeogenesis 
pathway is utilized by E. coli for glucose-6-phosphate, which will be eventually 
used in cell envelope synthesis including the O-specific chain of LPS structure 
(Figure 3.17) (Silhavy et al., 2010). 
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Furthermore, starch and sucrose metabolism and pyruvate metabolism 
pathways are connected to the glycolysis / gluconeogenesis pathway (Figure 
3.18). The glycolysis process has multiple reactions that metabolize glucose to 
two molecules of pyruvate, yielding the associated pair of molecules of ATP. 
Gluconeogenesis is the process of glucose synthesis from non-carbohydrate 
origins such as pyruvate and lactic acid (Berg et al., 2002). This does not 
necessary mean they work as in opposition to each other. 
On the other hand, all three UPEC strains showed down-regulation of the 
TCA cycle pathway and the amino acid metabolism of Glycine, Serine, and 
Threonine in LB and thus up-regulation in AUM (Table 3.4), which simulates the 
conditions found in UTI. In urine and AUM, peptides and amino acids are limited 
and are the key carbon source for UPEC during UTI; so central metabolic 
pathways are essential for UPEC fitness in vivo (Alteri et al., 2009).  
Furthermore, the glycolysis / gluconeogenesis pathway was down-
regulated in EC18 and SA189 in AUM. As we describe above, some essential 
steps of glycolysis are not essential in the gluconeogenesis process. 
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Figure 3.18: Glycolysis / Gluconeogenesis pathway of E. coli O18:K1:H7 UTI89 
(UPEC). Green boxes indicating genes presence in the genome and the 
completeness of the pathway. Map00010 of Kyoto Encyclopedia of Genes and 
Genomes (KEGG) (Kanehisa et al., 2017). 
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Membrane transport systems include ABC transporters, the 
phosphotransferase system (PTS) and bacterial secretion systems. These are 
required for processing environmental information. ATP-binding cassettes 
(ABC) are essential membrane protein transporters that dynamically carry 
molecules across cell membranes, implying the energy originated from the 
hydrolysis of ATP to ADP (Moussatova et al., 2008). The pathway was down-
regulated in both EC18 and SA189. The low energy source in AUM could 
explain the reason behind up-regulation to compensate for the nutrient 
limitation. 
As shown in Table 3.4, EC18 showed more down-regulated pathways 
than EC41 and SA189 in contrast to the up-regulated pathways in Table 3.3. 
Some of these pathways were exclusive to EC18 including carbohydrate 
metabolism pathways such as Glyoxylate and Dicarboxylate metabolism and 
pyruvate metabolism. This could be due to the lack of O-antigen (Figure 3.16) 
and thus the repeating polysaccharides of O antigen in EC18 strain (Figure 
3.17) meaning the strain will not require carbohydrate building blocks at the 
levels needed in other strains. 
 
3.4.5 Conclusion 
The G. mellonella model showed its usefulness in many studies. However, 
it did not detect the pathogenicity of EC18 strain, as it was isolated from clinical 




From these findings we can conclude that using proteomics approaches to 
investigate the bacterial pathogenesis of UPEC is appropriate. The proteomics 
findings of different strains in different conditions were reproducible with a high 
correlation. In addition, the proteome profile analysis reflected variations in O-
antigen genomic data for the isolates being examined.  
In this study, one aim was to represent the UPEC ST127 proteome profile. 
However, EC18 could not be considered as a typical representative of that 
sequence type.  On the other hand, EC41 and SA189 were similar regarding 
their proteome profiles. Nevertheless, due to their differences in geographical 
isolation, adding more isolates of ST127 in addition to reference strains of 
ST127 such as E. coli 536 (O6:K15:H31) will support this representation of the 
ST127 proteomic profile.  
This study has shown that environmental changes have an effect on the 
metabolic pathways expressed by a specific strain. These conditions can be 
engineered to simulate the environments UPEC isolates may encounter in the 
transition from a nutrient-limited environment (Urine) to a richer environment 
(Blood).  
The metabolic pathways highlighted above are essential for the growth of 
UPEC strains. However, the redundancy of some of these pathways for glucose 
metabolism, or the biosynthesis of amino acids, purines and pyrimidines can be 
interpreted as being a result of the necessity for UPEC isolates to be able to 
survive in a variety of environments. These tactics will enable the bacteria to 
exploit different environmental resources and cope with the lack, or limitation, of 











4 Chapter Four: Metabolic Adaption in 
Escherichia coli Isolates During Transition 
from UTI to Bloodstream Infection 
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4.1 Introduction 
Generally, E. coli inhabits the lower gastrointestinal tract (Moller et al., 
2003). However, for some strains such as Uropathogenic E. coli (UPEC), it is 
also adapted to the relatively harsh environment of the urinary tract. Urinary 
tract infections (UTIs) are mostly initiated as a result of UPEC strains 
contaminating and colonising the urethra and then migrating to the bladder 
lumen (Rosen et al., 2007). Several studies suggested that some UPEC strains 
can invade the epithelial cells of the bladder and initiate an intracellular infection 
cycle (Justice et al., 2004; Martinez et al., 2000). 
UPEC is the most common cause of UTI. UPEC strains can colonize the 
bladder and kidney, which may sometimes lead to possibly a fatal case of 
bacteraemia (Kaper et al., 2004; Smith et al., 2010). Many studies showed that 
E. coli is the most common pathogen responsible for Gram-negative 
bacteraemia (Al-Hasan et al., 2010; Dale et al., 2018; Lee et al., 2016; Shaw et 
al., 2015). 
In addition, previous work with paired urine and bloodstream UPEC strains 
revealed identical results for molecular typing and virulence gene content 
(Alghoribi, 2015), supporting the notion that strains progress from the urine to 
the bloodstream. However, the study showed different metabolic activity (Table 
4.1) and antibiotic susceptibility profiles (Table 4.2) in some pairs of isolates 
indicating phenotypic changes, potentially due to single nucleotide 
polymorphisms (SNPs) or epigenetic events. These changes were stable during 
regular maintenance in culture in laboratory media, such as LB and it is possible 
that the metabolic changes reflect the different requirements for growth in 
different clinical sites. 
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Table 4.1: Metabolic activity profiles of paired blood and urine E. coli isolates. Adapted from (Alghoribi, 2015). 
NO. Sample ST Phylogroup Biochemical Tests Bio-
score GGT ProA TyrA SAC 5KG ILATk SUCT GlyA BGUR O129R IMLTa ELLM 
1 Blood 131 B2 0 0 1 1 1 1 1 0 1 1 0 0 19 
1 Urine 131 B2 0 0 1 1 1 1 1 0 1 1 0 0 19 
10 Blood 131 B2 0 0 1 1 0 1 1 0 1 1 0 0 19 
10 Urine 131 B2 0 0 1 1 0 1 1 0 1 1 0 0 19 
18 Blood 127 B2 0 0 0 0 1 0 1 0 1 0 0 0 15 
18 Urine 127 B2 0 0 1 1 1 0 1 1 1 0 0 0 18 
41 Blood 127 B2 0 0 0 1 1 0 0 0 1 1 0 1 17 
41 Urine 127 B2 0 0 1 1 1 1 1 0 1 1 0 0 19 
22 Blood 73 B2 0 0 1 0 1 1 1 0 1 1 0 0 18 
22 Urine 73 B2 0 1 1 0 1 1 1 0 0 1 1 0 19 
73 Blood 73 B2 0 0 1 0 1 1 1 0 1 1 0 0 17 
73 Urine 73 B2 0 0 1 0 1 1 1 0 1 1 0 0 17 
47 Blood 38 D 0 0 1 1 1 1 1 0 1 1 0 0 19 
47 Urine 38 D 0 0 1 1 1 1 1 0 1 1 0 0 19 
86 Blood 38 D 0 0 1 1 1 1 1 0 1 1 0 0 19 
86 Urine 38 D 0 0 1 1 1 1 1 0 1 1 0 0 19 
ST=Sequence Type; 1= Positive; 0= Negative; GGT= Gamma-Glutamyl-Transferase; ProA= L-Proline Arylamidase; TyrA= Tyrosine Arylamidase; SAC= Saccharose/Sucrose; 5KG= 5-Keto-D-Gluconate; ILATk= L-
Lactate alkalinisation; SUCT= Succinate alkalinisation; GlyA= Glycine Arylamidase; BGUR= Beta-Glucoronidase; O129R= O/129 Resistance; IMLTa= L-Malate assimilation; ELLM= Ellman. 
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 Table 4.2: Antibiotics susceptibility profiles of paired blood and urine E. coli isolates. Adapted from (Alghoribi, 2015). 
R= Resistant; S= Susceptible; I= Intermediate; AMO= amoxicllin; AMP= ampicillin; AMC= amoxicillin/clavulanic acid; PIP/TAZ= piperacillin/tazobactam; CF= cefalotin; CXM= cefuroxime; CXM A.= cefuroxime axetil; 
FOX= cefoxitin; CTX= cefotaxime; CAZ= ceftazidime; FEP= cefepime; ATM= aztreonam; ETP= ertapenem; MEM= meropenem; AMK= Amikacin; GM= Gentamicin; TOB= Tobramycin; Cip= Ciprofloxacin; OFX= 
ofloxacin; TGC= tigecycline; TRI= trimethoprim. 
NO. Sample ST 
Antibiotic Susceptibility Tests 
Anti-score AMO AMP AMC PIP/TAZ CF CXM CXM A. FOX CTX CAZ FEP ATM ETP MEM AMK GM TOB Cip OFX TGC TRI 
1 Blood 131 R R R S I S S S S S S S S S S S S S S S R 4 
1 Urine 131 R R R S I S S S S S S S S S S S S S S S R 4 
10 Blood 131 R R R S R R R S R R R R S S I R R R R S R 15 
10 Urine 131 R R R S R R R S R R R R S S I R R R R S R 15 
18 Blood 127 R R S S S S S S S S S S S S S S S S S S S 2 
18 Urine 127 R R S S S S S S S S S S S S S S S S S S S 2 
41 Blood 127 R S S S S S S S S S S S S S S S S S S R R 3 
41 Urine 127 R R S R S S S S S S S S S S S S S S S S R 4 
22 Blood 73 R R R R R R R S S S S S S S S S S S S S S 7 
22 Urine 73 R R R R R R R S S S S S S S S S S S S S S 7 
73 Blood 73 S S S S S S S S S S S S S S S S S S S S S 0 
73 Urine 73 S S S S S S S S S S S S S S S S S S S S S 0 
47 Blood 38 R R S S I S S S S S S S S S S S S S S S R 3 
47 Urine 38 R R S S I S S S S S S S S S S S S S S S R 3 
86 Blood 38 R S S S I S S S S S S S S S S R R R R R R 7 
86 Urine 38 R S S S I S S S S S S S S S S R R R R R R 7 
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4.1.1 Aim and objectives  
We aim to reveal the mechanisms underlying metabolic adaptation of 
UPEC to allow growth in blood, using a label free quantitative proteomics and 
genomic approach. In this chapter we also aim to investigate how ST127 
isolates behave compared to other UPEC STs isolates. To achieve these 
Aims, the following objectives were set: 
• Extract proteins (soluble and insoluble) from all UPEC strains including 
both isolates of blood and urine paired cultures. 
• Ensure protein extraction yields were reproducible from different strains 
during preparation of extracted proteins for analysis on the OrbiTrap 
MS platform. 
• Carry out detailed analysis of MS data with different means of analysis 
and presentation of bioinformatics analysis of proteomics data. 
• Validate the proteomics findings with genomics analysis. 
 
4.2 Experimental design 
In this chapter we have four STs of UPEC isolates (ST38, ST73, ST127, 
and ST131). Each ST has two strains with paired isolates from blood and 
urine. Each sample will have two protein fractions (soluble and insoluble). 
Three individual biological replicates were done for each sample in this 
project, which will bring the total number of the project samples to 96 samples 




 Figure 4.1: Experimental design of the paired isolates study. The image indicates the sub category samples for each ST, with three 
biological replicates each. 
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4.3 Results 
4.3.1 Protein extractions 
All samples were cultured from a single colony in 10 ml LB broths and 
incubated at 37°C overnight. Extraction was performed at mid log phase (~ 3 
hours) on 100 ml of LB media per sample. Soluble proteins were extracted 
using the B-PER complete bacterial protein extraction reagent, while insoluble 
proteins were extracted using SDT lysis buffer. BCA protein estimation 
indicated higher protein extraction yield in insoluble fragments than the soluble 
one. Moreover, in unpaired t test analysis, insoluble proteins were statistically 
more significant than soluble fraction proteins in all paired isolates except 
ST127 strains (EC18 and EC41) and E. coli EC86 U (Figure 4.2).  
On the gel, it is clear that biological replicates of protein extractions on 
SDS PAGE analysis in blood isolates of EC18 and EC41 are consistent and 
with well resolved protein bands visible (Figure 4.3). 
 
4.3.2 Overview analysis of the proteome profiles 
Following analysing all the paired isolate samples, including the soluble 
and insoluble fractions in addition to all the replicates, we followed a specific 
analytical approach described in (2.6.3) to interpret and understand the 
biological meaning of the data set. 
The initial analysis was done using Perseus, Excel, and Venny tool, an 
interactive tool for comparing lists with Venn’s diagrams (Oliveros, 2015) 




Figure 4.2: BCA estimation for protein yield extracted from paired isolates (Urine and Blood) of UPEC strains cultured in in Lysogeny 
Broth (LB). Soluble proteins extracted by B-PER complete bacterial protein extraction reagent. Insoluble proteins extracted by SDT lysis 
buffer. Data are plotted as the mean of three biological replicates and error bars represent standard error of the mean (SEM). p-Value 
represented as (**** = p≤0.0001, *** = p≤0.001, ** = p≤0.01, * = p≤0.05, n.s. = not significant) for the soluble and insoluble proteins 




Figure 4.3: Samples of protein extractions for E. coli EC18 (Blood and Urine), 
and E. coli EC41 (Blood) loaded on SDS PAGE gels. (A) Soluble proteins 
extracted by B-PER complete bacterial protein extraction reagent; 30 µg of 
protein was loaded for all samples. (B) Insoluble proteins extracted by SDT 
lysis buffer. Blood isolates are referred to as B1 and B2. Urine isolates are 
referred to as U. 50 µg of protein was loaded for all samples. InstantBlue 
staining was used. 
 
A total of 2025 proteins were identified across all strains. The data 
indicated a good correlation between replicates of ≥ 0.9 (Appendix II). 1164 of 
these proteins were quantified in all strains. Moreover, 381 (32.73%) of these 
proteins were up-regulated (>1.5 fold) in blood isolates compared to urine 
isolates, and 194 (16.67%) proteins were down-regulated (>2 fold) across all 
strains in blood isolates compared those from urine (Figure 4.4). In addition, 
slightly up-regulated (1.3 - 1.5 fold) and down-regulated (1.5 - 2 fold) proteins 
with statical significance were included in the study. The ANOVA test indicates 
that 943 (81.01%) proteins were statistically significant.  
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In general, ST38 and ST73 have more shared regulated proteins 
compared to other STs. ST38 and ST73 share 69 (27.5%) up-regulated 
proteins and 41 (34.7%) down-regulated proteins. On the other hand, ST127 
share considerably less differentially expressed proteins with ST131. In fact, 
ST131 has less differentially regulated proteins than was observed for other 
STs (Table 4.3). This table shows a summary of differentially regulated 
proteins in all STs and their percentages regarding to the total quantified 
proteins. Remarkably, all STs isolates shared just one up-regulated protein 
(UPF0267 protein YqfB), while no down-regulated protein was shared 
between all STs (Figure 4.4). A list of intersecting proteins of Figure 4.4 are 
listed in Appendix III. 
 
Table 4.3: Up-regulated and down-regulated proteins (>1.5 fold) in all four 
STs. The numbers indicate the proteins common to all strains of an ST. 
 ST38 ST73 ST127 ST131 
Up-regulated proteins 177 143 136 37 
Down-regulated proteins 79 80 85 17 
Total  256 223 221 54 









Figure 4.4: Overlaps between differentially altered proteins in four STs showing the up-regulated and down-regulated proteins in blood 
vs. urine isolates. Venny 2.1 tool was used to produce the figures (Oliveros, 2015).  
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4.3.3 UPEC STs strain analysis  
Following the initial analysis, we continue examining the data using a 
method that examines relative expression. Relative expression data can be 
found out by dividing the average LFQ value of a replicate on the highest 
value among the samples. The first step was done on Excel, and then the *.txt 
file was uploaded into Perseus as described above (2.6.3.1).   
 
4.3.3.1 Perseus analysis of all UPEC strains  
Examining the relative expression data, we can see that 1164 proteins 
were clustered into ten clusters with a distance threshold of 2.028 (Figure 4.5). 
These clusters are different in size ranging from 426 proteins to just 7 proteins 
(Table 4.4).  
In Figure 4.5, we can see the preserved order of sample starting with 
urine isolates then the blood isolates of each strain of an ST. The heat map 
indicates the relativity to the highest LFQ value in each protein. Remarkably, 
ST127 strains (EC18 and EC41) in both isolates (urine and blood) displayed 
similar proteins expression profiles to each other. On the other hand, the blood 
isolates of ST131 (EC1 and EC10) showed similar profiles to the urine isolates 
of UPEC, especially at cluster 1152 (Figure 4.6). With a closer look at the row 
clusters, we can see what we describe in the heat map in addition to more 
detailed information. 1148 and 1132 clusters showed spikes in protein 
expression for both EC18 isolates, while it drops in cluster 1146. Moreover, 
proteins expression spiked for both isolates of EC73 and EC47 in clusters 
number 1120 and 995, respectively.  
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Figure 4.5: Hierarchical clustering (HCL) of relative expression data of LFQ 
ratios for paired isolates of ST131 (EC1 and EC10), ST127 (EC18 and EC41), 
ST73 (EC22 and EC73), and ST38 (EC47 and EC86). Row clusters ID 
numbers are shown. Scale range from 0.0 (light green) to 1 (light red).  
 
Table 4.4: Row clusters (n=10) of HCL of relative expression data of label-free 
protein quantification (LFQ) ratios for paired isolates of ST131 (EC1 and 
EC10), ST127 (EC18 and EC41), ST73 (EC22 and EC73), and ST38 (EC47 
and EC86). Size indicates the number of proteins in the cluster. 
Cluster No. 1153 1152 1151 1150 1148 1146 1145 1132 1120 995 




94 290 400 34 109 105 26 21 8 6 













Figure 4.6: Row clusters (n=10) of HCL of relative expression data of paired isolates of ST131 (EC1 and EC10), ST127 (EC18 and 
EC41), ST73 (EC22 and EC73) and ST38 (EC47 and EC86). Colour scale ranges from 0.0 (red) to >3.5 (light green) indicating distance 
from centre. 
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4.3.3.2 Protein-Protein interactions network of all UPEC strains 
To examine the clusters in Figure 4.5, we used STRING tool to look at 
the protein-protein interactions network. This step will enable us to visualise 
the enriched metabolic pathways and how significant they are in each cluster. 
E. coli CFT073 (NCBI:txid199310) data was used as a reference due to being 
UPEC strain and the high number of proteins from the samples that matched it 
(distinct protein-coding genes: 5369). 
Following analysis on STRING tool, the average coverage of matched 
proteins in all UPEC strain clusters (n=10) was 90.42% (Table 4.4). The 
analysis was focused on comparing between different STs, in particular ST127 
compared to other UPEC STs. Some clusters showed statistically significant 
enrichments detected in functional subsystems (n=7), while other showed no 
significant enrichment (n=3). 
Furthermore, clusters 1152 (Figure 4.7) and 1148 were enriched in 
metabolic pathways, especially in riboflavin, pyrimidine and carbon 
metabolism for cluster 1148 (Figure 4.8). Cluster 1146 was also enriched in 
metabolic pathways (e.g. histidine metabolism) in addition to biosynthesis of 
secondary metabolites (Figure 4.9). 
Although cluster 1132 showed highest fold change for strain EC18 
isolates, it did not show any enriched function (data not shown). However, in 
STRING, we can expand the examined list of proteins to include the closely 
relative proteins to the original list for PPI and functional annotation 
enrichment analysis. Thus, examining the extended network, we found out 
functional enrichment for galactose, and pyruvate metabolism (Figure 4.10). 
On the other hand, the expressed proteins in cluster 995 indicate enrichment 
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in Pentose and glucuronate interconversions, and metabolic pathways for 
EC47 isolates (Figure 4.12). Moreover, cluster 1120 showed enrichment of 




Figure 4.7: Interactions network enrichment analysis of cluster no. 1152 (all 
UPEC entries). Combined screenshots from the STRING website, showing 
results obtained upon entering a set of 307 proteins. The inset is showing the 
significant enrichments detected in functional subsystems, where enriched 
functions have been selected and the corresponding protein nodes in the 




Figure 4.8: Interactions network enrichment analysis of cluster no. 1148 (all 
UPEC entries). Combined screenshots from the STRING website, showing 
results obtained upon entering a set of 117 proteins. The inset is showing the 
significant enrichments detected in functional subsystems, where enriched 
functions have been selected and the corresponding protein nodes in the 




Figure 4.9: Interactions network enrichment analysis of cluster no. 1146 (all 
UPEC entries). Combined screenshots from the STRING website, showing 
results obtained upon entering a set of 106 proteins. The inset is showing the 
significant enrichments detected in functional subsystems, where enriched 
functions have been selected and the corresponding protein nodes in the 





Figure 4.10: Extended interactions network enrichment analysis of cluster no. 
1132 (all UPEC entries). Combined screenshots from the STRING website, 
showing results obtained upon entering a set of 23 proteins. The inset is 
showing the significant enrichments detected in functional subsystems, where 
enriched functions have been selected and the corresponding protein nodes in 









Figure 4.11: Interactions network enrichment analysis of cluster no. 1120 (all 
UPEC entries). Combined screenshots from the STRING website, showing 
results obtained upon entering a set of 10 proteins. The inset is showing the 
significant enrichments detected in functional subsystems, where enriched 
functions have been selected and the corresponding protein nodes in the 




Figure 4.12: Interactions network enrichment analysis of cluster no. 995 (all 
UPEC entries). Combined screenshots from the STRING website, showing 
results obtained upon entering a set of 7 proteins. The inset is showing the 
significant enrichments detected in functional subsystems, where enriched 
functions have been selected and the corresponding protein nodes in the 
network are highlighted in colour. Line thickness indicates the strength of data 
support. 
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4.3.4 UPEC ST127 strains analysis  
4.3.4.1 Perseus analysis of UPEC ST127 strains 
To have a closer look at ST127 strains, we performed a separate HCL 
using relative expression dataset from ST127 strains. We defined ten row 
clusters of the 1164 proteins with a distance threshold of 1.05 (Figure 4.13). 
These clusters are different in size ranging from 273 proteins to just 11 
proteins (Table 4.5). The following analysis of expression clusters are not to 
be compared with the earlier analysis in this chapter. The cluster numbers are 
generated randomly in Perseus and the data are not related to the previous 
clusters.  
In Figure 4.13, the order of samples has been specifically preserved, 
starting with urine isolates then the blood isolates of EC18 and EC41. The 
heat map indicates the relativity to the highest LFQ value in each protein.  
Remarkably, EC18 isolates (urine and blood) displayed similar protein 
expression profiles to each other, which was also the case for EC41 isolates. 
This clearly can be seen in Figure 4.13 and in clusters numbered 1151,1152, 
and 1146 (Figure 4.14).  
Moreover, protein expression for urine isolates of EC18 and EC41 were 
higher than the blood isolates in cluster number 1139. However, cluster 
number 1137 showed more elevated expression in blood isolates compared 




Figure 4.13: Hierarchical clustering (HCL) of relative expression data of label-
free protein quantification (LFQ) ratios for paired isolates of ST127 (EC18 and 
EC41). Row clusters ID numbers are shown. Scale range from 0.0 (light 
















Table 4.5: Row clusters (n=10) of HCL of relative expression data of label-free 
protein quantification (LFQ) ratios for paired uro-sepsis isolates of ST127 
(EC18 and EC41). Size indicates the number of proteins in the cluster. 
Cluster No. 1153 1152 1151 1150 1148 1147 1146 1139 1137 1113 




262 108 10 228 153 127 72 56 26 51 




Figure 4.14: Row clusters (n=10) of HCL of relative expression data of paired 
isolates of ST127 (EC18 and EC41). Colour scale ranges from 0.0 (red) to 




4.3.4.2 Protein-Protein interactions network of UPEC ST127 strains  
Following further analysis on STRING tool for ST127 isolates, the 
average coverage of matched proteins in all clusters (n=10) was found to be 
92.80% for ST127 strains (Table 4.5). All clusters showed significant 
enrichment detected in functional subsystems.  
Cluster 1153 showed highly expressed proteins in all isolates of ST127 
with enrichment of ribosome-based pathways (Figure 4.15). Both clusters of 
1152 and 1151 showed elevated protein expressions for EC18 isolates. 
Cluster 1152 showed functional enrichment in metabolic pathways including 
citrate cycle (TCA cycle) and carbon metabolism (Figure 4.16). Moreover, 
sphingolipid metabolism was the only enriched pathway in cluster 1151 
(Figure 4.17). On the other hand, cluster 1146 showed higher protein 
expression in EC41 isolates. Metabolic pathways, in particular glutathione 
metabolism, were enriched in this cluster (Figure 4.22). 
Interestingly, cluster 1139 showed higher enrichment in only P-loop 
containing nucleoside triphosphate hydrolase (INTERPRO Protein Domains 
and Features) in the urine isolates of ST127 UPEC strains, but not the 
corresponding blood stream isolates (Figure 4.23). However, cluster 1137 
showed an opposite protein expression profile indicating functional enrichment 
in the blood isolates of ST127 for only methane metabolism (Figure 4.18). 
Furthermore, a group of clusters (1113, 1147, 1148, 1150, and 1153) 
showed similar protein expression profiles (either high, intermediate, or low) 
for all isolates of ST127. Cluster with high expression profiles (1150 and 1153) 
were enriched in metabolic pathways including pyrimidine, purine, pyruvate 
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and carbon metabolism. In addition, the pentose phosphate pathway and 
aminoacyl-tRNA biosynthesis were also enriched (Figure 4.19)(Figure 4.15).  
Regarding intermediate expression profile clusters, 1147 and 1148 
showed functional enrichment in the metabolic pathways of 
glycerophospholipid, pyruvate, and beta-Alanine. Biosynthesis of secondary 
metabolite pathway and the phosphotransferase system (PTS) were also 
enriched (Figure 4.21)(Figure 4.20). 
Lastly, cluster 1113 was the only cluster with a low expression profile 
across all ST127 isolates (Figure 4.24). Functional here enrichment included 
metabolic pathways (e.g. histidine metabolism), pentose and glucuronate 





Figure 4.15: Interactions network enrichment analysis of cluster no. 1153. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 273 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 





Figure 4.16: Interactions network enrichment analysis of cluster no. 1152. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 117 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 




Figure 4.17: Interactions network enrichment analysis of cluster no. 1151. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 11 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 
highlighted in colour. Line thickness indicates the strength of data support. 
 
Figure 4.18: Interactions network enrichment analysis of cluster no. 1137. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 29 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 
highlighted in colour. Line thickness indicates the strength of data support. 
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Figure 4.19: Interactions network enrichment analysis of cluster no. 1150. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 245 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 
highlighted in colour. Line thickness indicates the strength of data support. 
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Figure 4.20: Interactions network enrichment analysis of cluster no. 1148. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 163 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 
highlighted in colour. Line thickness indicates the strength of data support. 
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Figure 4.21: Interactions network enrichment analysis of cluster no. 1147. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 132 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 




Figure 4.22: Interactions network enrichment analysis of cluster no. 1146. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 76 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 




Figure 4.23: Interactions network enrichment analysis of cluster no. 1139. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 61 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 




Figure 4.24: Interactions network enrichment analysis of cluster no. 1113. 
Combined screenshots from the STRING website, showing results obtained 
upon entering a set of 57 proteins. The inset is showing the significant 
enrichments detected in functional subsystems, where enriched functions 
have been selected and the corresponding protein nodes in the network are 
highlighted in colour. Line thickness indicates the strength of data support. 
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4.3.5 Genomic analysis of paired UPEC isolates 
A whole genome comparison between all the UPEC paired isolates was 
performed using a reference complete genome for each UPEC ST. The 
BLAST Ring Image Generator (BRIG 0.95-dev0004) (Alikhan et al., 2011) was 
used to compare and visualize UPEC genomes against the references. 
Additional data on assembly statistics are provided in Appendix IV. 
Genomic analysis was carried out for all UPEC paired isolates including; 
EC1, EC10, against UPEC ST131 reference strain EC958 (Forde et al., 
2014)(Figure 4.25); EC18, EC41, with UPEC ST127 reference strain 536 
(Hochhut et al., 2006)(Figure 4.26); EC22, EC73, and UPEC ST73 reference 
strain CFT073 (Welch et al., 2002)(Figure 4.27); and finally  EC47, EC86, and 
UPEC ST38 reference strain MRSN 346647 (Snesrud et al., 2017)(Figure 
4.28). 
On the whole, BRIG images indicated a low level of variation between 
paired isolates. However, EC1 isolates showed notable variation on BRIG 
analysis (Figure 4.25) and, thus, a further analysis was carried out with 
findings shown in Table 4.6. The Table shows a summary of the in silico 
analysis of MLST, serotype and Fim-type for all the UPEC isolates. This 
reveals the different serotype and Fim-type for blood and urine isolates of 
strain EC1, which suggests that there was more than one strain causing the 
UTI that progressed to uro-sepsis. Similar findings were reported by McNally 
and colleagues (McNally et al., 2013). 
The deletion of the EC18 O-antigen genes in both blood and urine 
isolates was confirmed here and was discussed in the previous chapter. Table 
4.7 indicates the numbers of features missing from each strain compared to its 
 160 
partner and gives the total length of the combined missing sequences. In 
addition, the number of completely and partially absent genes are shown. With 
the exception of strain EC1, which clearly has some substantial differences 





Figure 4.25: BLAST ring image of paired isolates (blood and urine) of ST131 
strains (EC1 and EC10). UPEC EC958 was used as reference strain. Blood 





Figure 4.26: BLAST ring image of paired isolates (blood and urine) of ST127 
strains (EC18 and EC41). UPEC 536 was used as reference strain. Blood 











Figure 4.27: BLAST ring image of paired isolates (blood and urine) of ST73 
strains (EC22 and EC73). UPEC CFT073 was used as reference strain. Blood 











Figure 4.28: BLAST ring image of paired isolates (blood and urine) of ST38 
strains (EC47 and EC86). UPEC MRSN 346647 was used as reference strain. 








Table 4.6: MLST, Serotyping and Fim-typing of each strain examined from the 
four UPEC lineages 
Organism ID Organism MLST SeroType FimType 
EC1U Escherichia coli ST131 O16:H5 fimH41 
EC1B Escherichia coli ST131 O25:H4 fimH30 
EC10U Escherichia coli ST131 O25:H4 fimH30 
EC10B Escherichia coli ST131 O25:H4 fimH30 
EC18U Escherichia coli ST127 H31 fimH2 
EC18B Escherichia coli ST127 H31 fimH2 
EC41U Escherichia coli ST127 O6:H31 fimH2 
EC41B Escherichia coli ST127 O6:H31 fimH2 
EC22U Escherichia coli ST73 H1 fimH10 
EC22B Escherichia coli ST73 H1 fimH10 
EC73U Escherichia coli ST73 O50/O2:H1 fimH10 
EC73B Escherichia coli ST73 O50/O2:H1 fimH10 
EC47U Escherichia coli ST38 O86:H18 fimH5 
EC47B Escherichia coli ST38 O86:H18 fimH5 
EC86U Escherichia coli ST5150 O1:H15 fimH65 





Table 4.7: Summarised genomic analysis comparing the urine and blood isolates of each strain of UPEC STs.  
Sequence 
type ST131 ST127 ST73 ST38 
Strain EC1 EC10 EC18 EC41 EC22 EC73 EC47 EC86 
Isolate type Urine Blood Urine Blood Urine Blood Urine Blood Urine Blood Urine Blood Urine Blood Urine Blood 
Missing 
features 116 133 107 86 16 18 20 23 8 7 111 107 29 24 27 22 
Total length 
(bp)  364012 269083 111143 295517 69768 43242 1861 41045 4482 4690 4824 19073 75489 34710 31915 7491 
Deleted 








4.4 Discussion  
4.4.1 Growth conditions and protein extractions 
As described earlier, one of main factors in bacterial pathogenesis is rapid 
growth (Anderson et al., 1979). In laboratories, enriched LB media has been 
widely used for culturing of diverse range of bacteria including fastidious ones. 
Complex nutrient rich LB medium contains a good carbon (catabolizable amino 
acids) and energy source (e.g., glucose) (Sezonov et al., 2007). 
Using a single type of media for our experiment with the paired isolates is 
crucial. To explain this, when two strains of one pair are grown in LB and are 
then analysed, the differences in their proteomes will be due the stain itself. 
This means it is not the result of an environmental effect, as described in the 
previous chapter. In addition, we extracted all fractions of protein at mid-log 
phase, which was at ~3 hours of incubation. The importance of this time point 
has been described in the previous chapter, as well as in other studies 
(Makrides, 1996; Sorensen & Mortensen, 2005; Stevens, 2000). Moreover, as 
described earlier, bacterial proteins were extracted based on their solubility. 
Both fractions (soluble and insoluble) of proteins were processed separately 
then the peaklists/spectra files were combined for each sample. 
In this study, extraction of insoluble protein gave a higher yield than the 
soluble extraction in all paired isolates. However, strangely, ST127 paired 
isolates (EC18 and EC41) and UPEC EC86 U showed no statistical significance 
(average p = 0.642) in their differences. No explanation could be offered for this 
finding. The protein extraction results were highly reproducible. 
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4.4.2 Overview of the proteomic profile analysis  
A total of 1164 proteins were quantified in this study across all STs. 
Almost half of these (528/1164) were differentially regulated (both up-regulation 
and down-regulation) when comparing isolates from blood with their paired 
isolate from urine. ST131 strains had the lowest number of differentially 
regulated proteins among other STs, suggesting conservation of phenotype in 
isolates from this ST during transition from urine to blood. On the other hand, 
ST38 isolates possessed the highest number of differentially regulated proteins. 
The fact that, ST131 isolates shared the lowest number of differentially 
regulated proteins with ST127 strains emphasises the unique profile of the latter 
clonal group.  
Of all these differentially regulated proteins, only one protein was seen to 
be up-regulated in blood compared to urine among pairs from all STs. UPF0267 
protein YqfB is PUA-like domain-containing protein according to the E. coli K-12 
sub-strain MG1655 database, however it was identified as hypothetical protein 
according to E. coli CFT073 database. This protein consists of 103 aa/ 312 bp. 
The molecular weight of the polypeptide is 11.905 kD and it is located in the 
cytosol (Shen et al., 2005). Following intensive searches in relevant databases 
for YqfB, the protein function remains uncharacterized. 
A relative expression method was used as the main approach to tackle 
this big dataset, trying to find a connection between the proteome profiles of all 
strains examined. The LFQ based analysis has been preferred in many studies 
(Cox et al., 2014). The LFQ method represents the protein intensities using 
standardisation to eliminate some outlier results to best represent the ratio of 
changes between various samples. Since the MaxQuant program can present 
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different categorical data, including intensity and LFQ, LFQ can be used to 
compare between samples and intensity for some complex cases (e.g. some 
fractions were conditioned or treated differently) (Schwanhausser et al., 2011). 
Intensities are more tidily arranged than LFQ and, significantly, normalized 
across all samples.  
 
4.4.3 Paired UPEC metabolic pathways  
Following analysis on STRING tool, the coverage and identification of the 
gene name entries was at a high rate (90.42%) (Table 4.4). However, functional 
enrichment was not detected for some clusters (clusters 1150, 1145, and 1132), 
due to the low number of proteins listed in those clusters. 
Interestingly, cluster 1132 showed highly expressed proteins almost 
exclusively in the EC18 samples, but this cluster did not show any enriched 
functions. Nevertheless, looking deeper into the extended network we detected 
functional enrichment in pathways such as galactose (galT) and pyruvate 
metabolism. The importance of galactose lies in the synthesis of 
exopolysaccharides (e.g. colanic acid) in E. coli (Whitfield & Paiment, 2003). In 
this study, yeast extract (a component of LB medium used for paired isolates 
growth) was the source of the carbohydrates (Grant & Pramer, 1962), which 
were subsequently metabolized into galactose (Medina et al., 2011).  
A deletion of galE can result in inhibition of isomerization of UDP-
galactose to UDP-glucose, and vice versa (Figure 4.29). A galE mutant E. coli 
was unable to grow in the galactose supplemented medium due to 
accumulation of the intermediate products of galactose-1-phosphate and UDP-
galactose (Barkan et al., 2011; Csiszovszki et al., 2011; Sundararajan, 1963). 
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Nevertheless, galactose was observed efficiently incorporated into the 
LPS structure of galE mutant E. coli via the UDP-galactose-LPS galactosyl-
transferase system, where galactose is transferred from the sugar nucleotide 
into the incomplete polysaccharide moiety of the endogenous 
lipopolysaccharide (Csiszovszki et al., 2011; Schnaitman & Austin, 1990).  
Figure 4.29: Schematic diagram illustrating the specific cascade of Galactose 
metabolism.  
 
UDP-glucose is essential for the LPS synthesis, cell wall sugar moieties, 
capsular polysaccharides and membrane-derived oligosaccharides, as well as 
exopolysaccharides, either directly or via UDP-galactose (Berbis et al., 2015). 
Knowing that there is an insertion-sequence (IS1) mediated deletion (from galE 
to wcaA) within the O-antigen and colanic acid gene clusters in EC18 paired 
isolates (Figure 3.16) that resulted in the semi-rough type of LPS (Figure 3.4) 
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could explain why proteins associated with metabolism of galactose are up-
regulated in this strain, compared to others. 
Proteins in EC47 isolates were also exclusively up regulated compared to 
all UPEC paired isolates in cluster 995 (Figure 4.6). Their up-regulation 
indicates enrichment in the interconversions of the monosaccharide pentose 
and glucuronate, the salts or esters of glucuronic acid (carbohydrate 
metabolism) (Figure 4.12). Additionally, exclusive up-regulation was also noted 
for EC73 isolates protein expression in cluster 1120 (Figure 4.6). The enriched 
pathways were metabolism of alanine, aspartate, glutamate (amino acid 
metabolism); and pyrimidine metabolism (nucleotide metabolism) (Figure 4.11). 
The changes in these pathways have been shown to affect the bacterial small 
colony variant (SCV) phenotype. SCV is a slow-growing aberrant form of the 
wild type bacteria, which has been implicated in cases of persistent, relapsing 
and infections caused by bacteria that have a reduced susceptibility to 
antibiotics (Cui et al., 2012; Proctor et al., 2006). In fact, many studies have 
reported that chronic UTIs are caused by SCV E. coli (Dutt et al., 2014; Hooton, 
2001; Trülzsch et al., 2003). It is still unclear how relevant these findings to the 
strains in question, but it may explain their ability to cause urosepsis.   
In cluster 1152 and 1148, some pathways showed elevated expression 
profiles in the blood isolates from all STs (except those of ST127, which 
exhibited elevated expression in blood and urine) (Figure 4.6). These pathways 
range from genetic information translation (e.g. ribosome and aminoacyl-tRNA 
biosynthesis) (Figure 4.7) to metabolic pathways (e.g. riboflavin, pyrimidine and 
carbon metabolism) (Figure 4.8). This potentially indicates an overall increase in 
metabolic activity in blood isolates. Although in the current work there was no 
analysis performed on the growth curves between the blood and urine isolates 
 171 
of each strain, this finding could indicate that blood isolates have a higher 
growth rate than the urine isolates, with exception to ST127 isolates. 
Finally, histidine metabolism, which was enriched in cluster 1146 (Figure 
4.9) showed mostly intermediate expression except for the drop in ST127 
paired isolates (discussed below). 
 
4.4.4 ST127 paired isolates showed exclusive proteome profile  
HCL expression datasets show clear clustering for both isolates of ST127 
strains. Gene ontology analysis of differentially expressed proteins between 
blood and urine isolates indicated an increase in pathways linked to aerobic 
respiration, peptidoglycan-based cell wall synthesis, cofactor binding and 
magnesium ion binding. A decrease in carbohydrate catabolic processes and 
aminobutyraldehyde dehydrogenase activity was indicated by down-regulation 
of a number of genes in blood isolates compared to those from urine. Biological 
processes related to organelle proteins, including the two lipid bilayers, were 
also altered. 
EC18 paired isolates showed contrasting proteomic expression profiles to 
EC41 isolates. These were more elevated in EC18 than EC41 isolates, primarily 
in proteins involved in the TCA cycle pathway and galactose metabolism. 
Central metabolic pathways such as the TCA cycle are essential for UPEC 
fitness in vivo (Alteri et al., 2009). Increased expression in EC18 strains could 
be related to the previously discussed missing O-antigen, being a mechanism 
by which the isolates compensate and persist in both conditions (blood and 
urine).  
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In contrast, EC41 isolates exhibited a higher level of expression for 
proteins related to glutathione metabolism. This pathway is responsible for 
synthesis of glutathione during the exponential growth phase, which is then 
secreted into the medium (Bachhawat & Yadav, 2018). Many functions are 
known for this pathway, including transportation of amino acids (Bachhawat & 
Kaur, 2017), maturation of cytosolic iron-sulphur proteins (Sipos et al., 2002), 
iron metabolism (Kumar et al., 2011) and scavenging of glutathione from other 
lysing cells (Hanigan, 2014). With respect to metabolism involving iron, which is 
scarce in urine and blood, hydrolysis of L-glutathione can generate a more 
reactive thiol cysteinylglycine, which leads to ferric iron reduction to ferrous iron 
and initiates a iron redox cycling (Paolicchi et al., 2002). Therefore, glutathione 
metabolism is essential as it has key roles in cell viability. This also correlates 
with the finding that EC41 isolate proteins involved in the TCA cycle pathway 
were down-regulated compared to EC18 isolates. A study found that disrupting 
the degradation pathways of L-cysteine, serine and L-glutathione leading to 
TCA cycle flux reduction, and blocking glycogen formation, significantly 
improved the glutathione production (Zhang et al., 2016).  
The urine isolates of UPEC ST127 strains showed up-regulation in P-loop 
containing nucleoside triphosphate hydrolase (Figure 4.23). It encodes a protein 
with a similar function to YqeH GTPase, which is required for ribosome 
assembly and essential for bacterial growth (Guo et al., 2013; Loh et al., 2007). 
This could indicate that the ST127 urine isolates are more resilient and active 
considering the environment they were isolated from, especially when there was 
not much genomic variation between each of the paired isolates. Additionally, 
the ability to utilize human urine as a substrate for growth advances the 
incidence of bacteriuria. Surviving the urine by maintaining the growth of 
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colonizing organisms requires more ribosomal synthesis (Ipe et al., 2016; Roos 
et al., 2006; Wullt et al., 1998).  
Methane metabolism was the only pathway that was up regulated in blood 
isolates of UPEC ST127 strains when compared to the urine isolates (Figure 
4.18). This pathway is responsible for processing methane as the only carbon 
and energy source. In Methylococcus capsulatus, a Gram-negative coccoid 
bacterium, metabolism of methane produces pyruvate as the end result in 
oxygen-limited environments (Kalyuzhnaya et al., 2013). Whilst it is not 
immediately clear why this pathway would be upregulated in UPEC from blood, 
this is an environment with reduced oxygen tension, which may drive alternative 
pathways for pyruvate metabolism (Ettwig et al., 2010; Yu & Liao, 2018). This 
could explain the elevated expression observed in pyruvate metabolism 
pathways in different clusters (1148, 1150, and 1153). 
In addition, glycerophospholipid metabolism was also enriched across all 
paired isolates of UPEC ST127. Glycerophospholipids are essential to the 
Gram-negative bacterial membrane (Dalebroux, 2017). Bacteria need to cope 
and adapt to changes in the surrounding environment in order to survive. To do 
so, alterations to some proteins, specifically phospholipids, can reform cellular 
shape and add to the integrity of the cellular envelope. These adaptations will 
enable the bacteria to overcome environmental stresses, such as transitioning 
from the urinary tract into the blood stream (Rowlett et al., 2017). 
Furthermore, proteins of the phosphotransferase system (PTS) showed an 
intermediate elevation in expression profile across all UPEC isolates. 
Membrane transport systems such as the PTS are required for interpreting 
environmental information. PTS is a major carbohydrate transport system in 
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bacteria which catalyses the phosphorylation of received sugar substrates 
associated with their crossing of the bacterial membrane (Deutscher et al., 
2006). In fact, PTS proteins are necessary for the full deployment of pathogenic 
effects by many bacterial species (Kok et al., 2003).  
Some pathways, such as that involved in histidine metabolism, were 
observed to have a low level of expression in ST127 isolates (Figure 4.24). The 
histidine metabolism pathway is highly conserved across many bacteria (Itoh et 
al., 2007) and its main function is to act as a catabolic pathway allowing 
utilisation of histidine as a carbon and energy source (Bender, 2012). Moreover, 
proteins of the histidine metabolism pathway (HisA, HisB and HisG) (See 
Appendix V) had the highest expression in the urine isolates of ST73. This may 
result in an advantage over isolates from the other STs, regarding growth in 
urine and establishing UTI.   
 
4.4.5 Variations in the genomes of paired isolates  
No detailed genomic analysis was carried out on these data as it was out 
of the scope of this study. Nevertheless, a whole genome alignment was 
performed to check for gross differences, for example missing genes in urine 
isolate compared to blood isolate and vice versa in addition to generating BRIG 
figures for the isolates of each ST.  
Isolates of ST73 for both strains (EC22 and EC73) were largely identical 
with minor sequence changes. For EC22 isolates, the analysis could not find 
any hits matching the O type genes, which could indicate a deletion of the O-
antigen, but no further analysis was conducted.   
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A similar description can also be used for EC47 isolates of ST38. EC86 
isolates were stated as ST38 in a previous study (Alghoribi, 2015). However, 
the MLST analysis showed that the isolates are ST5150, which is within the 
ST38 clonal complex. However, both isolates were similar regarding the other 
aspects of the genomic analysis.     
The genomic analysis of EC1 isolates (ST131) showed major differences 
among the “pair” regarding serotyping and fim-typing, which could indicate that 
the clinical case was associated with two different UPEC ST131 as it has been 
reported in a previous study (McNally et al., 2013). Thus, the discrepancy in 
number of deleted genes can be justified. 
For EC10 blood isolate, there was an issue with sequencing the sample 
and results indicated sample contamination; it was discovered that the 30% of 
the sequence data were derived from an environmental organism identified as 
Stenotrophomonas maltophilia. Data for the ST131 strain in that sample were 
extracted and compared the urine isolate. Unfortunately, the differences 
between the assembled genomes were too substantial to allow strong 
conclusions to be drawn regarding the genomic variations between the EC10 
isolates.  
In a number of instances there were genes identified in blood isolates that 
were not present in the corresponding urine isolates. This may be seen as 
going against the hypothesis of a single strain from the urine ascending to the 
bloodstream, as gaining “new” genes would not be expected in this situation. 
One explanation for this might be that the single colonies originally recovered 
from the clinical samples are taken to represent what is probably a population of 
clones derived from a single strain that originally colonised the bladder. The 
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members of the derived clones may vary slightly in genetic content following 
many generations of replication.  
Genomic analysis showed high similarity between isolates of ST127 from 
urine and blood. There were ~28 SNPs in the EC18 blood isolate compared to 
the one from urine and no SNPs between EC41 isolates. Plasmid analysis also 
showed no difference in blood/urine isolates of both strains of ST127. With this 
being said, our analysis showed no clear correlation between these SNPs and 
proteomic analysis for these strains.  
 
4.4.6 Conclusion  
In this chapter, using relative expression values proved to be more useful 
than just LFQ values, especially when dealing with many different stains. This 
methodology aims to facilitate a more approachable visualisation of the data by 
standardisation of the LFQ value to the maximum value observed for any 
particular protein. Although all paired isolates were maintained in LB for several 
sub-cultures, the changes in metabolic activities seem to be stable as noticed 
from our proteomic data.  
From the previous analysis, we can see that not all UPEC isolates 
generated the same profiles for expression of metabolic pathways, although 
they have all been grown in the same conditions. Some STs have a higher 
metabolic potential that could provide more virulence advantages. For example, 
ST131 isolates demonstrated in a previous study a high metabolic potential and 
this may facilitate its wider dissemination to various environments (Gibreel et 
al., 2012a). 
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Furthermore, in many examples we have seen that all isolates of the same 
ST exhibit similar proteomic profiles. One of the main observations regarding 
the expression profile of ST127 strains is that there was minimal variation 
among the paired strains (blood and urine). Similarly, ST131 paired isolates 
presented limited levels of variation in proteomic profiles between blood and 
urine isolates.  
However, in some STs, one isolate in a pair displayed a different 
proteomic profile to the other member of the pair. Nevertheless, this only was 
noted on a small number of proteins. We hoped the variation might give us 
insights into the different phenotypes seen for some paired isolates considering 
the proteomic approach we followed. Although we generated highly valid data 



















5 Chapter Five: Proteomic Analysis of 
Uropathogenic Escherichia coli ST127 During 
Co-Culture with Uroepithelial Cells 
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5.1 Introduction  
Having established the use of proteomic approaches to investigate UPEC 
pathogenicity, we sought to continue to study what variable changes can occur 
during co-culture with epithelial cells. As the previous chapter demonstrated, the 
variations in the proteomic profiles of the urine isolates and the blood isolates 
were not substantial. The two clinical sources of the isolates (urine and blood) 
represent somehow the status of before and after the transition from UTI to 
bloodstream infection, respectively. One question that remains to be answered 
is what happens during the key stage of a developing UTI when bacterial cells 
are exposed to the bladder epithelium. 
Thus, in order to have a more complete picture of the proteome of UPEC 
ST127 in UTI, we investigated the proteome profile during growth in the 
presence of uroepithelial cell line (HT1197) (Robino et al., 2014; Tolg et al., 
2011). Adherence to and invasion of the bladder epithelial cells is an important 
step toward establishing uropathogenicity (Martinez et al., 2000). UPEC isolates 
can then replicate within the intracellular space, either free in the cytosol or in 
enclosed envelope. The bacteria can survive longer in former condition (Kim et 
al., 2018). In enclosed vesicles, bacteria can evade and resist the physical flush 
of urine flow, the immune system and antibiotic treatment (Blango & Mulvey, 
2010; Duncan et al., 2004). 
Studies have shown that some UPEC isolates are opportunistic invaders 
of the intracellular space and not exclusively extracellular pathogens (Dhakal et 
al., 2008). This means that not all UPEC isolates are invasive pathogens and, in 
fact, isolates of UPEC ST127 showed no invasion of uroepithelial cells in many 
studies (Alkeskas et al., 2015; O'Hara, 2018).  
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Proteomic study of this situation of co-culture of UPEC ST127 isolates and 
HT1197 uroepithelial cells could shed some light into the essential bacterial 
proteins required for initiating UTI and possibly further invasion into the 
bloodstream. In addition, investigating the epithelial cell proteome profile could 
provide us with a base line of the reaction of the epithelial cells during UTI or in 
some cases persistent recurrent infection.  
 
5.1.1 Aim and objectives  
In this chapter we aim to uncover the mechanisms underlying metabolic 
adaptation of ST127 UPEC strains during growth in co-culture with the 
uroepithelial cell line HT1197, using a quantitative proteomics analysis. To 
achieve this Aim, the following objectives were set: 
• Global proteomics profiling of ST127 UPEC strains in control (cells only) 
and co-culture conditions.  
• Secretomics approach to identify novel factors secreted by ST127 UPEC 
strains when co-cultured with HT1197 cells.  








5.2 Experimental design  
In this chapter we have three UPEC strains of ST127 (EC18, EC41, and 
SA189) and E. coli K12 as a control strain. Each strain was co-cultured with 
uroepithelial cells HT1197 in MEM media. Each sample had three parts to 
analyse:  bacterial cell pellets (soluble and insoluble); supernatants (the 
secretome); and the epithelial cell pellets. Three individual biological replicates 
were performed for each sample, bringing the total number of samples to 93 
(Figure 5.1)(Figure 5.2). 
 
 
Figure 5.1: Experimental design of the co-culture analysis of growh of ST127 
UPEC strains and E. coli K12 with HT1197 uroepithelial cells. The figure 
indicates the sub category samples for each set of co-culture experirments with 




Figure 5.2: General work flow chart of the methodology followed for the co-











5.3 Results  
5.3.1 Co-culture experiment 
As described earlier, ST127 UPEC strains (EC18, EC41, and SA189) in 
addition to non-pathogenic control strain E. coli K12 were co-cultured with 
HT1197 uroepithelial cells for 5 hours. Compared to previous chapters, sample 
volumes are relatively smaller than previous experiments. 
With the exception of strain SA189, all strains showed a minimal effect on 
the cells and any effect could be suggested to be due to deprivation of the 
media. HT1197 uroepithelial cells co-cultured with SA189 showed significantly 
different morphological shape compared to the other E. coli strains (Figure 5.3). 	
 
5.3.1.1 Uropathogenic E. coli SA189 effect on HT1197 cells 
Co-culture of SA189 with HT1197 resulted in a unique effect on the cells. 
Cells appeared to be larger and developed an oval shape after the 3rd hour of 
incubation, compared to the other E. coli strains (Figure 5.3).  
The typical shape of uroepithelial cells is an elongated shape. This 
morphology was lost and replaced with cell rounding (Figure 5.3) in HT1197 
cells exposed to SA189. In addition, the nucleus seemed to be more 
condensed. However, performing an MTT assay on the cell co-cultured with 
SA189 at different time points (3, 4, and 5 hours) indicated that the cells were 
still viable (Figure 5.4). Moreover, SA189 also caused the uroepithelial cells to 
detach from the flask surface, resulting in their flotation in the medium at the 
end of the five hours incubation.  
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Figure 5.3: HT1197 uroepithelial cells co-cultured with UPEC ST127 strains and 
E. coli K12. Photos were taken at 40x magnification using an inverted 
microscope. 
 3rd hour 4th hour 5th hour 
HT1197  
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E. coli 
K12 
   
UPEC 
EC18 
   
UPEC 
EC41 
   
UPEC 
SA189 
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Figure 5.4: MTT assay for the co-cultured UPEC SA189 with HT1197. Readings 
were taken at different time points (3, 4, and 5 hours) in addition to the control 
cells of HT1197 only at 5th hours of incubation. Data are plotted as the mean of 
four biological replicates and error bars represent standard error of the mean 
(SEM). p-Value represented as n.s. (not significant) for the absorbance 
comparison to the control sample. 
 
Following that morphological finding, we sought to investigate the cause 
by going systematically from testing a range of possibilities, including nutrient 
deprivation to actual invasion of the epithelial cells. This part was done in 
collaboration with a student (G. Guilas), but the thesis author lead the work and 
analysed the data. First, HT1197 cells were treated with either an SA189 
supernatant from 3 hours incubation (mid log phase) or an overnight culture. 
The supernatants were filtered twice and treated with gentamycin to minimize 
the bacterial presence. Both cultures indicated the absence of the effect in 
question, which could indicate that there is no effect of the bacterial secretome 
or nutrients deprivation, respectively. 
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The other possible reason for the effect could be due to the bacterial 
surface and its proteins/receptors following direct cell-cell contact. Heat killed 
(70°C and 90°C) UPEC SA189 in addition to gentamycin-killed cells were co-
cultured with HT1197 cells. The unique effect was also absent in these cases 
which possibly indicates that the effect in question only occurs HT1197 cells are 
when co-cultured with live and untreated UPEC SA189. Further investigation of 
the cause of this effect was not performed. 
 
5.3.2 Protein extractions 
All samples were cultured from a single colony in 10 ml AUM media and 
incubated at 37°C for 3 hours (mid log phase). Protein extraction was 
performed after 5 hours of co-culture in 75 cm2 cell culture flasks. For bacterial 
pellets, soluble proteins were extracted using the B-PER complete bacterial 
protein extraction reagent, while insoluble proteins were extracted using SDT 
lysis buffer.  
BCA protein estimation indicated a higher protein extraction yield in 
insoluble fragments than the soluble one. Moreover, in unpaired t test analysis, 
insoluble proteins were statistically more significant in yield than those of the 
soluble fraction in all control sets and the EC18 co-culture experiment (Figure 
5.5). While for epithelial cell protein extractions, we found no statistical 
significance in co-culture experiments compared to the control set, except for 
SA189 co-culture (Figure 5.6).  
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Figure 5.5: BCA estimation for bacterial protein yield extracted from E. coli K12, 
E. coli EC18, E. coli EC41 and E. coli SA189 in co-culture conditions and MEM 
only control. Data are plotted as the mean of three biological replicates and 
error bars represent standard error of the mean (SEM). p-Value represented as 
(**** = p≤0.0001, *** = p≤0.001, ** = p≤0.01, * = p≤0.05, n.s. = not significant) 
for the soluble vs insoluble protein fractions on comparison within each sample. 
 
Figure 5.6: BCA estimation for protein yield extracted from HT1197 uroepithelial 
cells co-cultured with E. coli K12, E. coli EC18, E. coli EC41 and E. coli SA189. 
Data are plotted as the mean of three biological replicates and error bars 
represent standard error of the mean (SEM). p-Value represented as (**** = 
p≤0.0001, *** = p≤0.001, ** = p≤0.01, * = p≤0.05, n.s. = not significant) for the 









































































On SDS PAGE analysis, it was clear that HT1197 protein extractions from 
different co-culture sets and the control have a similar profile with well-resolved 
protein bands visible. However, due to exclusive effect of SA189 on HT1197, 
extracted proteins were very low yield, as shown on the gel (Figure 5.7).  
 
 
Figure 5.7: Protein extractions for HT1197 cells co-cultured with E. coli EC18, 
E. coli EC41, E. coli SA189 and E. coli K12 loaded on SDS PAGE gels. Protein 
extracted by 2% SDS in 100 mM Tris-Hcl; 30 µg of protein was loaded for all 






5.3.3 Analysis of the bacterial proteome profiles during co-culture 
with HT1197 cells 
Following analysis of the results using MaxQuant and Perseus to 
interrogate the E. coli K12 and UPEC strains (UTI89 and 536) databases, 1301 
proteins were identified in the bacterial pellets (soluble and insoluble) across all 
co-culture experiments including the control samples of E. coli strains in MEM. 
As there were three biological replicate experiments for each condition, proteins 
were classified as being present when observed in at least one replicate in 
either the experiment set or the control set. On the other hand, quantified 
proteins were those that were identified in a minimum of two replicates in each 
experimental group (co-culture experiment and control) (Table 5.1).  
 
Table 5.1: Total proteome profiles of all strains of UPEC ST127 and E. coli K12. 
The differentially regulated proteins indicate an experiment to control ratio which 










Total proteins identified 
in all strains 1301 
Proteins identified  
per strain 
362 391 398 1282 
Proteins quantified  
for each strain 
34 46 63 1086 
Differentially regulated 15 30 33 288 
 
Pathway enrichment analysis on subset of differentially expressed proteins 
was performed using DAVID webtool (Dennis et al., 2003) (Table 5.2). 
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Table 5.2: Pathways up-regulated in the bacterial proteome of all strains of 
UPEC ST127 and E. coli K12. Pathways are those enriched in up-regulated 
proteins (≥1.5 fold) in co-culture vs. control. 
Pathways K12 EC18 EC41 SA189 
RNA degradation é   é 
Glycolysis / Gluconeogenesis é é é é 
Butanoate metabolism  é  é 
Pyruvate metabolism  é é é 
Ribosome production   é é é 
Aminoacyl-tRNA biosynthesis   é é 
Citrate cycle (TCA cycle)   é é 
Purine metabolism    é 
Pyrimidine metabolism    é 
Amino sugar and nucleotide sugar metabolism    é 
Tyrosine metabolism    é 
Alanine, aspartate and glutamate metabolism    é 
Pentose phosphate pathway    é 
Starch and sucrose metabolism    é 
Metabolism of xenobiotics by cytochrome P450    é 
Glutathione metabolism    é 
Propanoate metabolism    é 
Cysteine and methionine metabolism    é 
One carbon pool by folate biosynthesis pathway    é 
Valine, leucine and isoleucine biosynthesis    é 
3-Chloroacrylic acid degradation    é 
Lipopolysaccharide biosynthesis    é 
1- and 2-Methylnaphthalene degradation    é 
Novobiocin biosynthesis    é 
Phenylalanine metabolism    é 
Taurine and hypotaurine metabolism    é 
Fructose and mannose metabolism    é 
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UPEC SA189 has more affected pathways when considering the number 
of isolated proteins (Table 5.1). Three pathways were shared between UPEC 
isolates in their up-regulation: glycolysis/gluconeogenesis; pyruvate 
metabolism; and ribosome production pathways. 
Down-regulated pathways (n=5) were considerably fewer in number 
compared to the up-regulated pathways (n=27). Enriched down-regulated 
pathways were only detected for UPEC EC18 and SA189, with no pathways 
shared between them (Table 5.3). 
 
Table 5.3: Pathways down-regulated in the bacterial proteome of all strains of 
UPEC ST127 and E. coli K12. Pathways are those enriched in down-regulated 
proteins (≥1.5 fold) in co-culture vs. control. 
Pathways K12 EC18 EC41 SA189 
Amino sugar and nucleotide sugar metabolism  ê   
Pyrimidine metabolism  ê   
Oxidative phosphorylation    ê 
ABC transporters    ê 
Pyruvate metabolism    ê 
 
5.3.4 Analysis of the secretome profiles from UPEC and HT1197 
cells during co-culture experiments 
We have identified 1878 proteins in secretome across all co-culture 
experiments including the control samples of E. coli strains in MEM through 
interrogation of the E. coli K12 and UPEC strain UTI89 and 536 databases. We 
identified proteins present in at least one replicate of the three biological 
replicates (Table 5.4).  
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Table 5.4: Total secretome profiles of HTT1197 cells and all strains of UPEC 
ST127 and E. coli K12 in co-culture and control conditions. The identified 
proteins were based on the on presence of at least one peptide in all replicates. 
Culture Identified proteins Culture Identified proteins 
MEM medium 2 Control cells 854 
K12 2 K12+cels 900 
EC18 13 EC18+cells 969 
EC41 250 EC41+cells 1146 
SA189 634 SA189+cells 1375 
 
For the secretome analysis, we checked for overlapping proteins using 
Venn diagrams to focus our analysis on specific categories. For instance, for 
each E. coli strain, four samples (e.g. UPEC EC18, control HT1197 cells, MEM 
medium and the co-culture of EC18 and HT1197) were used in one diagram. 
The analysis focused on the uniquely identified proteins in the co-culture 
condition after cross elimination with the control samples (MEM medium, E. coli 
in MEM, and HT1197 cells only). Thus, we have identified 412 proteins uniquely 
seen in EC18 co-culture, 391 proteins in EC41 co-culture, 305 proteins in 
SA189 co-culture, and 292 proteins in the K12 co-culture condition (Figure 5.8). 
Also, for a closer look into these secretome profiles, all uniquely identified 
secretomes in the co-culture conditions were compared (Figure 5.9). This step 
was done to show what proteins are shared between all UPEC ST127 co-
cultured conditions (n=17) and what are exclusive in EC18 (n=219), EC41 
(n=187) and SA189 (n=235). Interestingly, EC18 and EC41 under co-culture 
conditions shared more proteins (n=155) than either did with the SA189 co-
culture secretome.  
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Figure 5.8: Overlaps between identified secretomes in all strains of UPEC ST127 and E. coli K12 in co-culture and control conditions. 
Uniquely identified secretomes in co-culture conditions are highlighted in red. Venny 2.1 tool was used to produce the figures.                                            
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Figure 5.9: Overlaps between identified unique secretomes in co-culture conditions of all strains of UPEC ST127 and E. coli K12. These 
Venn diagrams showed all UPEC ST127 strains (EC18, EC41, and SA189) with (left) and without (right) K12. Venny 2.1 tool was used to 
produce the figures. 
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Further detail of the proteins shown in Figure 5.9 is given in Table 5.5, 
which displays the bacterial and epithelial proteins observed in various 
conditions. The Table shows that the bacterial proteins were the majority of the 
secreted proteins observed in co-culture conditions, except for the SA189 
experiment. Moreover, although more bacterial proteins were shared between 
EC18 and EC41 than SA189 (as stated above), epithelial proteins were 
predominant regarding the proteins shared by SA189 and the other UPEC 
during co-culture conditions. 
The Bacterial secreted proteins were checked for secretome prediction 
using SignalP 5.0 tool (Petersen et al., 2011). Out of the final 540 bacterial 
secretome, only 55 proteins (10.19%) were predicted to be secreted proteins 
using E. coli UTI89 database (Table 5.5).   
The epithelial secreted proteins were also analysed and confirmed using 
the Vertebrate Secretome Database (VerSeDa) (Cortazar et al., 2017). In 
general, the database showed that almost half (49.69%) of the epithelial 
proteins identified during co-culture were predicted to be secreted proteins 
using the Homo sapiens (GRCh37) dataset. 
Analysis on DAVID tool showed that most of the secretory proteins are 
enriched for ABC transporter pathways.  Furthermore, cross-examining the list 
of the bacterial secretome with the predicted secretory proteins in SignalP and 
the bacterial proteins extracted from the pellets, we found a list consisting of 
192 proteins (35.56%) that were present in the secretome, but were not in the 




Table 5.5: Bacterial and epithelial proteins identified in the secretomes during 
co-culture of all strains of UPEC ST127 with HT1197 cells. 














"EC18+cells" 219 203 25 16 5 
Exclusive to 
"EC41+cells" 187 175 17 12 8 
Exclusive to 
"SA189+cells" 235 3 2 232 119 
"EC18+cells" and 
"EC41+cells" 155 144 9 11 3 
"EC41+cells" and 
"SA189+cells" 32 9 1 23 11 
"EC18+cells" and 




17 5 1 12 7 




These proteins were analysed on DAVID tool to investigate the enriched 
pathways. Proteins highlighted in red (Table 5.6) are the only ones that showed 
pathway enrichments. Figure 5.10 shows some of the enriched pathways, 
where carbohydrate metabolism pathways such as glycolysis/gluconeogenesis 
and pyruvate metabolism are common and shared in these conditions.  
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Table 5.6: Details of bacterial secreted proteins from various co-culture 
conditions of all strains of UPEC ST127 with HT1197 cells. 
Venn diagram areas 
Secreted bacterial proteins 
that are not in the bacterial 
secretome database* 
Exclusive in "EC18+cells" 66 
Exclusive in "EC41+cells" 67 
Exclusive in "SA189+cells" 1 
"EC18+cells" and "EC41+cells" 52 
"EC41+cells" and "SA189+cells" 4 
"EC18+cells" and "SA189+cells" 1 
"EC18+cells", "EC41+cells" and "SA189+cells" 1 
Total 192 / 540 (35.56%) 














Figure 5.10: Pathways enriched in collections of proteins that were identified as part of the secretome under various co-culture conditions 
with UPEC ST127 strains and HT1197 cells, but were not present in bacterial secretome databases. Pathway enrichment of proteins 
seen exclusively in EC18, EC41, or both co-cultures conditions is shown.  
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5.3.5 Analysis of the epithelial proteome profiles during co-culture 
experiments with UPEC and HT1197 cells  
Examining the results of MaxQuant analysis against the human proteome 
database revealed that 1658 proteins were identified in the combined data for 
epithelial cells across all experiments, including the control sample (Table 5.7).  
These proteins were identified when present in at least one biological 
replicate in either the experiment set or the control set. The only proteins 
actually quantified in this work were those identified in a minimum of 2 
replicates in each experimental group (co-culture experiment and control). The 
data indicated a good correlation between replicates of ≥ 0.9 (Appendix VI). 
 
Table 5.7: Total proteome profiles of all epithelial cells co-cultured with UPEC 
ST127 strains and E. coli K12. The differentially regulated proteins indicate the 
experiment to control ratio where up-regulated and down-regulated proteins 














1393 1173 1202 1308 
Quantified  
(Per condition) 
992 987 980 486 
Differentially 





HCL clustering showed the unique profiling of the co-culture experiment of 
HT1197 epithelial cells with UPEC SA189 (Figure 5.11). On the other hand, the 
control condition and the rest of the UPEC (EC18 and EC41) co-culture 
conditions clustered together and apart from E. coli K12. This finding 
complements the finding of morphological analysis of the epithelial cells, as 
described above.  
 
Figure 5.11: Hierarchical clustering (HCL) following label-free quantification 
(LFQ) of proteins from HT1197 cells (CLL) co-cultured with E. coli K12, EC18, 
EC41, SA189, compared to a control of culture (CON) in MEM alone. LFQ 
intensities are the output of the MaxLFQ algorithm and are based on the raw 
intensities and normalized on multiple levels.  
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The overlap in quantified proteins in all co-culture conditions was 
examined to identify the similarity in proteome profiles between these conditions 
(Figure 5.12). All conditions had a similar number of proteins, apart from the 
SA189 co-culture condition (Table 5.7). Interestingly, the majority of the proteins 
fell into two sections: proteins that are shared between all co-culture conditions 





Figure 5.12: Overlaps between quantified epithelial proteins of HT1197 cells co-
cultured with UPEC ST127 strains and E. coli K12. Venny 2.1 tool was used to 





Furthermore, the differentially regulated proteins were also overlapped to 
detect the percentage of shared proteins between the up-regulated and the 
down-regulated proteins. With only two proteins (0.6%) shared between the 
different regulations, it emphasises the similarity of the data obtained across all 
co-culture conditions.  
The two identified proteins are ST13 and AKR1B1. ST13 protein is a 
fragment of Heat shock cognate 70 (Hsc70) interacting protein, which has a key 
role in protein folding and protein degradation. This protein was up-regulated in 
the EC18 condition and down-regulated in co-culture with SA189. The other 
protein (AKR1B1) was up-regulated in co-culture with EC41 and down-
regulated in the SA189 condition. This protein plays a role in folate biosynthesis 
(Werner et al., 2011). 
Regarding the differential regulation of proteins shared between all 
conditions, most of these proteins were exclusive to the SA189 co-culture 
experiments. For example, 147 of 186 up-regulated proteins and all 100 down-
regulated proteins were exclusively observed in UPEC SA189 co-culture with 
HT1197 cells. In another words, the ‘All conditions’ proteins section is 
dominated by proteins seen in SA189 co-culture experiments (Table 5.8).  
 
Table 5.8: Differentially regulated epithelial proteins of HT1197 co-cultured with 
UPEC ST127 strains and E. coli K12. 





HT1197 + K12, EC18, and EC41 478 38 3 
All conditions 483 186 100 
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Pathways enriched in up-regulated proteins in the UPEC SA189 condition 
were associated with proteins linked to Parkinson's disease and Alzheimer's 
disease. However, other pathways were down-regulated, such as some linked 
to cell cycle, regulation of the actin cytoskeleton and focal adhesion.  
On the other hand, the ‘pathogenic Escherichia coli infection pathway’ was 
the only pathway enriched in the co-culture experiments with other E. coli 
strains and the ‘ribosome production pathway’ was down-regulated. 
The experiment that showed the unique effect of exfoliation (SA189) had 
undetectable levels of paxillin protein (Figure 5.13). Thus, this condition has a 
significant decrease (p=0.0332) in cytoskeletal paxillin protein compared to the 
control.  
 
Figure 5.13: LFQ intensity of paxillin protein extracted from uroepithelial 
HT1197 cells co-cultured with E. coli K12, E. coli EC18, E. coli EC41 and E. coli 
SA189. Data are plotted as the mean of three biological replicates and error 
bars represent standard error of the mean (SEM). p-Value represented as (* = 
p≤0.05, n.s. = not significant) for the protein comparisons to the control sample. 
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5.4 Discussion  
5.4.1 Co-culture conditions and proteins extractions 
In this experimental set up, we had three sets of samples to analyse: 
bacterial proteins; epithelial cells proteins; and the secretome (including both 
bacterial and epithelial proteins). These three samples types were technically 
challenging with regards to the volumes obtained, since the co-culture 
experiments could only be done in in 75cm2 cell culture flasks, resulting in a 
maximum of 15 ml yield (supernatant). In addition to low volume of supernatant 
obtained, this experimental set up was technically challenging due to low 
number of cells. This is in contrast to previous proteomics experiments where 
bacteria are normally grown in 100 ml of media.  We expected low protein yield 
as consequence and hence could only run samples in three biological replicates 
without any technical replicates. 
Furthermore, the UPEC SA189 co-culture condition presented a new 
challenge with the unique effect on HT1197 uroepithelial cells. The rounding of 
the cells and detachment from the flask surface made the sample separation 
more difficult between the bacterial and epithelial parts. However, we were able 
to separate them using a 5 µm filter tube to collect the E. coli cells (2 µm). To 
investigate this effect further, we performed an MTT assay. Interestingly, SA189 
co-cultured epithelial cells (at different time points) showed no statistically 
significant difference to the control samples, indicating that there was no 
negative impact on cell viability. In a previous study, using HT1197 cells 
demonstrated an elevated level of nuclear de novo methyltransferase (DNMT1), 
known as the “maintenance DNMT”, when inoculated with UPEC UT189 (Tolg 
et al., 2011). It also revealed epigenetic modification and down-regulation of 
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growth-suppressor genes, such as cyclin-dependent kinase inhibitor 2A 
(CDKN2A) and O6-methylguanine-DNA-methyltransferase (MGMT), which 
suggests that infection initiates pathogen-specific modifications of the host cell 
epigenome.  
Regarding protein extractions, bacterial protein extractions were 
performed similarly to what have been described in the previous chapters 
including isolation of soluble and insoluble proteins. The insoluble proteins 
represented the significant proportion of proteins, compared to soluble ones. 
The insoluble proteins were also more abundant than soluble ones in the 
previous chapters, which could say more about the extraction methods of using 
SDT lysis buffer being more effective for future studies. Epithelial proteins were 
extracted using SDT lysis buffer. The amounts of proteins were similar to the 
control, except for the SA189 co-culture experiment. This can be explained due 
to loss some of the epithelial proteins during the retrieval process using filter 
tubes.  While trying to lyse the epithelial cells on the filter and eluting out the 
proteins, it is expected that a lower amount of proteins than anticipated will be 
recovered. 
Secretomes form an essential class of proteins that control and regulate 
many biological and physiological processes, which make it clinically important 
regarding identifying new biomarkers and therapeutic targets (Dwivedi et al., 
2016; Gagic et al., 2016; Monteiro et al., 2016). In this chapter, TCA 
precipitation assay enable us to isolate the secreted proteins in all co-culture 
and control conditions. The precipitation technique was found to be more 
successful with prolonged incubation (overnight) of the samples at 4°C. 
 
 206 
5.4.2 Overview of the proteomic profiles’ analysis  
Due to the presence of proteins from different organisms in this study, we 
used different databases to identify the extracted material. For the bacterial 
proteome, we used a collection of UPEC databases (n=2) in addition to the E. 
coli K12 database in order to cover diverse aspects of the bacterial proteome. 
Epithelial proteome data was analysed using the Human protein sequence 
database (forward and reversed version) (http://www.uniprot.org/, UniProt. 
Release May 2017). The reason not to include all of the databases together as 
one shared database, is to reduce and eliminate the expected background 
contamination of the epithelial proteins with the bacterial proteins and vice 
versa. However, we used a combined database for the secretome data analysis 
as it contains both bacterial and epithelial secreted proteins.  
Pathogenicity islands within UPEC strains encode many bacterial toxins 
such as cytotoxic necrotising factor 1 (CNF1), vacuolating auto-transporter toxin 
(Vat), secreted autotransporter toxin (Sat), and Hemolysin A (Bien et al., 2012; 
Terlizzi et al., 2017; Wiles et al., 2008). It has been reported that 30-50% of 
UPEC strains express Hemolysin A, which is associated with the infection 
severity (Mobley et al., 1990).  
Hemolysin A consists of 1024 aa/ 3075 bp. The molecular weight of the 
polypeptide is 110.25 kDa (predicted from the nucleotide sequence) according 
to the E. coli CFT073 database (Welch, 1991; Welch et al., 2002). This protein 
is encoded in ST127 reference strain 536 by the gene hlyA (protein accession 
no. Q1R2T5) (Dobrindt et al., 2002). In addition, it has been shown that HlyA 
toxin can target and degrade the paxillin protein, which plays a role in the 
protection of mammalian cell physical integrity (Dobrindt et al., 2002). 
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Remarkably, the HlyA protein was only produced and detected during the 
SA189 isolate co-culture experiment in both the bacterial proteins and the 
secretome data (data not shown). The paxillin protein was not detected in the 
epithelial cells co-cultured with SA189, but it was detected in every other 
sample. This finding could explain the exfoliation effect on the epithelial cells 
observed in this study. HlyA toxin triggers proteolysis of host proteins, which 
can also target proteins involved in the cytoskeleton, inflammation and 
apoptosis of the cells. In addition, the proteolysis process requires stable 
interactions between HlyA toxin and host membranes (Dhakal & Mulvey, 2012). 
Further discussion on this topic is presented in section 5.4.2.3. 
Furthermore, alpha hemolysin is encoded within the hlyCABD operon 
(Cavalieri et al., 1984; Linhartova et al., 2010). However, as mentioned in 
Chapter 3, the hlyA gene was not identified in the genome sequence of UPEC 
strains EC18 nor EC41. The UPEC SA189 genome possessed this gene as 
well as expressing the protein. 
 
5.4.2.1 Bacterial proteomic changes during the co-culture experiments  
Regarding the analysis of the bacterial and epithelial proteins, they were 
identified based on presence in at least one of the three biological replicates. 
This means that there are some proteins present in one condition, but not the 
other. Therefore, it is not statistically accurate to use this list of proteins to 
quantify all the differentially regulated proteins. Thus, we set the parameter to 
have a minimum of two replicates in each experimental group (co-culture 
experiment and control). Following this methodology, we can obtain average 
LFQ intensity readings of proteins for each experimental set. Sequentially, the 
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LFQ intensity ratios of the experiment to the control set can be used to highlight 
the proteins differentially regulated by 1.5 fold in both ways (up and down). 
Nevertheless, proteins expressed solely in co-culture experiments were 
examined (minimum of two replicates) for each strain (data not shown). The 
analysis generates a short list of proteins, which gave no extra information than 
what found in the following analysis regarding pathways enrichments. 
For alpha hemolysin protein, the database showed that this protein is an 
extracellular protein (Figure 5.14). Analysis on the PSORTb tool v 3.0.2 (Yu et 
al., 2010) showed that the localization site is extracellular with the same 
prediction result. 
Figure 5.14: Analysis of HlyA protein using the PSORTb tool. The screenshot 
indicates the prediction of hemolysin A protein as extracellular protein.  
 
For the bacterial proteins, enriched up-regulated pathways are listed in 
Table 5.2. The majority of the pathways fall under the metabolism pathways 
except for RNA degradation, ribosome and aminoacyl-tRNA biosynthesis 
pathways, as these come under genetic information processing (Kanehisa et 
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al., 2017). Carbohydrate metabolism pathways took the lead in this analysis as 
they were in the majority. For example, glycolysis/gluconeogenesis, citrate cycle 
(TCA cycle), butanoate metabolism and pyruvate metabolism pathways were 
among the top shared pathways among UPEC isolates.  
The importance of gluconeogenesis and TCA cycle pathways have been 
described in a previous study indicating that mutant strains in these central 
metabolic pathways were unable to colonize the bladder nor the kidneys of in 
vivo mouse model (Alteri et al., 2009). Both pathways are connected and 
working together to form intermediates of a metabolic pathway, where the TCA 
cycle provides substrates for gluconeogenesis when cells use amino acids as a 
carbon source. This also connects the pyruvate metabolism pathway, when 
amino acid are degraded to oxaloacetate or to pyruvate, which can be 
converted to acetyl-CoA and enter the TCA cycle (Figure 5.15) (Gottschalk, 
1986; Takahashi et al., 2000). The butanoate/butyrate pathway is also 
associated with the previous pathways via fermentation of acetyl-CoA to 
butyrate (Hadjifrangiskou et al., 2011; Monk et al., 2013).  
Other carbohydrate metabolism pathways were also enriched for SA189 
exclusively. In addition, amino acid metabolism pathways (e.g. tyrosine 
metabolism and alanine, aspartate and glutamate metabolism pathways) came 
second in up-regulated enrichment for SA189 strain.    
From our results, we can see that E. coli K12 has a minimal effect on 
epithelial cell protein expression compared to the UPEC isolates. The majority 
of metabolic variations lay with UPEC SA189, which could indicate a high 
potential for virulence as observation in the co-culture experiments (Gibreel et 
al., 2012a).  
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Figure 5.15: Acquisition of amino acids and roles of gluconeogenesis and the 
TCA cycle in fitness of UPEC. Adapted from (Alteri et al., 2009). 
 
In contrast, down-regulated pathways were all metabolism pathways 
except ABC transporter pathways (environmental information processing). More 
specifically, dppB, dppD, and dppF are the genes involved in down-regulation of 
Dipeptide transport systems in the SA189 co-culture experiment. These 
proteins are part of the binding-protein-dependent transport system for 
dipeptides, which are responsible for the translocation of substrate across the 
membrane (Haugen et al., 2007). This finding in particular is interesting as it 
contrasts previous studies that indicated the importance of dpp operon and 
reported its up-regulation during UTI (Mehta et al., 2015; Subashchandrabose 
et al., 2014). These contrasting results may be explained by strain level 
differences.  
There was only a low number of down-regulated pathways and they were 
only enriched in UPEC EC18 and SA189 experiments.  
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5.4.2.2 Secreted proteins observed during the co-culture experiments 
with UPEC and K12 E. coli with HT1197 cells 
The analysis regarding the secretome data was conducted using a new 
approach. The secretome contained both bacterial, epithelial and some cell 
medium proteins. We were interested to identify which proteins are secreted 
exclusively during the co-culture conditions. Thus, overlapping proteins with 
control HT1197 cells and UPEC isolates were excluded from the study. 
The uniquely identified proteins were compared to see which proteins are 
exclusive to experiments with each UPEC isolate and what is shared across all 
experiments. The majority of these proteins were bacterial proteins. In addition, 
co-culture with SA189 led to a lower count of secreted bacterial proteins 
compared to with the other UPEC. 
Interestingly, a high number of proteins that were exclusive in either EC18 
or EC41 were not predicted as secretory proteins using SignalP tool. Applying 
SignalP as a prediction tool for signal peptides is currently common practice. 
Proteins with signal peptides can be targeted to the secretory pathway, but are 
not necessarily secreted (Nielsen, 2017). A signal peptide is the N-terminal part 
of the protein that is targeted to the secretory pathway in both prokaryotes and 
eukaryotes (von Heijne, 1990). SignalP has an accuracy rate of 78.1% for 
predicting signal sequences (Zhang & Henzel, 2004), yet it remains the leading 
tool and the most accurate over other predication tools (Choo et al., 2009).  
Looking at the non-secretory proteins, ‘ribosome production’ was the 
major pathway enriched with these proteins. These proteins are generally not 
secreted but could be present in the secretome following cell lysis during the 
extraction process. Furthermore, although hemolysin A protein was isolated in 
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the secretome of UPEC SA189, analysis of its amino acid sequence on SignalP 
predicts the probability that the sequence does not have any kind of signal 
peptide (Figure 5.16). However, other studies indicated that type I secretion 
system is used to translocate hemolysin A (Gentschev et al., 2002; Thomas et 
al., 2014). 
Figure 5.16: Probability analysis of HlyA protein on SignalP 5.0 tool. The 
screenshot indicates the final prediction of hemolysin A protein as ‘other’ non 
signal peptide protein. 
 
The main differences between Type I secretion system and the other three 
secretion systems are: (1) the formation of periplasmic intermediates is not 
required for the passenger proteins, as it secreted directly into the extracellular 
medium; (2) the targeting signals are located at the carboxyl terminus of the 
secreted proteins; (3) generally, no cleavage of the secretion signals is 
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necessary during or after secretion (Gentschev et al., 2002; Holland et al., 
1990; Wagner et al., 1983). 
Around 50-78% of UPEC isolates from pyelonephritis cases express 
hemolysin A (Bien et al., 2012; Ristow & Welch, 2016). In many studies 
focusing on understanding the effects of hemolysin both in vitro and in vivo 
infection models, it is hypothesized that hemolysin A is secreted at sublytic and 
lytic doses in vivo (Garcia et al., 2013; Grimminger et al., 1991; Mansson et al., 
2007). Expression variability of hemolysin A in different clinical isolates limits 
our understanding of its regulation process (Murthy et al., 2019; Ristow & 
Welch, 2016). Yet, it makes a strong vaccine candidate as it not only modulates 
epithelial cell functions, but also disables macrophages and suppresses 
inflammatory responses (Dhakal & Mulvey, 2012; Smith et al., 2015). 
 
5.4.2.3 Epithelial proteome determination during the co-culture 
experiments with E coli and HT1197 cells  
The epithelial proteomes were processed similarly to the bacterial 
proteins, by comparing the co-culture conditions to the control sample of 
HT1197 uroepithelial cells in MEM medium alone. Noticeably, the epithelial 
proteins isolated in SA189 experiments were higher in numbers, which may not 
be surprising considering the unique effect of exfoliation on HT1197 cells. On 
the other hand, K12, EC18 and EC41 showed a shared and minimal effect on 
the epithelial proteome. 
Overall, host cell exfoliation involves degradation of cell-cell and cell-
matrix links, which seemingly requires break down of focal adhesions and other 
functionally related structures (Nakagawa et al., 2006). Actinin and filamin have 
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been shown to work cooperatively to enhance the cytoskeletal structures rigidity 
of the actin filament networks (Esue et al., 2009). In the current study, this was 
observed in the form of enriched pathways for down-regulated proteins (talin, 
actinin, rac, filamin, and vinculin) in the UPEC SA189 co-culture experiment, 
which revealed that the actin filament networks are probably weakening. 
Lytic doses of HlyA can induce the exfoliation process. However, sublytic 
doses can activate some host proteases, including mesotrypsin, which will 
ultimately lead to the degradation of paxillin (Dhakal & Mulvey, 2012; Ristow & 
Welch, 2016). Paxillin protein is a 68 kDa multi domain support protein that can 
control the interaction forces between cytoskeletal changes and host cell 
adhesion via synchronized interactions with numerous essential and regulatory 
proteins (Deakin & Turner, 2008). In a previous study, human bladder epithelial 
cells (BECs) were infected with a reference UPEC isolate (UTI89) to test the 
stability of paxillin protein. The infected cells showed a decreasing level of the 
protein over the course of infection, with totally undetectable level after 4 hours 
of co-culture incubation time (Dhakal & Mulvey, 2012). These findings are 
consistent with those in the current study, as revealed by extraction of the whole 
proteome profile after 5 hours of uroepithelial cell co-cultured with different 
UPEC isolates.  
HlyA initiates the degradation of paxillin. For example, targeted deletion of 
hlyA gene in UPEC strain UTI89 resulted in an elimination of paxillin 
degradation in BECs. However, complementation of the hlyA mutant restored 
the phenotype (Dhakal & Mulvey, 2012). HlyA has the possibility to induce host 
cell apoptosis and tissue turnover rates within BECs (Smith et al., 2008). In fact, 
possession of the hlyA gene and ability to express it enhances UPEC strain 
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tissue damage within the urinary tract, consequently causing more severe 
clinical UTI (Johnson, 1991; Marrs et al., 2005).  
The fact that all UPEC strains in this study were clinical isolates that 
exhibited notable differences in their effect on the epithelial cells adds to the 
fact that pathogenesis in UPEC is still a complex subject to understand. It varies 
from one strain to another in the same ST, not to mention the host variations in 
clinical cases and differences in susceptibility from one case to another.  
 
5.4.3 Conclusion  
In this study, different UPEC isolates from clinical samples were examined 
and observed to vary in their effect on uroepithelial cells. Knowing that all 
isolates belong to ST127, the data suggest that not all isolates of the same ST 
necessarily mediate UTI using the same mode of action. Although not 
surprising, the extent of the difference between the effect of strain SA189 
compared to other strains was notable. 
The findings of the study also suggest that the observed effect of epithelial 
cells peeling off the cell culture plate is a type of defence mechanism towards 
infection with UPEC strain SA189. In addition, changes in cells shape were 
likely to be due the depletion of paxillin protein, which plays a role in 
maintaining the cytoskeletal structure of epithelial cells.  
Furthermore, from the data, it is reasonable to conclude that the exfoliation 
effect on HT1197 cells is a result of the presence of the viable UPEC SA189, 
which may indicate that UPEC SA189 mediates the exfoliation effect via 
adhesion, potentially followed by invasion. This indication is yet to be confirmed. 
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This work has demonstrated the potential of whole proteome profiling for 
investigating host-pathogen interactions. The approach can be applied to 
investigate both bacterial (soluble and insoluble) and epithelial proteins, which 
enables detection of variations in enriched pathways using numerous data 
analytical tools such as DAVID.  It should be acknowledged that extracting the 
proteins following five hours incubation places some challenges on the protein 


























6.1 Is shotgun proteomics an effective tool for investigating 
the bacterial proteome?  
Uropathogeneic E. coli is the most common cause of UTI. These cases 
have been growing rapidly in the last decade with more AMR strains surfacing 
causing a hefty burden on the health services due to increased hospital visits, 
hospitalised patient, and prescribed antibiotics.  Currently, there is a need to 
take a different approach to investigate these pathogens.   
This study was able to determine the differences in proteomes of different 
isolates of UPEC ST127 and the data correlated well with the background data 
from the genome analysis, in some specific cases. In addition, proteomics data 
were highly reproducible for each strain as a result of standardisation of the 
incubation conditions and protein extraction methodology. The ability to have a 
quantitative analysis of the proteins gives us a more accurate understanding, in 
contrast to just using the genomic data or traditional protein analysis techniques 
(Western blot). 
 These conditions can be engineered to simulate the variety of 
environments UPEC isolates may need to survive in. The methods that have 
been developed will support future studies that could significantly enhance our 







6.2 Are there proteomic variations between paired isolates of 
UPEC from urosepsis and if so, what are they? 
UPEC strains can invade the epithelial cells of the bladder and initiate an 
intracellular infection cycle. They can colonize the bladder and kidney, which 
may sometimes lead to a possibly fatal case of bacteraemia. In many studies it 
has been shown that E. coli is the most common pathogen responsible for 
Gram-negative bacteraemia. Previous work with UPEC paired urine and 
bloodstream isolates revealed identical results for molecular typing and 
virulence gene content. However, different antibiotic susceptibility and metabolic 
activity profiles indicated phenotypic changes, potentially due to SNPs or 
epigenetic events.  
Functional annotation enrichment analysis of differentially expressed 
proteins indicated up-regulation in pathways linked to aerobic respiration, 
peptidoglycan-based cell wall structure, cofactor binding, and magnesium ion 
binding. Down-regulated genes in a number of blood isolates were involved in 
carbohydrate catabolic process and aminobutyraldehyde dehydrogenase 
activity. Biological processes related to organelle proteins, including the two 
lipid bilayers, were also altered. 
The current study revealed that strains of some STs have a higher 
metabolic potential that could provide more virulence advantages. The study 
also indicted that one isolate in a pair displayed a different proteomic profile to 
the other member of the pair, for some STs. However, in other STs, minimal 




6.3 What metabolic adaptations of UPEC took place during 
infection of the epithelial cells? 
The point at which UPEC invade the epithelial cells in the bladder and 
kidney is significant, as it determines the intracellular colonization and possibly 
further dissemination into the bloodstream, respectively. 
While investigating UPEC ST127 pathogenicity during infection, 
proteomics revealed upregulation in the pentose phosphate and 
glycolysis/gluconeogenesis pathways in UPEC EC18 (an O-antigen deficient 
mutant). These two pathways could be important routes of carbon flux through 
the central metabolic pathways during growth in urine. Co-culture of UPEC 
SA189 with uroepithelial cells HT1197 cells leads to exfoliation effects in 
HT1197 not seen with other UPEC strains. Analysis of the UPEC SA189 
secretome revealed highly abundant bacterial proteins, including hemolysin A. 
These data suggest that not all isolates of the same ST necessarily mediate UTI 
using the same mode of action.  
This work has demonstrated the potential of whole proteome profiling for 
investigating host-pathogen interactions. The approach can be applied to 
investigate future co-cultured sets involving UPEC form different STs and 







6.4 Future directions 
Following this work, to understand in more detail the different virulence of 
EC18 in GML, mutational analysis will be the recommended direction to follow 
in order to investigate some of these essential genes. A high-density 
transposon mutagenesis method (e.g. TraDIS) could be used (Goh et al., 2017; 
Hadjifrangiskou et al., 2012). This step will identify genes that are essential for 
growth and virulence in GML and these may represent targets for development 
of novel vaccines or therapies to prevent and treat UTI. Moreover, generating a 
recombinant strain of EC18 and attempting to restore the function of the O 
antigen could help us to understand its function in pathogenesis of this strain.  
In addition, biofilm studies could be a useful confirmatory assay to 
distinguish between the three strains of UPEC ST127 (EC18, EC41, and 
SA189). As described above, O antigen mutation should have no effect on 
biofilm formation (Demirdjian et al., 2017), but it may affect the motility. In 
addition, study of biofilm formation in LB versus AUM should give insight into 
the capability of these strains to cause catheter related UTI. 
Moreover, another approach can be followed regarding the data analysis 
in this study. As mentioned earlier, we processed both fractions of proteins 
(soluble and insoluble) separately. However, we pooled data for both fractions 
as one sample for full analysis. Analysing the data sets of both fractions 
individually may give a deeper insight into the proteome profile of UPEC ST127. 
Another approach that can be followed is to perform multiple reaction 
monitoring (MRM), a targeted proteomic analysis, to confirm the changes in 
expression of some key proteins (Banaei-Esfahani et al., 2017). 
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In order to have a more global representation of UPEC STs, we could 
include addition of a representative strain for each ST into the proteomic 
profiling. For example, UPEC ST131 reference strain EC958 (Forde et al., 
2014); UPEC ST127 reference strain 536 (Hochhut et al., 2006); UPEC ST73 
reference strain CFT073 (Welch et al., 2002); UPEC ST38 reference strain 
MRSN 346647 (Snesrud et al., 2017). This approach would enable similarities 
between the isolates (e.g. paired isolates) and their representative reference 
strain with respect to proteomic profile, and therefore would enable a more 
complete representation of the major lineages of UPEC causing UTI and 
bacteraemia. 
Another direction that could give us a complete comparison of the major 
lineages of UPEC is to compare the urine isolates growing in AUM (not pooled 
human urine for standardization purposes) and the blood isolates growing in 
blood (Berendsen et al., 2017; Dubourg et al., 2019). This approach could give 
information about how members of each ST react in its original (isolation) 
environment.   
Secretome analysis of the UPEC ST127 strains during infection in the in 
vivo G. mellonella model could be used to explore further the mechanism by 
which the bacteria can establish infection in this model. This may help explain 
why strain EC18 does not kill the larvae, when most other ST127 strains do. 
How relevant this model is to UTI, however, remains to be seen as strain EC18 
was recovered from a case of urosepsis.   
The observed link between HlyA and paxillin in this work is notable and 
exploring the paxillin protein cascade pathway and its related proteins could 
explain the mechanism by which UPEC SA189 was able to induce the cells to 
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lyse, in contrast to the other UPEC isolates. Seemingly important, the 
identification and classification of host receptors and signalling factors, which 
encourage adherence and invasion of host tissue cells by UPEC isolates, could 
explain the susceptibility of some people to acquire UTIs. For example, the 
novel mannoside FimH inhibitors were used to interfere with cell attachment 
and prevent the occurrence of UTI (Totsika et al., 2013). These findings could, 
hypothetically, lead to identification of novel targets for therapeutic applications 
to prevent or treat UTI. 
Furthermore, additional validation assays such as an invasion assay and 
TEM are suggested for further confirmatory work regarding UPEC SA189 mode 
of action toward the uroepithelial cells. 
Nevertheless, the work generated during this project has highlighted the 
significance of using proteomic approaches in bacterial pathogenesis studies. 
Proteomic tools are not just used as a confirmatory assay for specific proteins of 
interest. On the contrary, they can be used as an investigative and screening 
tool for studying the whole bacterial proteome in different scenarios, starting 
from bacterial metabolic adaptation in various environments through to host-
pathogen interactions. The scientific interest that this project has received, 




























Appendix I: Intersecting proteins from up-regulated and down-regulated proteins in figure 3.12. 













EC18, EC41 and SA189  57 
rpsB, queA, apt, rimO, serS, proQ, upp, murA, nanA, fis, rpoA, rpsD, rpsM, 
rpsE, rpsH, rpsN, rplE, rpsC, rpsJ, glyQ, rpoZ, rplJ, rplI, rpsT, tsf, gpt, asnS, 
dut, pfkA, rpmE, rplK, rplA, cspE, ansB, eda, glpX, cspA, ybiS, frdB, suhB, 
yiaF, rplW, galU, nusA, seqA, rpsA, secG, UTI89_C1228, Rph, kdsA, frdA, 
yeeX, yeaD, gloA, adhE, nfsA, rlpA 
EC18 and EC41  15 HemL, mnmA, accD, yajQ, deoD, infC, hslO, greA, slyD, sspA, fabG, rna, mukE, fdx, potD 
EC18 and SA189  23 pyrH, proS, proA, yeiP, pyrG, rpsI, rpsK, tuf1, fusA, glyS, efp, rpoC, rpsR, ybiT, nusG, yceD, dcuA, menB, dacA, ffh, gltX, pheT, pal 
EC41 and SA189  122 
rapA, proB, thiI, glnS, prfA, ynfB, thrS, aspS, cdd, rbn, glk, ispG, rnc, grcA, 
rplS, rim, eno, pgk, rpsO, rbfA, def, rplQ, rplO, rplX, rplV, rplD, rpsG, rpsL, 
gpmI, hldD, glmU, rsmG, mnmG, ubiE, tpiA, rpoB, pgi, prfC, infA, tyrS, argS, 
rpiA, metK, rpmC, aroK, rpmH, rplL, deoA, prfB, pheS, leuS, deoC, ileS, ptsI, 
pflB, glpQ, typA, ackA, yebC, yeeN, lysS, lysU, ompW, UTI89_C2572, ftnA, 
gapA, glnA, hpt, ptsH, yagU, yciN, cydA, cydB, hybC, stpA, mprA, yecF, 
UTI89_C2931, pykF, yibL, ybaU, phnA, sodB, yhbY, tdcF, rsmE, udp, glmS, 
yjjA, pspE, rffA, psuG, tdcG, gmk, yggS, nrdB, dhaK, UTI89_C1792, napA, 
metG, yqhD, pdxJ, ddlA, talB, valS, treC, yihD, glpD, malP, yhgF, ansB, tktA, 















EC18, EC41 and SA189  68 
yaeH, iraP, gpmA, UTI89_C1067, efeO, maeA, ndk, glyA, tdh, atpD, atpG, 
fbp, uxuA, sucC, purC, atpA, purH, mtlA, pfkB, uspF, cysE, lpdA, yccJ, kbl, 
aroG, hflK, gltA, cysK, hemY, lrp, crp, ecnB, ygaU, yajC, mglB, hisJ, moaB, 
sucD, ppsA, metQ, yciK, nuoF, fdoG, uxuB, yadF, yqjD, maeB, sthA, mdh, 
nuoC, asd, pckA, carB, carA, yjjK, malE, hemX, prlC, yhdH, tolC, mppA, 
oppA, icdA, pepN, artI, nagE, degP, acnB 
EC18 and EC41  26 
pepA, fabZ, ribH, iscS, atpE, rpmF, gldA, fdoH, purB, hupB, uspA, ppiA, 
yhbH, rnr, yhjJ, clpB, gadB, cobB, groL, malK, uspG, slp, nuoG, ydjA, dcp, 
trxB 
EC18 and SA189  33 
yaiE, ribB, plsB, dps, eco, tnaA, psd, gcvT, panC, lepB, ushA, yeaF, cspD, 
lpoB, bolA, elbB, ahpC, yieF, thiB, narP, fkpA, pgl, cysQ, gor, ygiC, sseA, 
UTI89_C2206, osmE, rne, agp, aspC, ybiB, modA 
EC41 and SA189  42 
nagB, nuoK, nuoB, mscL, rhlB, bamA, ihfB, ihfA, recA, atpC, atpH, atpF, 
topA, dacC, tpx, fur, ybeZ, arcA, ompR, hflC, cyoA, dksA, sdhA, ivy, narL, 
nuoE, sucA, sucB, rnk, ssb, fadL, dsbG, UTI89_C1651, sodA, purL, pyrC, 
traT, yfdQ1, ydgA, ydeN, UTI89_C1031, sdhB 
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Appendix II: Data correlation of label free quantification (LFQ) of three 
biological replicates of paired UPEC isolates grown in LB. all correlations are 
significant (≥ 0.9). 
Sample 
Correlation of biological replicates  
1 and 2 1 and 3 2 and 3 
EC1 U 0.951 0.961 0.965 
EC10 U 0.962 0.969 0.953 
EC18 U 0.979 0.945 0.929 
EC41 U 0.959 0.927 0.927 
EC22 U 0.954 0.968 0.966 
EC73 U 0.956 0.970 0.965 
EC47 U 0.955 0.966 0.956 
EC86 U 0.961 0.974 0.957 
EC1 B 0.973 0.968 0.964 
EC10 B 0.965 0.969 0.965 
EC18 B 0.976 0.939 0.954 
EC41 B 0.976 0.951 0.953 
EC22 B 0.924 0.942 0.933 
EC73 B 0.962 0.970 0.953 
EC47 B 0.960 0.966 0.973 
EC86 B 0.964 0.972 0.956 
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Appendix III: Intersecting proteins from up-regulated and down-regulated proteins in figure 4.4. 













ST127 and ST73 12 
mug, frdD, rpmC, rpmH, fdoH, elaB, nuoG, ydcY, gpr, malP, glpT, 
ydcH 
ST131, ST127, and ST73 3 phoU, nupG, slyB 
ST127, ST73, and ST38  2 exbB, sodC 














ST127 and ST73  5 slyD, folP, gsk, baeR, UTI89_C1522 












(>= 0 bp) 
# contigs (>= 
1000 bp) 
Total length 
(>= 0 bp) 
Total length (>= 
1000 bp) # contigs 
Largest 
contig Total length GC (%) N50 N75 L50 L75 
# N's per 
100 kbp 
EC1U 238 125 5259561 5205625 178 346928 5243127 50.79 191087 109319 11 21 0.00 
EC1BC 172 93 5319155 5273012 145 710931 5311228 50.79 263041 116284 7 14 0.00 
EC10U 128 71 5314278 5288069 88 611843 5300795 50.65 204841 151505 9 17 0.00 
EC10BC 390 325 10109725 10076909 352 655261 10097256 57.89 83546 27796 25 81 0.00 
EC18U 194 67 4938441 4875836 110 557129 4904929 50.65 203407 77181 9 18 0.00 
EC18BC 216 71 4963854 4893504 115 557129 4923453 50.64 190721 77181 9 19 0.00 
EC41U 170 80 5304098 5259454 114 786064 5282179 50.53 170883 102403 9 19 0.00 
EC41BC 157 65 5266795 5222096 99 786064 5244259 50.52 185544 110925 8 17 0.00 
EC22U 128 80 5135902 5110130 103 468496 5127472 50.53 202690 107883 9 17 0.00 
EC22BC 165 77 5146678 5114116 98 468602 5129491 50.54 234838 113556 9 16 0.00 
EC73U 181 80 5138186 5102693 104 806262 5120183 50.51 287488 120801 6 13 0.00 
EC73BC 2875 587 5988688 5400431 781 104403 5537324 50.67 23196 10625 72 157 0.05 
EC47U 174 99 5250645 5216218 121 413278 5231387 50.55 148279 86740 11 22 0.00 
EC47BC 167 89 5308622 5270159 115 676219 5289073 50.52 149666 87439 10 21 0.00 
EC86U 215 100 5196477 5158203 120 452732 5173971 50.56 134514 65691 13 27 0.00 
EC86BC 163 98 5235202 5200661 128 541598 5223729 50.55 149015 65691 10 22 0.02 
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Appendix V: Pathway enrichment of UPEC ST127 clusters. 
Cluster 
No. Pathway ID Pathway description 
Gene 




340 Histidine metabolism 3 0.00236 hisA,hisB,hisG 
1100 Metabolic pathways 18 0.00236 atpB,gabD,gadB,gmd,hisA,hisB,hisG,ispF,pntB,pyrB,pyrI,speF,thrA,thrC,uxaA,uxaC,uxuA,uxuB 
40 Pentose and glucuronate interconversions 4 0.00284 uxaA,uxaC,uxuA,uxuB 
250 Alanine, aspartate and glutamate metabolism 4 0.00445 gabD,gadB,pyrB,pyrI 
1137 680 Methane metabolism 3 0.0447 fdoG,gpmA,gpmB 
1139 IPR027417 P-loop containing nucleoside triphosphate hydrolase 10 0.0287 clpX,ffh,ftsE,gmk,hda,lolD,obg,rhlB,udk,ybiT 
11
46
 480 Glutathione metabolism 4 0.00426 btuE,gnd,gshA,gsp 
1100 Metabolic pathways 22 0.00426 add,atpH,cdd,dapE,dapF,epd,folE,glk,glmS,glyA,gnd,gshA,gsp,ilvD,manA,murD,nadE,nuoB,pgk,purC,thyA,tyrB 
11
47























190 Oxidative phosphorylation 7 0.00715 atpG,nuoC,nuoG,nuoI,nuoJ,nuoN,ppk 
260 Glycine, serine and threonine metabolism 6 0.0168 gcvH,gcvP,gcvT,lysC,pssA,sdaB 
564 Glycerophospholipid metabolism 5 0.0296 glpB,glpD,glpQ,psd,pssA 
1120 Microbial metabolism in diverse environments 16 0.0296 
ack,cysK,cysQ,dld,fdnH,fruA,fucI,fucO,gltB,lysC,mdh,mgsA,napA,pfkB,pps
A,usg 
2060 Phosphotransferase system (PTS) 7 0.0296 fruA,manX,manZ,nagE,ptsH,ptsI,ptsN 
51 Fructose and mannose metabolism 6 0.0452 fruA,fucI,manX,manZ,mtlD,pfkB 
620 Pyruvate metabolism 6 0.0452 ack,dld,fucO,mdh,mgsA,ppsA 










3010 Ribosome 15 9.18E-08 rplC,rplE,rplM,rplR,rplT,rpmA,rpmB,rpmC,rpmD,rpmG,rpsD,rpsL,rpsN,rpsP,rpsS 
970 Aminoacyl-tRNA biosynthesis 9 1.03E-05 epmA,gltX,lysS,lysU,metG,pheS,thrS,trpS,tyrS 
1120 Microbial metabolism in diverse environments 28 3.67E-05 
accC,accD,aceE,aphA,asd,aspC,dapD,fba,fdnG,fdoH,frdD,gapA,glnA,hybC
,ldhA,lpdA,nemA,pgl,phnA,ppc,pta,pykF,rpiA,serC,sseA,tktA,tolQ,zwf 









190 Oxidative phosphorylation 9 0.000631 atpA,atpC,atpE,atpF,cydB,frdD,ndh,nuoF,nuoL 
620 Pyruvate metabolism 10 0.000695 accC,accD,aceE,frdD,ldhA,lpdA,ppc,pta,pykF,tdcE 
30 Pentose phosphate pathway 8 0.000782 deoB,deoC,fba,pgl,rbsK,rpiA,tktA,zwf 
1230 Biosynthesis of amino acids 14 0.00892 aroC,aroD,aroG,asd,aspC,dapD,fba,gapA,glnA,pykF,rpiA,sdaA,serC,tktA 
230 Purine metabolism 11 0.00915 adk,deoB,deoD,dnaN,guaC,nrdA,nrdB,ppx,purL,pykF,ushA 
240 Pyrimidine metabolism 9 0.011 dcd,deoA,deoD,dnaN,nrdA,nrdB,udp,upp,ushA 
460 Cyanoamino acid metabolism 3 0.0114 ansA,ansB,bglX 
10 Glycolysis / Gluconeogenesis 7 0.0175 aceE,bglA,crr,fba,gapA,lpdA,pykF 








20 Citrate cycle (TCA cycle) 8 1.29E-06 c0805,fumB,icdA,sdhA,sdhB,sucA,sucB,sucD 
1200 Carbon metabolism 14 2.79E-06 c0805,folD,frdB,fumB,glpX,gpmI,icdA,pfkA,prs,sdhA,sdhB,sucA,sucB,sucD 
1110 Biosynthesis of secondary metabolites 21 7.26E-06 
c0805,dxs,frdB,fumB,galE,galK,galM,galT,glpX,gpmI,gpt,hemB,icdA,pfkA,pr
s,sdhA,sdhB,sucA,sucB,sucD,trpB 
1120 Microbial metabolism in diverse environments 16 0.000607 
c0805,folD,frdB,fumB,galM,glpX,gpmI,icdA,narH,pfkA,prs,sdhA,sdhB,sucA,
sucB,sucD 
61 Fatty acid biosynthesis 4 0.00321 c1187,fabD,fabH,fabI 
52 Galactose metabolism 5 0.0152 galE,galK,galM,galT,pfkA 
190 Oxidative phosphorylation 5 0.0152 cyoA,cyoB,frdB,sdhA,sdhB 
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3010 Ribosome 28 3.56E-22 rplA,rplB,rplD,rplF,rplI,rplK,rplL,rplN,rplO,rplP,rplQ,rplS,rplV,rplX,rplY,rpsA,rpsB,rpsC,rpsE,rpsF,rpsG,rpsH,rpsJ,rpsK,rpsM,rpsR,rpsT,rpsU 







970 Aminoacyl-tRNA biosynthesis 12 8.21E-09 argS,asnS,aspS,cysS,fmt,glyS,hisS,ileS,leuS,proS,serS,valS 
240 Pyrimidine metabolism 15 5.68E-06 carB,dut,ndk,nrdD,pnp,pyrG,pyrH,rpoA,rpoB,rpoC,rpoZ,tdk,tmk,trxB,ydfG 
230 Purine metabolism 16 6.26E-05 apt,c0775,guaA,guaB,hpt,ndk,nrdD,pnp,purA,purB,purD,pykA,rpoA,rpoB,rpoC,rpoZ 




3020 RNA polymerase 4 8.56E-05 rpoA,rpoB,rpoC,rpoZ 
1200 Carbon metabolism 17 0.000737 accA,accB,cysE,eda,eno,fbp,fdhF,frdA,frdC,frmA,fumA,kdgK,pckA,pgi,pykA,talB,tpiA 
10 Glycolysis / Gluconeogenesis 9 0.00258 agp,c0775,eno,fbp,frmA,pckA,pgi,pykA,tpiA 
61 Fatty acid biosynthesis 5 0.00524 accA,accB,fabA,fabB,fabF 
550 Peptidoglycan biosynthesis 6 0.00524 ddlA,ddlB,mrcA,murA,murC,murF 
3018 RNA degradation 5 0.00672 dnaK,eno,groL,pnp,rne 













3060 Protein export 5 0.0104 ftsY,secA,secD,secY,yidC 
520 Amino sugar and nucleotide sugar metabolism 8 0.0134 c0775,galU,glmM,glmU,murA,nanA1,nanE,pgi 
1120 Microbial metabolism in diverse environments 23 0.0134 
accA,accB,agp,c0775,cysE,dapA,eda,eno,fbp,fdhF,frdA,frdC,frmA,fumA,kd
gK,narG,nfnB,nirB,pckA,pgi,pykA,talB,tpiA 
620 Pyruvate metabolism 8 0.0213 accA,accB,frdA,frdC,fumA,gloA,pckA,pykA 
1212 Fatty acid metabolism 5 0.026 accA,accB,fabA,fabB,fabF 
30 Pentose phosphate pathway 6 0.0307 c0775,eda,fbp,kdgK,pgi,talB 
562 Inositol phosphate metabolism 2 0.0372 suhB,tpiA 
Appendix VI: Data correlation of label free quantification (LFQ) of three 
biological replicates of uroepithelial cells co-cultured with E. coli strains. all 
correlations are significant (≥ 0.9). 
Sample 
Correlation of biological replicates  
1 and 2 1 and 3 2 and 3 
HT1197 control 0.972 0.960 0.974 
K12 co-culture 0.983 0.968 0.985 
EC18 co-culture 0.967 0.949 0.982 
EC41 co-culture 0.960 0.937 0.976 


















Appendix VII: CD containing the proteomics data of all chapters in the thesis in 
the following files: 
• Chapter 3 proteomics Data. 
• Chapter 4 proteomics Data. 
• Chapter 5.1 Bacterial proteomics Data. 
• Chapter 5.2 Secretome Data. 
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